Processing 00000000.tx.1: 15-Deoxy-12,14-Prostaglandin J2 Protects against Nitrosative PC12 Cell Death through Up-regulation of Intracellular Glutathione Synthesis* So-Young Lim, Jung-Hee Jang, Hye-Kyung Na, Shelly C. 

Phrase: "15-Deoxy-12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "14-Prostaglandin J2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "Protects against Nitrosative PC12 Cell Death"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0007587:Cell Death [Cell Function]
   790   C0085262:PC12 Cell [Cell]
           PC-12
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "through Up-regulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0041904:Up-Regulation [Cell Function,Molecular Function]
  1000   C0162493:Up-Regulation [Genetic Function]
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]
   861   C1327622:Regulation [Biologic Function]

Phrase: "of Intracellular Glutathione Synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1157234:glutathione synthesis [Molecular Function]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: "* So-Young Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449205:LIM [Body Location or Region]
   827   C1538613:LIM [Gene or Genome]

Phrase: "Jung-Hee Jang,"

Phrase: "Hye-Kyung Na,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1272460:{NA} [Qualitative Concept]

Phrase: "Shelly C."
Processing 00000000.tx.2: Lu, Irfan Rahman||, and Young-Joon Surh** From the College of Pharmacy, Seoul National University, Seoul 151-742, Korea, the Division of Gastrointestinal and Liver Disease, USC Research Center for Liver Disease, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, and the ||Department of Environmental Medicine, Division of Lung Biology and Disease, University of Rochester Medical Center, Rochester, New York 14642 Received for publication, June 11, 2004 , and in revised form, August 11, 2004.  

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "Irfan Rahman||,"

Phrase: "and"

Phrase: "Young-Joon Surh"

Phrase: "*"

Phrase: "*"

Phrase: "From the College"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0557806:College [Manufactured Object]

Phrase: "of Pharmacy,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031322:Pharmacy [Health Care Related Organization]
  1000   C0031336:Pharmacy [Biomedical Occupation or Discipline]
  1000   C3244303:pharmacy [Intellectual Product]

Phrase: "Seoul National University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C3245503:national [Intellectual Product]

Phrase: "Seoul 151-742,"

Phrase: "Korea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: "the Division of Gastrointestinal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1293097:Division [Therapeutic or Preventive Procedure]
   770   C2919030:Division [Organization]
   770   C2919031:Division [Activity]

Phrase: "and"

Phrase: "Liver Disease,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0023895:Liver disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "USC Research Center for Liver Disease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0683939:research center [Manufactured Object,Organization]
   753   C0205099:Center [Spatial Concept]

Phrase: "Keck School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036375:School [Manufactured Object,Organization]

Phrase: "University of Southern California,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0006754:California [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1710133:Southern [Spatial Concept]
   812   C3146274:California [Plant]

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "California 90033,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006754:California [Geographic Area]
   861   C3146274:California [Plant]

Phrase: "and"

Phrase: "the ||Department of Environmental Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Division of Lung Biology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1293097:Division [Therapeutic or Preventive Procedure]
   770   C2919030:Division [Organization]
   770   C2919031:Division [Activity]

Phrase: "and"

Phrase: "Disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "University of Rochester Medical Center,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Rochester,"

Phrase: "New York 14642"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "June 11,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "August 11,"

Phrase: "2004."
Processing 00000000.tx.3: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Nitrosative stress with subsequent inflammatory cell death has been associated with many neurodegenerative disorders. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Nitrosative stress with subsequent inflammatory cell death"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0038435:Stress [Finding]

Phrase: "has"

Phrase: "been"

Phrase: "associated with many neurodegenerative disorders."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   806   C1522560:Neurodegenerative Disorders [Functional Concept]
   797   C1292726:associated disorders [Functional Concept]
   760   C0012634:Disorders [Disease or Syndrome]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.4: Expression of inducible nitric-oxide synthase and production of nitric oxide (NO) have been frequently elevated in many inflammatory disorders. 

Phrase: "Expression of inducible nitric-oxide synthase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
   716   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   716   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "production of nitric oxide (NO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "have"

Phrase: "been"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "elevated in many inflammatory disorders."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1290884:Inflammatory disorder [Disease or Syndrome]
   760   C0012634:Disorders [Disease or Syndrome]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0333348:Inflammatory [Functional Concept]
   760   C3163633:Elevated [Qualitative Concept]
Processing 00000000.tx.5: NO can rapidly react with superoxide anion, producing more reactive peroxynitrite. 

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "can"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "react with superoxide anion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   770   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "producing"

Phrase: "more reactive peroxynitrite."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]
Processing 00000000.tx.6: In the present study, exposure of rat pheochromocytoma (PC12) cells to the peroxynitrite donor 3-morpholinosydnonimine hydrochloride (SIN-1) induced apoptosis, which accompanied depletion of intracellular glutathione (GSH), c-Jun N-terminal kinase activation, mitochondrial membrane depolarization, the cleavage of poly(ADP-ribose)polymerase, and DNA fragmentation. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "exposure of rat pheochromocytoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]

Phrase: "(PC12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085262:PC-12 [Cell]
  1000   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "cells to the peroxynitrite donor 3-morpholinosydnonimine hydrochloride"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(SIN-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]

Phrase: ")"

Phrase: "induced apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "which"

Phrase: "accompanied"

Phrase: "depletion of intracellular glutathione"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333668:Depletion [Functional Concept]

Phrase: "(GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "c-Jun N-terminal kinase activation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C1879547:Activation [Activity]
   780   C0248813:c-jun N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   780   C0380051:c-JUN N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1367731:JUN N-terminal kinase [Gene or Genome]
   719   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mitochondrial membrane depolarization,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1816452:mitochondrial membrane depolarization [Cell Function]
           mitochondrial depolarisation
   901   C1816453:membrane depolarization [Cell Function]
   734   C0596952:Mitochondrial membrane [Cell Component]

Phrase: "the cleavage of poly(ADP-ribose)polymerase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "DNA fragmentation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376669:DNA Fragmentation [Molecular Function]
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]
Processing 00000000.tx.7: During SIN-1-induced apoptotic cell death, expression of inducible cyclooxygenase (COX-2), and peroxisome proliferator-activated receptor- (PPAR) was elevated. 

Phrase: "During SIN-1-induced apoptotic cell death,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0162638:apoptotic cell death [Cell Function]
   827   C0007587:Cell Death [Cell Function]
   799   C0007634:Cell [Cell]
   799   C0011065:Death [Organism Function]
   799   C1269647:Cell [Cell]
   799   C1306577:Death, NOS [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "expression of inducible cyclooxygenase (COX-2),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "peroxisome proliferator-activated receptor- (PPAR)"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "was"

Phrase: "elevated."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]
Processing 00000000.tx.8: SIN-1 treatment resulted in elevated production of 15-deoxy-12,14-prostaglandin J2 (15d-PGJ2), an endogenous PPAR activator. 

Phrase: "SIN-1 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "resulted in elevated production of 15-deoxy-12,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0033268:production [Occupational Activity]
   744   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]
   744   C0205250:Elevated [Qualitative Concept]
   744   C3163633:Elevated [Qualitative Concept]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "14-prostaglandin J2 (15d-PGJ2),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "an endogenous PPAR activator."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
Processing 00000000.tx.9: Preincubation with 15d-PGJ2 rendered PC12 cells resistant to nitrosative stress induced by SIN-1. 

Phrase: "Preincubation with 15d-PGJ2"

Phrase: "rendered"

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "resistant to nitrosative stress induced"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "by SIN-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]
Processing 00000000.tx.10: 15d-PGJ2 fortified an intracellular GSH pool through up-regulation of glutamylcysteine ligase, thereby preventing cells from SIN-1-induced GSH depletion. 

Phrase: "15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "fortified"

Phrase: "an intracellular GSH pool through up-regulation of glutamylcysteine ligase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0337051:Pool [Geographic Area]
   739   C1509144:pool [Clinical Attribute]
   739   C2349200:Pool [Functional Concept]

Phrase: "thereby preventing cells from SIN-1-induced GSH depletion."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.11: The above findings suggest that 15d-PGJ2 may act as a survival mediator capable of augmenting cellular thiol antioxidant capacity through up-regulation of the intracellular GSH synthesis in response to the nitrosative insult.  

Phrase: "The above findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "may"

Phrase: "act as a survival mediator"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0038952:Survival [Activity]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0220921:survival [Functional Concept]
   760   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "capable of augmenting cellular thiol antioxidant capacity"

Phrase: "through up-regulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0041904:Up-Regulation [Cell Function,Molecular Function]
  1000   C0162493:Up-Regulation [Genetic Function]
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]
   861   C1327622:Regulation [Biologic Function]

Phrase: "of the intracellular GSH synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to the nitrosative insult."
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Inflammation is a central feature of neurodegenerative disorders, such as Alzheimer's disease, stroke, and neurovascular disease (1, 2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "is"

Phrase: "a central feature of neurodegenerative disorders,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "such as Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "stroke,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038454:Stroke [Disease or Syndrome]

Phrase: "and"

Phrase: "neurovascular disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: In Alzheimer tissue, pro-inflammatory enzymes, such as cyclooxygenase-2 (COX-2)1 and inducible nitric-oxide synthase (iNOS), are notably up-regulated (3, 4). 

Phrase: "In Alzheimer tissue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "pro-inflammatory enzymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "such as cyclooxygenase-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0387583:Cyclo-Oxygenase II [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367485:CYCLOOXYGENASE 2 [Gene or Genome]
  1000   C1565860:Cyclo-Oxygenase-2 [Amino Acid, Peptide, or Protein,Enzyme]
           Cyclooxygenase
   861   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(COX-2)1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0389003:Cyclo-Oxygenase I [Amino Acid, Peptide, or Protein,Enzyme]
           Cyclooxygenase
  1000   C1335271:CYCLOOXYGENASE 1 [Gene or Genome]
   861   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1565860:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "inducible nitric-oxide synthase (iNOS),"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "are"

Phrase: "notably"

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.14: Excessive nitric oxide (NO) production is considered as one of the main causes of neuronal cell death (5). 

Phrase: "Excessive nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ")"

Phrase: "production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "considered as one of the main causes of neuronal cell death"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   775   C2754100:neuronal cell death [Cell Function]
           neuron death
   770   C0007465:Causes of Death [Finding]
           Death Causes
   759 E C0804771:Cause of death [Clinical Attribute]
   756   C0007587:Cell Death [Cell Function]
   738   C0007634:Cell [Cell]
   738   C0011065:Death [Organism Function]
   738   C0015127:causes [Functional Concept]
   738   C0205225:Main [Qualitative Concept]
   738   C0205447:One [Quantitative Concept]
   738   C0521390:Neuronal [Immunologic Factor]
   738   C0750591:considered [Idea or Concept]
   738   C1269647:Cell [Cell]
   738   C1306577:Death, NOS [Finding]
   738   C1314792:Causes [Functional Concept]
   738   C1542147:Main [Qualitative Concept]
   738   C1704653:Cell [Medical Device]
   738   C1948049:Cell [Spatial Concept]
   704 E C1524003:Cause [Conceptual Entity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.15: Many studies suggest that the cytotoxic effect of NO is mediated via peroxynitrite formed by the reaction between NO and superoxide anion () (6, 7). 

Phrase: "Many studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the cytotoxic effect of NO"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   753   C1280500:Effect [Qualitative Concept]
   753   C1511636:cytotoxic [Functional Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "mediated via peroxynitrite"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]

Phrase: "formed by the reaction"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0205431:Formed [Functional Concept]
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "between NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "superoxide anion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   861   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "("

Phrase: ")"

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.16: The level of 3-nitrotyrosine, a relatively specific marker of nitrosative damage caused by peroxynitrite, has been reported to increase in Alzheimer's disease as well as other neurodegenerative disorders (8). 

Phrase: "The level of 3-nitrotyrosine,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0456949:Level 3 [Intellectual Product]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "a relatively specific marker of nitrosative damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0005516:Marker [Clinical Attribute]

Phrase: "caused by peroxynitrite,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase in Alzheimer's disease"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   777   C0277564:Acquired disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0442805:Increase [Functional Concept]
   715 E C1517378:Gain [Quantitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "as well as"

Phrase: "other neurodegenerative disorders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.17: Up-regulation of COX has also been frequently observed in patients with neurological symptoms (9). 

Phrase: "Up-regulation of COX"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0041904:Up-Regulation [Cell Function,Molecular Function]
   833   C0162493:Up-Regulation [Genetic Function]
   770   C0547043:Up [Spatial Concept]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1282911:Up [Spatial Concept]
   770   C1327622:Regulation [Biologic Function]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "observed in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1441672:Observed [Functional Concept]

Phrase: "with neurological symptoms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0235031:neurological symptoms [Sign or Symptom]
   861   C0683368:symptoms [Functional Concept]
   861   C1457887:Symptoms [Sign or Symptom]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.18: COX is a rate-limiting enzyme responsible for the synthesis of a series of prostaglandins (PGs) and thromboxanes that have multiple physiological functions. 

Phrase: "COX"

Phrase: "is"

Phrase: "a rate-limiting enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "responsible for the synthesis of a series of prostaglandins (PGs)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "thromboxanes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040061:Thromboxanes [Biologically Active Substance,Eicosanoid]

Phrase: "that"

Phrase: "have"

Phrase: "multiple physiological functions."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0542341:Functions [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.19: Two isoforms of COX have been described: COX-1 and COX-2. 

Phrase: "Two isoforms of COX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ":"

Phrase: "COX-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0389003:COX-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "COX-2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1565860:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.20: COX-1 is ubiquitously expressed in most tissues and produces prostanoids that are involved in maintaining homeostatic functions. 

Phrase: "COX-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0389003:COX-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "ubiquitously"

Phrase: "expressed in most tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0040300:Tissues [Tissue]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "produces"

Phrase: "prostanoids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0033554:Prostanoids [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   966 E C1623719:Prostanoid [Biologically Active Substance,Lipid]

Phrase: "that"

Phrase: "are"

Phrase: "involved in maintaining homeostatic functions."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0019868:homeostatic [Biologic Function]
           Homeostasis, function
   760   C0542341:Functions [Functional Concept]
   760   C1314939:Involved [Functional Concept]
   726   C0024501:Maintain [Activity]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.21: COX-2 is induced under proinflammatory conditions and can mediate deleterious effects in the neurodegenerative disorders (9, 10). 

Phrase: "COX-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1565860:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "induced under proinflammatory conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205263:Induced [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "can"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "deleterious effects in the neurodegenerative disorders"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.22: However, the role of COX-2 in neuronal cell death is conflicting. 

Phrase: "However,"

Phrase: "the role of COX-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in neuronal cell death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2754100:neuronal cell death [Cell Function]
           neuron death
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "conflicting."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009671:conflicting [Individual Behavior]
   966 E C1705242:Conflict [Qualitative Concept]
Processing 00000000.tx.23: As prolonged intake of non-steroidal anti-inflammatory drugs (NSAIDs) with COX-2 inhibitory effects has been reported to reduce the risk of Alzheimer's disease and delay its onset (2, 11), a number of studies have focused on the neuroprotective effects of NSAIDs. 

Phrase: "As prolonged intake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512806:Intake [Functional Concept]

Phrase: "of non-steroidal anti-inflammatory drugs (NSAIDs)"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   991   C3536840:Non-steroidal Antiinflammatory Drug [Pharmacologic Substance]
   988 E C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   937   C0003212:steroidal anti-inflammatory drugs [Pharmacologic Substance,Steroid]
   884   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   840   C1515999:Anti-inflammatory [Qualitative Concept]
   839   C0260264:Steroid drugs [Steroid]
   804   C0013227:Drugs [Pharmacologic Substance]
   804   C0333348:Inflammatory [Functional Concept]
   804   C1518422:Non [Functional Concept]
   771 E C1254351:Drug [Pharmacologic Substance]
   733 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   733   C0038317:Steroid [Steroid]
   733 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   704 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "with COX-2 inhibitory effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "delay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205421:Delay [Temporal Concept]

Phrase: "its onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "11"

Phrase: ")"

Phrase: ","

Phrase: "a number of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "focused on the neuroprotective effects of NSAIDs."
Meta Candidates (Total=23; Excluded=5; Pruned=0; Remaining=18)
   812   C3536840:Non-steroidal Antiinflammatory Drug [Pharmacologic Substance]
   809 E C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   797   C0003212:steroidal anti-inflammatory drugs [Pharmacologic Substance,Steroid]
   775   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   761   C0728866:effect of drugs [Functional Concept]
           drug effects
   756   C0815279:Neuroprotective Effects [Functional Concept]
   756   C1515999:Anti-inflammatory [Qualitative Concept]
           Anti-inflammatory effect
   755   C1516019:Antiinflammatory Effect [Physiologic Function]
   754   C0242912:Neuroprotective Drugs [Pharmacologic Substance]
   738   C0013227:Drugs [Pharmacologic Substance]
   738   C0205234:Focused [Spatial Concept]
   738   C0333348:Inflammatory [Functional Concept]
   738   C1280500:effects [Qualitative Concept]
   738   C1285542:focused [Functional Concept]
   738   C1518422:Non [Functional Concept]
   721 E C0728867:Drug effect [Pathologic Function]
   721 E C1411996:drug effect [Biologic Function]
   718   C0260264:Steroid drugs [Steroid]
   704 E C1254351:Drug [Pharmacologic Substance]
   704 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.24: Recently, it has been recognized that the neuroprotective effects of NSAIDs are mediated via peroxisome proliferator-activated receptor- (PPAR) activation, independently of COX-2 inhibition (12). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "recognized"

Phrase: "that"

Phrase: "the neuroprotective effects of NSAIDs"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   773   C0728866:effect of drugs [Functional Concept]
           drug effects
   767   C1515999:Anti-inflammatory effect [Qualitative Concept]
   767   C1516019:Antiinflammatory Effect [Physiologic Function]
   764   C0815279:Neuroprotective Effects [Functional Concept]
   762   C0242912:Neuroprotective Drugs [Pharmacologic Substance]
   742   C1280500:effects [Qualitative Concept]
   728 E C0728867:Drug effect [Pathologic Function]
   728 E C1411996:drug effect [Biologic Function]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "mediated via peroxisome proliferator-activated receptor-"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   882   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   790   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0752063:Peroxysome [Cell Component]
   753   C1879547:Activated [Activity]
   753   C2984308:Peroxisome [Functional Concept]
   719 E C1515877:Activate [Functional Concept]

Phrase: "(PPAR"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: ")"

Phrase: "activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "independently of COX-2 inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.25: Cyclopentenone PGs have various biological effects, such as growth inhibition, induction of apoptosis, differentiation, antioxidant, and anti-inflammation etc. depending on its concentrations and the cell type (13, 14). 

Phrase: "Cyclopentenone PGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0033554:Prostaglandins [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   827 E C1266240:Prostaglandin [Laboratory Procedure]

Phrase: "have"

Phrase: "various biological effects,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0005532:Biological [Biomedical Occupation or Discipline]
   827   C0205460:biological [Qualitative Concept]
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "such as growth inhibition,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0018270:'growth' NOS [Organism Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C2911660:Growth [Activity]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "induction of apoptosis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3266896:Induction of Apoptosis [Cell Function]
           Apoptosis Induction
   790   C0205263:Induction [Functional Concept]
   790   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "antioxidant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "and"

Phrase: "anti-inflammation etc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1548556:etc. [Idea or Concept]

Phrase: "depending on its concentrations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0086045:Concentrations [Mental Process]
   737   C0725813:depend [Medical Device]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "the cell type"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007634:Cell Type [Cell]
           Cell
  1000   C0449475:cell type [Intellectual Product]
   861   C0332307:Type [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1547052:*Type [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.26: Among them, PGJ2 is synthesized by non-enzymatic dehydration within the cyclopentane ring of PGD2, one of the major products of COX-2. 

Phrase: "Among them,"

Phrase: "PGJ2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050218:PGJ2 [Eicosanoid,Pharmacologic Substance]

Phrase: "is"

Phrase: "synthesized by non-enzymatic dehydration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011175:Dehydration [Disease or Syndrome]
   760   C1518422:Non [Functional Concept]
   760   C1883254:Synthesized [Activity]

Phrase: "within the cyclopentane ring"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0521164:Ring [Spatial Concept]
   861   C1260969:Ring [Medical Device]
   861   C1705184:Ring [Medical Device]

Phrase: "of PGD2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033532:PGD2 [Biologically Active Substance,Eicosanoid]
  1000   C1865138:PGD2 [Gene or Genome]
  1000   C3541268:PGD2 [Laboratory Procedure]

Phrase: "one of the major products of COX-2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]
Processing 00000000.tx.27: PGJ2 is metabolized further to yield 12-PGJ2 and 15-deoxy-12,14-PGJ2 (15d-PGJ2). 

Phrase: "PGJ2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050218:PGJ2 [Eicosanoid,Pharmacologic Substance]

Phrase: "is"

Phrase: "metabolized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524026:Metabolized [Cell Function]

Phrase: "further to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1517331:Further [Spatial Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "yield"

Phrase: "12-PGJ2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050218:PGJ2 [Eicosanoid,Pharmacologic Substance]

Phrase: "and"

Phrase: "15-deoxy-12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "14-PGJ2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050218:PGJ2 [Eicosanoid,Pharmacologic Substance]

Phrase: "(15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.28: Members of the J2 series PGs are characterized by the presence of a reactive ,-unsaturated carbonyl functional group in the cyclopentenone ring that can bind covalently by means of the Michael addition reaction with nucleophiles such as the free sulfhydryls of GSH and cysteine residues in cellular proteins (15, 16). 

Phrase: "Members of the J2 series PGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "are"

Phrase: "characterized by the presence of a reactive ,-unsaturated carbonyl functional group"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   756   C0598132:functional group [Chemical Viewed Functionally]
   754   C0441835:Group A [Classification]
   754   C0596259:carbonyl group [Inorganic Chemical]
   738   C0205245:Functional [Functional Concept]
   738   C0205332:Reactive [Qualitative Concept]
   738   C0392148:Presence [Therapeutic or Preventive Procedure]
   738   C0441833:Group [Idea or Concept]
   738   C0522535:Unsaturated [Quantitative Concept]
   738   C0542341:Functional [Functional Concept]
   738   C0687744:group [Population Group]
   738   C1257890:Group [Population Group]
   738   C1552516:Group [Health Care Related Organization]
   738   C1705428:Group [Conceptual Entity]
   738   C1705429:Group [Population Group]
   738   C1880022:Characterized [Activity]
   738   C2700217:Functional [Conceptual Entity]

Phrase: "in the cyclopentenone ring"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0521164:Ring [Spatial Concept]
   861   C1260969:Ring [Medical Device]
   861   C1705184:Ring [Medical Device]

Phrase: "that"

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "covalently by means of the Michael addition reaction"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1704970:Means [Conceptual Entity]
   744   C1883712:Addition [Functional Concept]
   711 E C0444504:Mean [Quantitative Concept]
   711 E C2347634:Mean [Quantitative Concept]
   711 E C2348143:Mean [Quantitative Concept]

Phrase: "with nucleophiles"

Phrase: "such as the free sulfhydryls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038734:Sulfhydryls [Organic Chemical]

Phrase: "of GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: "and"

Phrase: "cysteine residues in cellular proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.29: Interestingly, 15d-PGJ2 has been reported to exert dual effects on cell survival and apoptosis (14, 17, 18). 

Phrase: "Interestingly,"

Phrase: "15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "dual effects on cell survival"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(14,"

Phrase: "17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.30: Thus, 15d-PGJ2 at relatively high concentrations causes cell death, whereas at submicromolar concentrations this cyclopentenone PG elicits cytoprotective effects. 

Phrase: "Thus,"

Phrase: "15d-PGJ2 at relatively high concentrations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   748   C0442778:J2 [Finding]
   748   C1416167:J2 [Gene or Genome]
   748   C1421123:J2 [Gene or Genome]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "whereas at submicromolar concentrations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "this cyclopentenone PG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "cytoprotective effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.31: However, molecular mechanisms underlying cytoprotective effects of 15d-PGJ2 are poorly understood. 

Phrase: "However,"

Phrase: "molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "cytoprotective effects of 15d-PGJ2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.32: In this study we hypothesize that 15d-PGJ2 rescues PC12 cells from the nitrosative stress induced by peroxynitrite through up-regulation of intracellular GSH biosynthesis.  

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "hypothesize"

Phrase: "that 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "rescues"

Phrase: "PC12 cells from the nitrosative stress induced"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   778   C0085262:PC12 Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "by peroxynitrite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]

Phrase: "through up-regulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0041904:Up-Regulation [Cell Function,Molecular Function]
  1000   C0162493:Up-Regulation [Genetic Function]
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]
   861   C1327622:Regulation [Biologic Function]

Phrase: "of intracellular GSH biosynthesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005572:biosynthesis [Functional Concept]
   827   C0220781:Biosynthesis [Biologic Function]
Processing 00000000.tx.33: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Materials15d-PGJ2 and GW9662 were obtained from Cayman Chemical Co. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials15d-PGJ2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050218:PGJ2 [Eicosanoid,Pharmacologic Substance]

Phrase: "and"

Phrase: "GW9662"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1137010:GW9662 [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Cayman Chemical Co."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0079078:Caiman [Reptile]
   760   C0220806:Chemical [Chemical]
   760   C1301820:Obtained [Functional Concept]
   760   C3272558:Chemical [Intellectual Product]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.34: (Ann Arbor, MI). 

Phrase: "(Ann Arbor,"

Phrase: "MI)."
Processing 00000000.tx.35: 3-Morpholinosydnonimine hydrochloride (SIN-1) and Mn (II) tetrakis (4-benzoic acid) prophyrin (MnTBAP) were purchased from BIOMOL (Plymouth Meeting, PA). 

Phrase: "3-Morpholinosydnonimine hydrochloride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0951117:3-morpholinosydnonimine hydrochloride [Organic Chemical,Pharmacologic Substance]
   901   C0525082:3-morpholino-sydnonimine [Organic Chemical,Pharmacologic Substance]
   827   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(SIN-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Mn (II"

Phrase: ")"

Phrase: "tetrakis"

Phrase: "(4-benzoic acid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0053225:Benzoic Acid [Organic Chemical,Pharmacologic Substance]
           benzoic
   901   C1161334:benzoic acid [Organic Chemical,Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "prophyrin"

Phrase: "(MnTBAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0384992:MnTBAP [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "purchased from BIOMOL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Plymouth Meeting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0556656:Meeting [Health Care Activity]

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.36: Dihydrorhodamine 123 (DHR 123) was supplied from Fluka and Riedel-de Han (Buchs, Switzerland). 

Phrase: "Dihydrorhodamine 123 (DHR 123)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058109:dihydrorhodamine 123 [Organic Chemical]

Phrase: "was"

Phrase: "supplied from Fluka"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C1999230:Supplied [Activity]
   756 E C0243163:supply [Idea or Concept]
   756 E C0699914:supply [Quantitative Concept]
   756 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   756 E C1561604:supply [Functional Concept]
   756 E C1875802:SUPPLY [Medical Device]

Phrase: "and"

Phrase: "Riedel-de Han (Buchs,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.37: Tetramethylrhodamine ethyl ester (TMRE) was obtained from Molecular Probes, Inc. 

Phrase: "Tetramethylrhodamine ethyl ester (TMRE)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   827   C0014898:Ester [Organic Chemical]

Phrase: "was"

Phrase: "obtained from Molecular Probes,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   770   C0182400:Probes [Medical Device]
   770   C1301820:Obtained [Functional Concept]
   770   C1521991:Molecular [Qualitative Concept]
   737 E C1704681:Probe [Gene or Genome]
   737 E C1706701:Obtain [Activity]
   737 E C2347609:Probe [Chemical Viewed Functionally]
   737 E C3536729:Probe [Manufactured Object]

Phrase: "Inc."
Processing 00000000.tx.38: (Eugene, OR). 

Phrase: "(Eugene,"

Phrase: "OR"

Phrase: ")."
Processing 00000000.tx.39: The in situ cell death detection kit was supplied by Roche Applied Science. 

Phrase: "The in situ cell death detection kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0812225:KIT [Medical Device]
   799   C1150635:KIT [Molecular Function]
   799   C1705212:Kit [Medical Device]
   799   C1705213:KIT [Medical Device]
   799   C3273202:Kit [Manufactured Object]

Phrase: "was"

Phrase: "supplied by Roche Applied Science."
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   806   C0681834:Applied Science [Research Activity]
   760   C0036397:Science [Occupation or Discipline]
   760   C0185125:Applied [Health Care Activity]
   760   C0331965:Roche [Health Care Related Organization]
   760   C1999230:Supplied [Activity]
   726 E C0243163:supply [Idea or Concept]
   726 E C0699914:supply [Quantitative Concept]
   726 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   726 E C1561604:supply [Functional Concept]
   726 E C1632850:Apply [Functional Concept]
   726 E C1875802:SUPPLY [Medical Device]
   726 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.40: GSH and buthionine-[S,R]-sulfoximine (BSO) were purchased from Sigma. 

Phrase: "GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: "and"

Phrase: "buthionine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0054251:buthionine [Amino Acid, Peptide, or Protein]

Phrase: "[S,R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]

Phrase: "]-sulfoximine"

Phrase: "(BSO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0054252:BSO [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.41: Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum, horse serum, F-12, and N-2 supplement were obtained from Invitrogen Life Technologies, Inc. 

Phrase: "Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "(DMEM"

Phrase: ")"

Phrase: ","

Phrase: "fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "horse serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1518416:Serum, Horse [Immunologic Factor]
   861   C0019944:Horse [Mammal]
   861   C0229671:Serum [Body Substance]
   861   C0242616:Horse [Mammal]
   861   C1265527:Horse [Mammal]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "F-12,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "N-2 supplement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0242295:Supplement [Food]
   827   C1947943:Supplement [Intellectual Product]
   827   C2348609:Supplement [Functional Concept]

Phrase: "were"

Phrase: "obtained from Invitrogen Life Technologies,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0039421:technologies [Occupation or Discipline]
   760   C0376558:Life [Idea or Concept]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "Inc."
Processing 00000000.tx.42: Cell Culture and Viability MeasurementPC12 cells were maintained routinely in DMEM supplemented with heat-inactivated 10% horse serum and 5% fetal bovine serum at 37 C in a humidified atmosphere of 10% CO2, and 90% air. 

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "Viability MeasurementPC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   877   C1441322:Viable cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "routinely in DMEM"

Phrase: "supplemented with heat-inactivated 10% horse serum"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1518416:Serum, Horse [Immunologic Factor]
   748   C0018837:Heat [Natural Phenomenon or Process]
   748   C0019944:Horse [Mammal]
   748   C0229671:Serum [Body Substance]
   748   C0242616:Horse [Mammal]
   748   C1265527:Horse [Mammal]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   714   C0242295:Supplement [Food]
   714   C1947943:Supplement [Intellectual Product]
   714   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "5% fetal bovine serum at 37 C in"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0007452:Bovine [Mammal]
   744   C0015965:Fetal [Embryonic Structure]
   744   C0229671:Serum [Body Substance]
   744   C0521457:Fetal [Functional Concept]
   744   C1140701:bovine [Mammal]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]

Phrase: "a humidified atmosphere of 10% CO2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004178:Atmosphere [Natural Phenomenon or Process]
   753   C0678214:atmosphere [Quantitative Concept]

Phrase: "and"

Phrase: "90% air."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0001861:Air [Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.43: All cells were cultured in poly-D-lysinecoated culture dishes. 

Phrase: "All cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in poly-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0747726:POLY [Conceptual Entity]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "D-"

Phrase: "lysinecoated culture dishes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]
   793   C0020498:DISH [Disease or Syndrome]
Processing 00000000.tx.44: Cells were cultured for 1 day before treatment, and switched to serum-free N-2-defined medium. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 1 day"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "before treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "switched to serum-free N-2-defined medium."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   744   C0009458:Medium [Intellectual Product]
   744   C0229671:Serum [Body Substance]
   744   C0332296:free [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   744   C1704788:Defined [Conceptual Entity]
   744   C1705217:Medium [Substance]
   744   C1880497:Free [Qualitative Concept]
   744   C1996904:Free [Qualitative Concept]
   744   C3244283:medium [Intellectual Product]
   744   C3539106:Defined [Intellectual Product]
   711   C1707719:Switch [Manufactured Object]
Processing 00000000.tx.45: Cell viability was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described previously (19). 

Phrase: "Cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined by the 3-"

Phrase: "(4,"

Phrase: "5-dimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyltetrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006222:Bromide [Inorganic Chemical]

Phrase: "(MTT) assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.46: Measurement of PeroxynitriteGeneration of peroxynitrite from SIN-1 was determined spectrophotometrically using DHR 123. 

Phrase: "Measurement of PeroxynitriteGeneration of peroxynitrite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:Measurement [Functional Concept]

Phrase: "from SIN-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "spectrophotometrically"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DHR 123."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058109:dihydrorhodamine 123 [Organic Chemical]
Processing 00000000.tx.47: The peroxynitrite-dependent oxidation of DHR 123 to rhodamine 123 was measured according to the previously reported method (20). 

Phrase: "The peroxynitrite-dependent oxidation of DHR 123"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030011:Oxidation [Molecular Function]

Phrase: "to rhodamine 123"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0073192:Rhodamine 123 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "measured according to the previously reported method"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   774   C0449768:Measured to [Quantitative Concept]
   748   C0025663:Method [Intellectual Product]
   748   C0444706:Measured [Qualitative Concept]
   748   C0449851:Method [Functional Concept]
   748   C0680240:according [Social Behavior]
   748   C0684224:Reported [Intellectual Product]
   748   C0700287:Reported [Health Care Activity]
   748   C0871511:METHOD [Intellectual Product]
   748   C3496591:Reported [Clinical Attribute]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714 E C3273238:Report [Intellectual Product]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.48: At pH 7.4 and 37 C, peroxynitrite production from SIN-1 decomposition reaches a steady state after 3 min and remains essentially linear for up to 60 min. 

Phrase: "At pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "37 C,"

Phrase: "peroxynitrite production from SIN-1 decomposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "reaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596012:Reaches [Finding]
  1000   C2584321:Reach [Organism Function]

Phrase: "a steady state after 3 min"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0678587:steady state [Natural Phenomenon or Process]
   753   C0205361:Steady [Qualitative Concept]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "remains"

Phrase: "essentially linear for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205132:Linear [Spatial Concept]

Phrase: "up to 60 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.49: One hour after SIN-1 addition, the medium was collected and mixed with phosphate-buffered saline containing 20 M DHR 123. 

Phrase: "One hour after SIN-1 addition,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439227:Hour [Temporal Concept]
   753   C0564385:/hour [Quantitative Concept]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "mixed with phosphate-buffered saline"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C0205430:Mixed [Functional Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C3160715:Mixed [Finding]
   726 E C1421951:MIX [Gene or Genome]
   726 E C1720722:Mix [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20 M DHR 123."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0058109:dihydrorhodamine 123 [Organic Chemical]
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.50: After 10 min of incubation at 22 C, the fluorescence intensity of DHR 123 was measured using a microplate reader (TECAN GmbH, Salzburg, Austria) at an excitation wavelength of 500 nm and an emission at 536 nm (500 nm = 78,800 M-1 cm-1). 

Phrase: "After 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "of incubation"

Phrase: "at 22 C,"

Phrase: "the fluorescence intensity of DHR 123"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a microplate reader"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0182258:Microplate Reader [Medical Device]
   861   C1514743:Reader [Professional or Occupational Group]
   861   C1706461:Reader [Manufactured Object]

Phrase: "(TECAN GmbH,"

Phrase: "Salzburg,"

Phrase: "Austria"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004348:Austria [Geographic Area]
   928 E C0337795:austrian [Population Group]

Phrase: ")"

Phrase: "at an excitation wavelength"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449819:Wavelength [Quantitative Concept]

Phrase: "of 500 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "an emission at 536 nm (500 nm = 78,800"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0233929:Emission [Body Substance]
   742   C2349995:Emission [Substance]

Phrase: "M-"

Phrase: "1 cm-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.51: Peroxynitrite concentrations were calculated from the DHR 123 fluorescence intensity (21). 

Phrase: "Peroxynitrite concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "calculated from the DHR 123 fluorescence intensity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0058109:dihydrorhodamine 123 [Organic Chemical]
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0444686:Calculated [Functional Concept]
   748   C0522510:Intensity [Qualitative Concept]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.52: Synthetic peroxynitrite oxidizes DHR 123 to rhodamine 123 with 44% efficiency (20). 

Phrase: "Synthetic peroxynitrite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]

Phrase: "oxidizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:oxidize [Molecular Function]

Phrase: "DHR 123 to rhodamine 123"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0058109:dihydrorhodamine 123 [Organic Chemical]
   806   C0073192:Rhodamine 123 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "with 44% efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:Efficiency [Quantitative Concept]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.53: Thus, formation of rhodamine 123 from DHR 123 after reaction with SIN-1 was corrected to total peroxynitrite production by dividing the value by 0.44. 

Phrase: "Thus,"

Phrase: "formation of rhodamine 123"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "from DHR 123"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058109:dihydrorhodamine 123 [Organic Chemical]

Phrase: "after reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "with SIN-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]

Phrase: "was"

Phrase: "corrected to total peroxynitrite production"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0033268:production [Occupational Activity]
   760   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]
   760   C0205202:Corrected [Qualitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   726 E C2349182:Correct [Qualitative Concept]

Phrase: "by dividing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:dividing [Functional Concept]

Phrase: "the value by 0.44."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1522609:Value [Quantitative Concept]
Processing 00000000.tx.54: Western Blot AnalysisWestern blot analysis was performed with anti-poly-(ADP-ribose)polymerase (PARP), anti-phospho-c-Jun N-terminal kinase (JNK), anti-JNK, and anti-PPAR polyclonal antibodies (1:500 dilution, all products of Santa Cruz Biotechnology) as described previously (19). 

Phrase: "Western Blot AnalysisWestern blot analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   911   C0949466:Western blot analysis [Laboratory Procedure]
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed with anti-poly-(ADP-ribose)polymerase"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   853   C0032405:Poly ADP Ribose Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           poly ADP polymerase
   853   C1538577:POLY(ADP-RIBOSE) POLYMERASE [Gene or Genome]
   814   C0032403:Poly ADP Ribose [Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C0001461:ADP Ribose [Biologically Active Substance,Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0035549:Ribose [Carbohydrate]
   748   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0523452:ADP [Laboratory Procedure]
   748   C0747726:POLY [Conceptual Entity]
   748   C0884358:Performed [Functional Concept]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1538577:PARP [Gene or Genome]
  1000   C1709384:PARP [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "anti-phospho-c-Jun N-terminal kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   877   C1367731:JUN N-terminal kinase [Gene or Genome]
   845   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   845   C1334482:Jun kinase [Gene or Genome]
   845   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "anti-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1150587:JNK [Molecular Function]
   861   C1367731:JNK [Gene or Genome]
   861   C1705632:JNK [Gene or Genome]

Phrase: "and"

Phrase: "anti-PPAR polyclonal antibodies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   893   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   876 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   813   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   795   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   785   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   710   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   710   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500 dilution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "all products of Santa Cruz Biotechnology"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1514468:Products [Entity]
   719 E C1704444:Product [Quantitative Concept]

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.55: An anti-COX-2 polyclonal antibody (1:1000, Transduction Laboratories, Lexington, KY) was used for detection of COX-2. 

Phrase: "An anti-COX-2 polyclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000,"

Phrase: "Transduction Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Lexington,"

Phrase: "KY"

Phrase: ")"

Phrase: "was"

Phrase: "used for detection of COX-2."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C1524063:Use of [Functional Concept]
   760   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1273517:used [Finding]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
   760   C1565860:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.56: PGE2 Enzyme ImmunoassayPC12 cells were plated at a density of 2 x 105 cells/4 ml in 60-mm plates and incubated for the desired times after 3 mM SIN-1 treatment. 

Phrase: "PGE2 Enzyme ImmunoassayPC12 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated at a density of 2 x 105 cells/4 ml"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   754   C2699156:Cells/mL [Quantitative Concept]
   738   C0007634:Cells [Cell]
   738   C0178587:density [Quantitative Concept]
   738   C0439526:/mL [Quantitative Concept]
   738   C3282337:Cells [Cell]
   737   C0162339:Cell Density [Quantitative Concept]
   737   C1166718:cells plate [Cell Component]
   704   C0005971:Plate [Medical Device]
   704   C1139930:plate [Medical Device]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
   704   C3537155:Plate [Manufactured Object]

Phrase: "in 60-mm plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "incubated for the desired times"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1632851:Times [Quantitative Concept]
   726   C0871633:desire [Mental Process]
   726 E C3541383:Time [Temporal Concept]

Phrase: "after 3 mM SIN-1 treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0039798:treatment [Functional Concept]
   804   C0087111:Treatment [Therapeutic or Preventive Procedure]
   804   C1522326:Treatment [Functional Concept]
   804   C1533734:Treatment [Therapeutic or Preventive Procedure]
   804   C1705169:Treatment [Conceptual Entity]
   804   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.57: PGE2 released into incubation medium was measured by using an enzyme immunoassay kit (Amersham Biosciences). 

Phrase: "PGE2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012472:PGE2 [Eicosanoid,Hormone,Pharmacologic Substance]
  1000   C3538990:PGE2 [Laboratory Procedure]

Phrase: "released into incubation medium"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0391871:Released [Functional Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C1283071:Released [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "measured by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0444706:Measured [Qualitative Concept]
   833   C3541902:MEASURED [Diagnostic Procedure]
   799 E C0079809:Measure [Quantitative Concept]
   799 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an enzyme immunoassay kit (Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.58: 50 l of culture medium was used for an assay. 

Phrase: "50 l of culture medium"

Phrase: "was"

Phrase: "used for an assay."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.59: PGE2 concentration was determined spectrophotometrically according to the instructions provided from the supplier. 

Phrase: "PGE2 concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined"

Phrase: "spectrophotometrically according to the instructions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0302828:instructions [Intellectual Product]
   760   C0680240:according [Social Behavior]
   760   C1442085:Instructions [Idea or Concept]
   760   C3263700:Instructions [Clinical Attribute]
   726 E C0039401:Instruction [Educational Activity]

Phrase: "provided from the supplier."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0470689:Supplier [Health Care Related Organization]
   770   C0470690:supplier [Health Care Related Organization]
   770   C1999230:Provided [Activity]
Processing 00000000.tx.60: 15d-PGJ2 Enzyme ImmunoassayPC12 cells were plated at a density of 5 x 106 cells/7 ml in 100-mm plates, and the 15d-PGJ2 production was determined by using an enzyme immunoassay kit according to the instructions provided from the supplier (Assay Designs, Inc., Ann Arbor, MI). 

Phrase: "15d-PGJ2 Enzyme ImmunoassayPC12 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated at a density of 5 x 106 cells/7 ml"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   754   C0128666:ML 7 [Organic Chemical]
   754   C2699156:Cells/mL [Quantitative Concept]
   738   C0007634:Cells [Cell]
   738   C0178587:density [Quantitative Concept]
   738   C0439526:/mL [Quantitative Concept]
   738   C3282337:Cells [Cell]
   737   C0162339:Cell Density [Quantitative Concept]
   737   C1166718:cells plate [Cell Component]
   704   C0005971:Plate [Medical Device]
   704   C1139930:plate [Medical Device]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
   704   C3537155:Plate [Manufactured Object]

Phrase: "in 100-mm plates,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "the 15d-PGJ2 production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1514503:Prostaglandin Production [Physiologic Function]
   812   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "determined by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an enzyme immunoassay kit according to the instructions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0812225:KIT [Medical Device]
   744   C1150635:KIT [Molecular Function]
   744   C1705212:Kit [Medical Device]
   744   C1705213:KIT [Medical Device]
   744   C3273202:Kit [Manufactured Object]

Phrase: "provided from the supplier"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0470689:Supplier [Health Care Related Organization]
   770   C0470690:supplier [Health Care Related Organization]
   770   C1999230:Provided [Activity]

Phrase: "(Assay Designs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1707689:Design [Activity]
   827   C2983265:DESIGN [Intellectual Product]

Phrase: "Inc.,"

Phrase: "Ann Arbor,"

Phrase: "MI)."
Processing 00000000.tx.61: In brief, the culture media and cell lysates were transferred to a goat anti-rabbit IgG microtiter plate and incubated with anti-15d-PGJ2 polyclonal antibody and alkaline phosphatase conjugated with 15d-PGJ2 at room temperature for 2 h. 

Phrase: "In brief,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282927:brief [Qualitative Concept]
  1000   C1879313:Brief [Temporal Concept]

Phrase: "the culture media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0162867:Media [Tissue]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1254021:Media [Tissue]
   861   C2242979:Culture [Laboratory Procedure]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "transferred to a goat anti-rabbit IgG microtiter plate"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   764   C1709027:Microtiter Plate [Research Device]
   762   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0005971:Plate [Medical Device]
   742   C0018019:goat [Mammal]
   742   C0034493:Rabbit [Mammal]
   742   C0348011:transferred [Functional Concept]
   742   C1139930:plate [Medical Device]
   742   C1265549:goat [Mammal]
   742   C1510458:Goat [Mammal]
   742   C3537155:Plate [Manufactured Object]
   708 E C0040671:Transfer [Mental Process]
   708 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "incubated with anti-15d-PGJ2 polyclonal antibody"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   770   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   744   C0442778:J2 [Finding]
   744   C1266240:Prostaglandin [Laboratory Procedure]
   744   C1416167:J2 [Gene or Genome]
   744   C1421123:J2 [Gene or Genome]
   744   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "alkaline phosphatase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1149880:phosphatase [Molecular Function]
   861   C1979842:Alkaline [Qualitative Concept]

Phrase: "conjugated with 15d-PGJ2"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   760   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   760   C0442778:J2 [Finding]
   760   C0522529:Conjugated [Spatial Concept]
   760   C1266240:Prostaglandin [Laboratory Procedure]
   760   C1416167:J2 [Gene or Genome]
   760   C1421123:J2 [Gene or Genome]
   726 E C0301869:Conjugate [Immunologic Factor]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.62: The plate was rinsed three times with washing solution and further incubated with 200 l of p-nitrophenyl phosphate substrate at 37 C for 3 h. 

Phrase: "The plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "was"

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "three times with washing solution"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "incubated with 200 l of p-nitrophenyl phosphate substrate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0068854:nitrophenylphosphate [Organophosphorus Compound,Pharmacologic Substance]
   742   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   742   C0031701:phosphate [Organophosphorus Compound]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   742   C1710236:Substrate [Manufactured Object]

Phrase: "at 37 C"

Phrase: "for 3 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.63: The reaction was terminated by addition of 50 l of stop solution. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by addition of 50 l of stop solution."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0037633:Solution [Substance]
   742   C0525069:Solution [Biomedical or Dental Material]
   742   C1553404:terminated [Idea or Concept]
   742   C1883712:Addition [Functional Concept]
   742   C1947925:Stop [Activity]
   742   C2348570:Terminated [Functional Concept]
   742   C2746065:Stop [Temporal Concept]
Processing 00000000.tx.64: The changes in absorbance at 405 nm were measured using a spectrophotometric microplate reader. 

Phrase: "The changes in absorbance"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   816   C0025320:The change [Physiologic Function]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "at 405 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a spectrophotometric microplate reader."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0182258:Microplate Reader [Medical Device]
   827   C1514743:Reader [Professional or Occupational Group]
   827   C1706461:Reader [Manufactured Object]
Processing 00000000.tx.65: Terminal Deoxynucleotidyl Transferase-mediated dUTP Nick End-labeling (TUNEL)The commercially available in situ Cell Death Detection kit was used to assess the internucleosomal DNA fragmentation. 

Phrase: "Terminal Deoxynucleotidyl Transferase-mediated dUTP Nick End-labeling (TUNEL)"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   920   C0872284:terminal deoxynucleotidyl transferase nick end labeling [Molecular Biology Research Technique]
   906   C0600528:terminal nick end labeling [Molecular Biology Research Technique]
   835   C0012881:Terminal Deoxynucleotidyl Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Terminal Transferase
           Deoxynucleotidyl Transferase
   835   C0687124:Terminal deoxynucleotidyl transferase [Indicator, Reagent, or Diagnostic Aid]
   835   C1333243:DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL [Gene or Genome]
           TERMINAL TRANSFERASE
   793   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0086597:mediated [Social Behavior]
   793   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   793   C0205088:Terminal [Temporal Concept]
   793   C0444930:End [Spatial Concept]
   793   C1167624:Labeling [Mental Process]
   793   C1705314:Terminal [Manufactured Object]
   793   C1705315:Terminal [Spatial Concept]
   793   C1947902:Labeling [Manufactured Object]
   793   C2746065:End [Temporal Concept]
   793   C2827499:Labeling [Governmental or Regulatory Activity]
   760 E C0181496:Label [Manufactured Object]

Phrase: "The commercially available in situ Cell Death Detection kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0812225:KIT [Medical Device]
   793   C1150635:KIT [Molecular Function]
   793   C1705212:Kit [Medical Device]
   793   C1705213:KIT [Medical Device]
   793   C3273202:Kit [Manufactured Object]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the internucleosomal DNA fragmentation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0376669:DNA Fragmentation [Molecular Function]
   827   C0332472:Fragmentation [Anatomical Abnormality]
   827   C1881708:FRAGMENTATION [Phenomenon or Process]
Processing 00000000.tx.66: PC12 cells (5 x 105 cells/3 ml in chamber slide) were fixed for 30 min in 10% neutral buffered formalin solution at room temperature. 

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(5 x 105 cells/3 ml in chamber slide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C2699156:Cells/mL [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "fixed for 30 min"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0702093:/min [Temporal Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in 10% neutral buffered formalin solution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0037633:Solution [Substance]
   804   C0525069:Solution [Biomedical or Dental Material]
   717   C0492002:Neutral buffered formalin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   708   C1550067:10% Formalin [Biomedical or Dental Material,Organic Chemical]
   708   C1561470:10% Formalin [Intellectual Product]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.67: Endogenous peroxidase was inactivated by incubation with 0.3% hydrogen peroxide in methanol for 30 min at room temperature and further incubated in a permeabilizing solution (0.1% sodium citrate and 0.1% Triton X-100) for 2 min at 4 C. 

Phrase: "Endogenous peroxidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "inactivated by incubation"

Phrase: "with 0.3% hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0020275:Hydrogen [Element, Ion, or Isotope]
   812   C0031180:Peroxide [Inorganic Chemical]
   812   C0523702:HYDROGEN [Laboratory Procedure]
   812   C0885426:hydrogen [Inorganic Chemical]

Phrase: "in methanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "incubated in a permeabilizing solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "(0.1% sodium citrate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0142825:sodium citrate [Organic Chemical,Pharmacologic Substance]
   812   C0008857:Citrate [Organic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: ")"

Phrase: "for 2 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.68: The cells were incubated with the TUNEL reaction mixture for 60 min at 37 C followed by labeling with peroxidase-conjugated anti-goat antibody (Fab fragment) for additional 30 min. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with the TUNEL reaction mixture"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   738   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0086597:mediated [Social Behavior]
   738   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   738   C0439962:Mixture [Substance]
   738   C0443286:Reaction [Functional Concept]
   738   C0444930:End [Spatial Concept]
   738   C1114821:Reaction [Clinical Attribute]
   738   C1167624:Labeling [Mental Process]
   738   C1439852:Incubated [Laboratory Procedure]
   738   C1947902:Labeling [Manufactured Object]
   738   C2746065:End [Temporal Concept]
   738   C2827499:Labeling [Governmental or Regulatory Activity]
   726   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   726   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
   704 E C0181496:Label [Manufactured Object]

Phrase: "for 60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37 C"

Phrase: "followed by labeling"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C1167624:Labeling [Mental Process]
   790   C1947902:Labeling [Manufactured Object]
   790   C2827499:Labeling [Governmental or Regulatory Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with peroxidase-conjugated anti-goat antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0018019:goat [Mammal]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C1265549:goat [Mammal]
   804   C1510458:Goat [Mammal]

Phrase: "(Fab fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021031:Fab Fragment [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "for additional 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0456693:/30 min [Temporal Concept]
   901   C1442458:30 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.69: After staining with diaminobenzidine for 10 min, cells were rinsed with phosphate-buffered saline and mounted with 50% glycerol. 

Phrase: "After staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "with diaminobenzidine"

Phrase: "for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rinsed with phosphate-buffered saline"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726   C1701810:Rinse [Functional Concept]
   726   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "mounted with 50% glycerol."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C0449878:mounted [Finding]
   737 E C0181909:Mount [Medical Device]
Processing 00000000.tx.70: Measurement of Mitochondrial Transmembrane Potential (m) The fluorescent probe TMRE was used to measure the mitochondrial transmembrane potential (m). 

Phrase: "Measurement of Mitochondrial Transmembrane Potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:Measurement [Functional Concept]

Phrase: "("

Phrase: "m)"

Phrase: "The fluorescent probe TMRE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   804   C0014898:Ester [Organic Chemical]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the mitochondrial transmembrane potential"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0025251:Transmembrane Potential [Cell Function]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C1167322:transmembrane [Cell Component]
   827   C2752508:transmembrane [Cell Component]
   827   C3245505:Potential [Qualitative Concept]

Phrase: "("

Phrase: "m)."
Processing 00000000.tx.71: This dye binds in a manner dependent on the mitochondrial electric potential. 

Phrase: "This dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "binds in a manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "dependent on the mitochondrial electric potential."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
Processing 00000000.tx.72: PC12 cells were plated at a density of 4 x 105 cells/2.4 ml in chamber slides. 

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated at a density of 4 x 105 cells/2.4 ml"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   751   C2699156:Cells/mL [Quantitative Concept]
   736   C0007634:Cells [Cell]
   736   C0178587:density [Quantitative Concept]
   736   C0439526:/mL [Quantitative Concept]
   736   C3282337:Cells [Cell]
   734   C0162339:Cell Density [Quantitative Concept]
   734   C1166718:cells plate [Cell Component]
   703   C0005971:Plate [Medical Device]
   703   C1139930:plate [Medical Device]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]
   703   C3537155:Plate [Manufactured Object]

Phrase: "in chamber slides."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0444330:slides [Research Device]
   827 E C1705201:Slide [Manufactured Object]
Processing 00000000.tx.73: The cells were pretreated with 2 M 15d-PGJ2 for 24 h, and SIN-1 was then added to the medium at the final concentration of 3 mM. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with 2 M 15d-PGJ2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   774   C0049896:prostaglandin M [Eicosanoid]
   748   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C0442778:J2 [Finding]
   748   C1266240:Prostaglandin [Laboratory Procedure]
   748   C1416167:J2 [Gene or Genome]
   748   C1421123:J2 [Gene or Genome]

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "SIN-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to the medium"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1883712:Add [Functional Concept]

Phrase: "at the final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 3 mM."
Processing 00000000.tx.74: After 5 h of incubation with SIN-1, PC12 cells were washed with DMEM and incubated with TMRE (150 nM) in DMEM for additional 30 min at 37 C, then washed twice with DMEM, and examined under a confocal microscope (Leica Microsystems Heidelberg GmbH, Heidelberg, Germany). 

Phrase: "After 5 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of incubation"

Phrase: "with SIN-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with DMEM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1548982:Washed [Idea or Concept]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "incubated with TMRE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   760   C0014898:Ester [Organic Chemical]
   760   C0076306:tetramethylrhodamine [Organic Chemical,Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "(150 nM) in DMEM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0312860:NM [Cell Function]

Phrase: "for additional 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0456693:/30 min [Temporal Concept]
   901   C1442458:30 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "at 37 C,"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with DMEM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "examined under a confocal microscope"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1626420:Confocal microscope [Medical Device]
   760   C0181839:Microscope [Medical Device]
   760   C0332128:Examined [Finding]
   760   C1706379:Microscope [Medical Device]

Phrase: "(Leica Microsystems Heidelberg GmbH,"

Phrase: "Heidelberg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.75: TMRE rapidly equilibrates between cellular compartments due to potential differences. 

Phrase: "TMRE rapidly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   812   C0014898:Ester [Organic Chemical]

Phrase: "equilibrates between cellular compartments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C1185625:Compartments [Body Space or Junction]
   770   C1382196:Compartments [Natural Phenomenon or Process]
   737 E C2986730:Compartment [Spatial Concept]

Phrase: "due to potential differences."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C3245505:Potential [Qualitative Concept]
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.76: A decrease in TMRE fluorescence is indicative of a reduction in m. 

Phrase: "A decrease in TMRE fluorescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "is"

Phrase: "indicative of a reduction"

Phrase: "in m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.77: The fluorescence was monitored as red fluorescence (excitation: 555 nm, emission: >590 nm) at hyperpolarized membrane potentials. 

Phrase: "The fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "monitored as red fluorescence"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0332575:Red [Finding]
   770   C1260956:Red [Qualitative Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "(excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: ":"

Phrase: "555 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "emission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233929:Emission [Body Substance]
  1000   C2349995:Emission [Substance]

Phrase: ":"

Phrase: ">590 nm) at hyperpolarized membrane potentials."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0312860:NM [Cell Function]
Processing 00000000.tx.78: For the quantification of the fluorescence intensity, four fields containing about 400 cells were analyzed, and the fluorescence intensity of the red was determined as the indicator of m. 

Phrase: "For the quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "of the fluorescence intensity,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "four fields"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   827   C1521738:Field [Conceptual Entity]
   827   C2346620:Field [Conceptual Entity]
   827   C2349184:Field [Conceptual Entity]
   827   C3539073:FIELD [Spatial Concept]

Phrase: "containing about 400 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0332256:Containing [Functional Concept]
   770   C2700400:Containing [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: ","

Phrase: "and"

Phrase: "the fluorescence intensity of the red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "determined as the indicator of m."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1235732:Indicator [Bird]
   753   C1522602:Indicator [Functional Concept]
Processing 00000000.tx.79: GSH MeasurementThe GSH content was measured using a commercial kit according to the manufacturer's protocol (GSH-400 method, OXIS International, Portland, OR) using 4-chloro-1-methyl-7-trifluoromethyl-quinolinum methylsulfate. 

Phrase: "GSH MeasurementThe GSH content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a commercial kit according to the manufacturer's protocol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0812225:KIT [Medical Device]
   744   C1150635:KIT [Molecular Function]
   744   C1705212:Kit [Medical Device]
   744   C1705213:KIT [Medical Device]
   744   C3273202:Kit [Manufactured Object]

Phrase: "(GSH-400 method,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "OXIS International, Portland,"

Phrase: "OR)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "4-chloro-1-methyl-7-trifluoromethyl-quinolinum methylsulfate."
Processing 00000000.tx.80: Cells were harvested and homogenized in metaphosphoric working solution. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "homogenized in metaphosphoric working solution."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037633:Solution [Substance]
   760   C0043227:Working [Occupational Activity]
   760   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.81: After centrifugation, 50 l of R1 solution (solution of chromogenic reagent in HCl) was added to the 700 l of supernatant, followed by gentle vortex mixing. 

Phrase: "After centrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "50 l of R1 solution"

Phrase: "(solution of chromogenic reagent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037633:Solution [Substance]
   770   C0525069:Solution [Biomedical or Dental Material]

Phrase: "in HCl)"

Phrase: "was"

Phrase: "added to the 700 l of supernatant,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C1524062:Added [Functional Concept]
   748   C1550101:Supernatant [Body Substance]
   714 E C1883712:Add [Functional Concept]

Phrase: "followed by gentle vortex mixing."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0205430:mixing [Functional Concept]
   760   C0439648:Vortex [Spatial Concept]
   760   C0720654:Gentle [Organic Chemical,Pharmacologic Substance]
   760   C2719416:Vortex [Pharmacologic Substance]
   726 E C1421951:MIX [Gene or Genome]
   726 E C1719822:Follow [Intellectual Product]
   726 E C1720722:Mix [Qualitative Concept]
Processing 00000000.tx.82: Following the addition of 50 l of R2 solution (30% NaOH), the mixtures were incubated at 25  3 C for 10 min. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the addition of 50 l of R2 solution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1883712:Addition [Functional Concept]

Phrase: "(30% NaOH"

Phrase: ")"

Phrase: ","

Phrase: "the mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "incubated at 25  3 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.83: After centrifugation, the absorbance of the clear supernatant was read at 400 nm. 

Phrase: "After centrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "the absorbance of the clear supernatant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1268822:Absorbance [Clinical Attribute]
   753   C2825050:Absorbance [Phenomenon or Process]

Phrase: "was"

Phrase: "read at 400 nm."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034754:Read [Daily or Recreational Activity]
   770   C0312860:NM [Cell Function]
   770   C1705179:read [Finding]
Processing 00000000.tx.84: The protein concentration was determined using the BCA protein assay kit. 

Phrase: "The protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427716:Protein concentration [Laboratory Procedure]
  1000   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BCA protein assay kit."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.85: Reverse Transcription-Polymerase Chain Reaction (RT-PCR)Total RNA was isolated from PC12 cells using TRIzol (Invitrogen Life Technologies, Inc.) following the manufacturer's instructions. 

Phrase: "Reverse Transcription-Polymerase Chain Reaction"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0814037:reverse transcription polymerase chain reaction [Genetic Function]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035380:Reverse Transcription [Genetic Function]
   804   C0040649:Transcription [Genetic Function]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]

Phrase: "(RT-PCR)Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from PC12 cells"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   833   C0085262:PC12 Cells [Cell]
           PC-12
   770   C0007634:Cells [Cell]
   770   C0205409:Isolated [Functional Concept]
   770   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   770   C1548221:Isolated [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C0370215:Isolate [Substance]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TRIzol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0916178:trizol [Organic Chemical]

Phrase: "(Invitrogen Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.86: RT-PCR was performed according to standard techniques. 

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed according to standard techniques."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0025664:techniques [Intellectual Product]
   760   C0449851:Techniques [Functional Concept]
   760   C0680240:according [Social Behavior]
   760   C0884358:Performed [Functional Concept]
   760   C1442989:Standard [Qualitative Concept]
   760   C2828392:Standard [Intellectual Product]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.87: PCR conditions for glutamylcysteine ligase catalytic (GCLC), glutamylcysteine ligase modulatory (GCLM), and the housekeeping, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) genes were as follows: for GCLC and GAPDH, 35 cycles of 94 C for 30 s; 

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "conditions for glutamylcysteine ligase catalytic (GCLC), glutamylcysteine ligase modulatory (GCLM),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0007382:Catalytic [Natural Phenomenon or Process]
   744   C0012634:condition [Disease or Syndrome]
   744   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0348080:Condition [Qualitative Concept]
   744   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "the housekeeping,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020053:Housekeeping [Occupational Activity]

Phrase: "glyceraldehyde-3-phosphate dehydrogenase (GAPDH) genes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   991   C1414968:Glyceraldehyde-3-Phosphate Dehydrogenase Gene [Gene or Genome]
           GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE
   804   C0017337:Genes [Gene or Genome]
   771   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   722   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   717   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "for GCLC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0007382:Catalytic [Natural Phenomenon or Process]
   812   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0521125:For [Qualitative Concept]

Phrase: "and"

Phrase: "GAPDH,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "35 cycles of 94 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1511572:Cycle [Temporal Concept]

Phrase: "for 30 s"

Phrase: ";"
Processing 00000000.tx.88: 55 C for 30 s; 

Phrase: "55 C for 30 s"

Phrase: ";"
Processing 00000000.tx.89: and 72 C for 45 s and for GCLM, 35 cycles of 95 C for 1 min; 

Phrase: "and"

Phrase: "72 C for 45 s"

Phrase: "and for GCLM, 35 cycles of 95 C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1515981:And [Idea or Concept]
   706   C1511572:Cycle [Temporal Concept]

Phrase: "for 1 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.90: 60 C for 1 min; 

Phrase: "60 C for 1 min"

Phrase: ";"
Processing 00000000.tx.91: 68 C for 2 min; 

Phrase: "68 C for 2 min"

Phrase: ";"
Processing 00000000.tx.92: and 68 C for 7 min (22). 

Phrase: "and"

Phrase: "68 C for 7 min (22"

Phrase: ")."
Processing 00000000.tx.93: The sequence of each primer used is as follows (forward and reverse, respectively): GCLC subunit, 5'-GCC AAG GTC ATC CAT GAC AAC-3' and 5'-AGT GTA GCC CAG GAT GCC CTT-3'; 

Phrase: "The sequence of each primer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "is"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "(forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "and"

Phrase: "reverse, respectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1555029:Reverse [Idea or Concept]

Phrase: ")"

Phrase: ":"

Phrase: "GCLC subunit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0600499:Catalytic Subunit [Amino Acid Sequence]
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "5'-GCC AAG GTC ATC CAT GAC AAC-3'"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   854   C0626910:5'-CAT [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   829   C1420223:CAT-3 [Gene or Genome]
   791   C0007450:Cat [Mammal]
   791   C0325090:Cat [Mammal]
   791   C0439084:>5 [Quantitative Concept]
   791   C0524517:Cat [Mammal]
   791   C0728893:+5 [Quantitative Concept]
   791   C0796552:AAG [Antibiotic,Organic Chemical]
   791   C1417239:AAG [Gene or Genome]
   791   C2986643:AAG [Gene or Genome]
   735 E C0325089:feline [Mammal]
   708 E C1825121:CATS [Gene or Genome]

Phrase: "and"

Phrase: "5'-AGT GTA GCC CAG GAT GCC CTT-3'"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   791   C0040405:ctt [Diagnostic Procedure]
   791   C0061145:GAT [Amino Acid, Peptide, or Protein]
   791   C0439084:>5 [Quantitative Concept]
   791   C0728893:+5 [Quantitative Concept]
   791   C1422172:GAT [Gene or Genome]
   791   C2697657:GTA [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.94: GCLM subunit, 5'-AGA CCG GGA ACC TGC TCA AC-3' and 5'-CAT CAC CCT GAT GCC TAA GC-3'; 

Phrase: "GCLM subunit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "5'-AGA CCG GGA ACC TGC TCA AC-3'"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   879   C0004475:5-AC [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   791   C0041405:TCA [Geographic Area]
   791   C0085758:TCA [Congenital Abnormality]
   791   C0175754:ACC [Congenital Abnormality,Disease or Syndrome]
   791   C0282160:ACC [Congenital Abnormality]
   791   C0439084:>5 [Quantitative Concept]
   791   C0728893:+5 [Quantitative Concept]
   791   C1412573:AC [Gene or Genome]
   791   C1415587:TCA [Gene or Genome]
   791   C1420714:TGC [Gene or Genome]
   791   C1516476:CCG [Health Care Related Organization]
   791   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   791   C3536819:TCA [Pharmacologic Substance]
   791   C3539770:AC [Gene or Genome]
   791   C3541413:ACC [Gene or Genome]

Phrase: "and"

Phrase: "5'-CAT CAC CCT GAT GCC TAA GC-3'"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   879   C1420223:CAT-3 [Gene or Genome]
   807   C0626910:5'-CAT [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   791   C0007450:Cat [Mammal]
   791   C0039872:TAA [Hazardous or Poisonous Substance,Organic Chemical]
   791   C0061145:GAT [Amino Acid, Peptide, or Protein]
   791   C0162872:TAA [Disease or Syndrome]
   791   C0266539:CCT [Congenital Abnormality,Disease or Syndrome]
   791   C0325090:Cat [Mammal]
   791   C0439084:>5 [Quantitative Concept]
   791   C0524517:Cat [Mammal]
   791   C0728893:+5 [Quantitative Concept]
   791   C1422172:GAT [Gene or Genome]
   791   C3537453:GC [Gene or Genome]
   735 E C0325089:feline [Mammal]
   708 E C1825121:CATS [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.95: GAPDH, 5'-AGT GTA GCC CAG GAT GCC CTT-3' and 5'-GCC AAG GTC ATC CAT GAC AAC-3'. 

Phrase: "GAPDH,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5'-AGT GTA GCC CAG GAT GCC CTT-3'"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   791   C0040405:ctt [Diagnostic Procedure]
   791   C0061145:GAT [Amino Acid, Peptide, or Protein]
   791   C0439084:>5 [Quantitative Concept]
   791   C0728893:+5 [Quantitative Concept]
   791   C1422172:GAT [Gene or Genome]
   791   C2697657:GTA [Gene or Genome]

Phrase: "and"

Phrase: "5'-GCC AAG GTC ATC CAT GAC AAC-3'."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   854   C0626910:5'-CAT [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   829   C1420223:CAT-3 [Gene or Genome]
   791   C0007450:Cat [Mammal]
   791   C0325090:Cat [Mammal]
   791   C0439084:>5 [Quantitative Concept]
   791   C0524517:Cat [Mammal]
   791   C0728893:+5 [Quantitative Concept]
   791   C0796552:AAG [Antibiotic,Organic Chemical]
   791   C1417239:AAG [Gene or Genome]
   791   C2986643:AAG [Gene or Genome]
   735 E C0325089:feline [Mammal]
   708 E C1825121:CATS [Gene or Genome]
Processing 00000000.tx.96: Amplification products were resolved by 1.0% agarose gel electrophoresis, stained with ethidium bromide, and photographed under ultraviolet light. 

Phrase: "Amplification products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "resolved by 1.0% agarose gel electrophoresis,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0013856:Electrophoresis, Agarose Gel [Laboratory Procedure]
   778   C0596607:Gel Electrophoresis [Laboratory Procedure]
   778   C1706746:Agarose Gel [Research Device]
   774 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   748   C0013855:Electrophoresis [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0036681:Agarose [Carbohydrate]
   748   C1382104:Gel [Substance]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]

Phrase: "stained with ethidium bromide,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   770   C0006222:Bromide [Inorganic Chemical]
   770   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "photographed under ultraviolet light."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0041625:Ultraviolet Light [Natural Phenomenon or Process]
   791 E C0181651:ultraviolet lights [Medical Device]
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C1306462:Light [Functional Concept]
   770   C1532472:Ultraviolet [Qualitative Concept]
   770   C1881376:Light [Qualitative Concept]
   737   C0441468:photograph [Manufactured Object]
Processing 00000000.tx.97: All primers were purchased from Bionics (Seoul, Korea). 

Phrase: "All primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "purchased from Bionics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0005549:Bionics [Occupation or Discipline]
   790   C0869011:purchased [Activity]

Phrase: "(Seoul,"

Phrase: "Korea"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: ")."
Processing 00000000.tx.98: GCL Reporter Gene AssayThe luciferase reporter construct pGL3 containing the rat GCLC promoter was prepared as reported previously (23). 

Phrase: "GCL Reporter Gene AssayThe luciferase reporter construct pGL3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1854336:PGL3 [Disease or Syndrome]
   793   C3273620:PGL3 [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the rat GCLC promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.99: Transient transfection was carried out by using DOTAP Liposomal Transfection Reagent (Roche Applied Science). 

Phrase: "Transient transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0439787:Out [Spatial Concept]
   833   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DOTAP Liposomal Transfection Reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")."
Processing 00000000.tx.100: Transfection was performed at 13x105 cells per well in 6-well plates. 

Phrase: "Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "performed at 13x105 cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0884358:Performed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "per well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "in 6-well plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.101: Twelve hours later, the transfection medium was removed and replaced with N-2 medium containing Me2SO or 2 M 15d-PGJ2 and incubated for additional 24 h. 

Phrase: "Twelve hours later,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]

Phrase: "the transfection medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "replaced with N-2 medium containing Me2SO"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0009458:Medium [Intellectual Product]
   748   C0332256:Containing [Functional Concept]
   748   C0439536:Medium [Quantitative Concept]
   748   C0559956:Replaced [Functional Concept]
   748   C1299987:replaced [Functional Concept]
   748   C1705217:Medium [Substance]
   748   C2700400:Containing [Activity]
   748   C3244283:medium [Intellectual Product]
   714 E C1554078:Replace [Idea or Concept]

Phrase: "or"

Phrase: "2 M 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   804   C0442778:J2 [Finding]
   804   C1416167:J2 [Gene or Genome]
   804   C1421123:J2 [Gene or Genome]

Phrase: "and"

Phrase: "incubated for additional 24 h."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1524062:Additional [Functional Concept]
Processing 00000000.tx.102: Cell extracts were assayed for luciferase and -galactosidase activities. 

Phrase: "Cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "assayed for luciferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "and -"

Phrase: "galactosidase activities."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1150051:galactosidase activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.103: Luciferase activity was normalized to -galactosidase activity. 

Phrase: "Luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "to -galactosidase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150051:galactosidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.104: The result was expressed as means  S.D. of three independent experiments. 

Phrase: "The result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "was"

Phrase: "expressed as means  S.D. of three independent experiments."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   762   C0332291:Independent of [Functional Concept]
   742   C0085862:Independent [Idea or Concept]
   742   C0205449:Three [Quantitative Concept]
   742   C0681814:Experiments [Research Activity]
   742   C1299583:Independent [Finding]
   742   C1704970:Means [Conceptual Entity]
   708 E C0444504:Mean [Quantitative Concept]
   708 E C1706386:Experiment [Conceptual Entity]
   708 E C2347634:Mean [Quantitative Concept]
   708 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.105: Measurement of GCL ActivityGCL activity was determined as described by Seelig and Meister (24) with slight modifications. 

Phrase: "Measurement of GCL ActivityGCL activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:Measurement [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "as"

Phrase: "described by Seelig"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Meister"

Phrase: "(24"

Phrase: ")"

Phrase: "with slight modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.106: The assay measures the rate of oxidation of NADH (assumed to be equal to the rate of formation of ADP) from the change in absorbance at 340 nm in reaction mixtures containing the following: 0.1 M Tris-HCl (pH 8.0), 150 mM KCl, 5 mM Na2ATP, 2 mM phosphoenolpyruvate, 10 mM L-glutamate, 10 mM L--aminobutyrate, 20 mM MgCl2,2mM Na2EDTA, 0.2 mM NADH, 17 g/ml of pyruvate kinase, and 17 g/ml of lactate dehydrogenase. 

Phrase: "The assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "measures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]
  1000   C1879489:Measures [Functional Concept]

Phrase: "the rate of oxidation of NADH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "("

Phrase: "assumed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "equal to the rate of formation of ADP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205163:Equal To [Qualitative Concept]
           Equal
   744   C1549782:Equal [Idea or Concept]

Phrase: ")"

Phrase: "from the change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "in absorbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1268822:Absorbance [Clinical Attribute]
  1000   C2825050:Absorbance [Phenomenon or Process]

Phrase: "at 340 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "in reaction mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "0.1 M Tris-HCl (pH 8.0"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   850   C0126577:M-8 [Organic Chemical,Pharmacologic Substance]
   793   C0020283:[pH] [Quantitative Concept]
   793   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   793   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   793   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0441923:M+ [Intellectual Product]
   793   C0450407:ph+ [Finding]
   793   C0450408:ph++ [Finding]
   793   C0450409:ph+++ [Finding]
   793   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "150 mM KCl,"

Phrase: "5 mM Na2ATP,"

Phrase: "2 mM phosphoenolpyruvate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031642:Phosphoenolpyruvate [Biologically Active Substance,Organophosphorus Compound]

Phrase: "10 mM L-glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   812   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "10 mM L--aminobutyrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0178474:Aminobutyrate [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "20 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2mM Na2EDTA,"

Phrase: "0.2 mM NADH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "17 g/ml of pyruvate kinase,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "17 g/ml of lactate dehydrogenase."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.107: Cells were harvested and lysed in 0.1 M Tris-HCl (pH 8.0) containing 0.1% Triton X-100, and the supernatant was used for the assay. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "lysed in 0.1 M Tris-HCl (pH 8.0"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   757   C0126577:M-8 [Organic Chemical,Pharmacologic Substance]
   739   C0020283:[pH] [Quantitative Concept]
   739   C0024348:lysed [Pathologic Function]
   739   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   739   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   739   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441923:M+ [Intellectual Product]
   739   C0450407:ph+ [Finding]
   739   C0450408:ph++ [Finding]
   739   C0450409:ph+++ [Finding]
   739   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "used for the assay."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.108: The protein concentration was determined using the BCA protein assay kit. 

Phrase: "The protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427716:Protein concentration [Laboratory Procedure]
  1000   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BCA protein assay kit."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.109: The enzyme activity was expressed in international units per mg of protein and calculated by using the molar extinction coefficient, 6.22 for NADH.  

Phrase: "The enzyme activity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "expressed in international units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0439453:international units [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1512888:International [Idea or Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]

Phrase: "per mg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439269:mg% [Quantitative Concept]
  1000   C1960952:mg % [Quantitative Concept]
  1000   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "calculated by"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0444686:Calculated [Functional Concept]
   833   C1441506:Calculated [Activity]
   833   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the molar extinction coefficient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0015347:extinction [Mental Process]
   827   C1707429:*Coefficient [Quantitative Concept]

Phrase: "6.22 for NADH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.110: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  SIN-1 Caused Apoptotic Death in PC12 CellsTo assess the nitrosative stress-induced cytotoxicity, PC12 cells were treated for 24 h with varying concentrations of the peroxynitrite donor SIN-1. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "SIN-1 Caused Apoptotic Death in PC12 CellsTo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0007465:Death Cause [Finding]
   744   C0011065:Death [Organism Function]
   744   C1306577:Death, NOS [Finding]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the nitrosative stress-induced cytotoxicity,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   741 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   741 E C1511636:cytotoxic [Functional Concept]

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated for 24 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with varying concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of the peroxynitrite donor SIN-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0815304:sin [Idea or Concept]
Processing 00000000.tx.111: Peroxynitrite released from SIN-1 was quantified by measuring the fluorescence intensity derived from DHR 123 oxidized by peroxynitrite (Fig. 1A). 

Phrase: "Peroxynitrite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]

Phrase: "released from SIN-1"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0391871:Released [Functional Concept]
   770   C0815304:sin [Idea or Concept]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "quantified by measuring"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "the fluorescence intensity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "derived from DHR 123"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0058109:dihydrorhodamine 123 [Organic Chemical]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "oxidized by peroxynitrite"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]
   756   C0030011:oxidize [Molecular Function]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.112: In parallel with increased peroxynitrite release, SIN-1 treatment decreased the cell viability as determined by the MTT reduction assay (Fig. 1A). 

Phrase: "In parallel with increased peroxynitrite release,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0150312:In [Quantitative Concept]
   753   C0332285:In [Spatial Concept]
   753   C2348042:Parallel [Qualitative Concept]
   753   C2826345:PARALLEL [Research Activity]

Phrase: "SIN-1 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "determined by the MTT reduction assay"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0201596:MTT reduction assay [Laboratory Procedure]
   783   C2986858:MTT Assay [Research Activity]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]
   753   C0647210:mtt [Lipid]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.113: Cells treated with 3 mM SIN-1 exhibited gradual cleavage of PARP, one of the common biochemical features of apoptosis (Fig. 1B). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with 3 mM SIN-1 exhibited gradual cleavage of PARP,"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   756   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   754   C0032405:PARP-1 [Amino Acid, Peptide, or Protein,Enzyme]
           PARP
   754   C1418486:MM-1 [Gene or Genome]
   754   C1428200:PARP-1 [Gene or Genome]
   754   C1709384:PARP-1 [Gene or Genome]
           PARP
   738   C0010813:cleavage [Cell Function]
   738   C0439833:Gradual [Qualitative Concept]
   738   C0596311:Cleavage [Phenomenon or Process]
   738   C0815304:sin [Idea or Concept]
   738   C1330957:cleavage [Cell Function]
   738   C1522326:Treated [Functional Concept]
   738   C1538577:PARP [Gene or Genome]
   704   C0015272:Exhibit [Intellectual Product]
   704 E C1292734:TREAT [Functional Concept]

Phrase: "one of the common biochemical features of apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.114: The SIN-1-induced cytotoxicity was abolished by cotreatment with the membrane permeable peroxynitrite scavenger MnTBAP (Fig. 1C). 

Phrase: "The SIN-1-induced cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   741 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   741 E C1511636:cytotoxic [Functional Concept]

Phrase: "was"

Phrase: "abolished by cotreatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0009429:cotreatment [Therapeutic or Preventive Procedure]
   790   C0814472:co-treatment [Health Care Activity]

Phrase: "with the membrane permeable peroxynitrite scavenger MnTBAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0384992:MnTBAP [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.115: Activation of the JNK-signaling cascades has been frequently implicated in neuronal cell death induced by a wide variety of toxicants (25). 

Phrase: "Activation of the JNK-signaling cascades"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   843   C2250067:activation of JNK cascade [Cell Function]
   753   C1879547:Activation [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "implicated in neuronal cell death"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C2754100:neuronal cell death [Cell Function]
           neuron death
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "induced by a wide variety of toxicants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205263:Induced [Functional Concept]
   748   C0332464:Wide [Spatial Concept]
   748   C0599787:toxicants [Hazardous or Poisonous Substance]
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.116: JNK activation via phosphorylation during the SIN-1-induced PC12 cell death coincided with the PARP cleavage (Fig. 1D). 

Phrase: "JNK activation via phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "during the SIN-1-induced PC12 cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0007587:Cell Death [Cell Function]
   827   C0085262:PC12 Cell [Cell]
   799   C0007634:Cell [Cell]
   799   C0011065:Death [Organism Function]
   799   C1269647:Cell [Cell]
   799   C1306577:Death, NOS [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "coincided with the PARP cleavage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0010813:cleavage [Cell Function]
   760   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]
   760   C1538577:PARP [Gene or Genome]
   760   C1709384:PARP [Gene or Genome]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.117: Both events were blocked by the peroxynitrite scavenger MnTBAP, in a concentration-dependent manner (Fig. 1D). 

Phrase: "Both events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]

Phrase: "were"

Phrase: "blocked by the peroxynitrite scavenger MnTBAP,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0017108:scavenger [Medical Device]
   753   C0028778:Blocked [Pathologic Function]
   753   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]
   753   C0332206:Blocked [Functional Concept]
   753   C0384992:MnTBAP [Organic Chemical,Pharmacologic Substance]
   753   C1003377:scavenger [Fish]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "in a concentration-dependent manner"

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.118: View larger version (42K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.119: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.120: SIN-1-induced cytotoxicity in PC12 cells. 

Phrase: "SIN-1-induced cytotoxicity in PC12 cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   721   C0022686:Cytotoxic cell [Cell]
Processing 00000000.tx.121: A, PC12 cells were exposed to indicated concentrations of SIN-1 for 24 h. 

Phrase: "A,"

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to indicated concentrations of SIN-1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0086045:Concentrations [Mental Process]
   748   C0815304:sin [Idea or Concept]
   748   C1444656:Indicated [Finding]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.122: Peroxynitrite release was quantified based on the fluorescence intensity of DHR 123 dye oxidized by peroxynitrite. 

Phrase: "Peroxynitrite release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "quantified"

Phrase: "based on the fluorescence intensity of DHR 123 dye"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   764   C0058109:dihydrorhodamine 123 [Organic Chemical]
   742   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   742   C0016315:Fluorescence [Natural Phenomenon or Process]
   742   C0522510:Intensity [Qualitative Concept]
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   726   C0016320:fluorescent dye [Indicator, Reagent, or Diagnostic Aid]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "oxidized by peroxynitrite."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]
   756   C0030011:oxidize [Molecular Function]
Processing 00000000.tx.123: Cell viability was determined by the MTT reduction assay. 

Phrase: "Cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined by the MTT reduction assay."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0201596:MTT reduction assay [Laboratory Procedure]
   783   C2986858:MTT Assay [Research Activity]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]
   753   C0647210:mtt [Lipid]
   753   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.124: The results are presented as means  S.D. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "presented as means  S.D."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0449450:Presented [Idea or Concept]
   760   C1704970:Means [Conceptual Entity]
   726 E C0150312:Present [Quantitative Concept]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.125: (n = 3). 

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.126: *, significantly different from the untreated control (p < 0.01). 

Phrase: "*,"

Phrase: "significantly different from the untreated control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "(p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.127: B, time-dependent PARP cleavage induced by SIN-1 (3 mM) treatment. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "time-dependent PARP cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0010813:cleavage [Cell Function]
   812   C0596311:Cleavage [Phenomenon or Process]
   812   C1330957:cleavage [Cell Function]

Phrase: "induced by SIN-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induced [Functional Concept]
   770   C0815304:sin [Idea or Concept]

Phrase: "(3 mM) treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.128: C, PC12 cells were exposed to 3 mM SIN-1 for 24 h in the absence or presence of the peroxynitrite scavenger MnTBAP (0.3 mM). 

Phrase: "C,"

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to 3 mM SIN-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of the peroxynitrite scavenger MnTBAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(0.3 mM"

Phrase: ")."
Processing 00000000.tx.129: The results are presented as means  S.D. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "presented as means  S.D."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0449450:Presented [Idea or Concept]
   760   C1704970:Means [Conceptual Entity]
   726 E C0150312:Present [Quantitative Concept]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.130: (n = 3). 

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.131: *, significantly different from the group treated with SIN-1 alone (p < 0.01). 

Phrase: "*,"

Phrase: "significantly different from the group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "treated with SIN-1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0815304:sin [Idea or Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.132: D, MnTBAP inhibited SIN-1-induced JNK activation and PARP cleavage. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "MnTBAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0384992:MnTBAP [Organic Chemical,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "SIN-1-induced JNK activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "PARP cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]
Processing 00000000.tx.133: PC12 cells were exposed to 3 mM SIN-1 in the absence or presence of varying concentrations (30, 100, and 300 M) of MnTBAP for 10 h. 

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to 3 mM SIN-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of varying concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(30,"

Phrase: "100,"

Phrase: "and"

Phrase: "300"

Phrase: "M) of MnTBAP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0384992:MnTBAP [Organic Chemical,Pharmacologic Substance]
   790   C0441923:M+ [Intellectual Product]

Phrase: "for 10 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.134: Protein from cell lysates was resolved by SDS-PAGE and analyzed by Western blot using antibodies against PARP, pJNK, and JNK. 

Phrase: "Protein from cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "resolved by SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "analyzed by Western blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies against PARP,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "pJNK,"

Phrase: "and"

Phrase: "JNK."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]
Processing 00000000.tx.135: The actin band is shown to confirm equal loading of proteins.  

Phrase: "The actin band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "equal loading of proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1708715:Loading [Activity]
Processing 00000000.tx.136: SIN-1 Treatment Induced Activation of COX-2 and PPAR To investigate the probable involvement of inflammatory pathways in nitrosative PC12 cell death induced by SIN-1, COX-2 expression was measured by Western blot analysis. 

Phrase: "SIN-1 Treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "Induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "Activation of COX-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "PPAR To"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   937   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   937   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   840   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0752063:Peroxysome [Cell Component]
   804   C1879547:Activated [Activity]
   804   C2984308:Peroxisome [Functional Concept]
   771 E C1515877:Activate [Functional Concept]
   733 E C3546463:peroxisomal [Cell Component]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the probable involvement of inflammatory pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "in nitrosative PC12 cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007587:Cell Death [Cell Function]
   861   C0085262:PC12 Cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "induced by SIN-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induced [Functional Concept]
   770   C0815304:sin [Idea or Concept]

Phrase: "COX-2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "measured by Western blot analysis."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.137: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.138: 2A illustrates a time-related up-regulation of COX-2 in cells exposed to peroxynitrite. 

Phrase: "2A"

Phrase: "illustrates"

Phrase: "a time-"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "up-regulation of COX-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0041904:Up-Regulation [Cell Function,Molecular Function]
   833   C0162493:Up-Regulation [Genetic Function]
   770   C0547043:Up [Spatial Concept]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1282911:Up [Spatial Concept]
   770   C1327622:Regulation [Biologic Function]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to peroxynitrite."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]
Processing 00000000.tx.139: The release of PGE2, one of the major COX-2 products, was also substantially elevated by SIN-1 treatment (Fig. 2A). 

Phrase: "The release of PGE2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "one of the major COX-2 products,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "also substantially"

Phrase: "elevated by SIN-1 treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0815304:sin [Idea or Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3163633:Elevated [Qualitative Concept]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.140: To clarify the role of COX-2 during the nitrosative cell death, two selective COX-2 inhibitors, SC-58635, and NS-398, were coincubated with 2 mM SIN-1 for 24 h. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the role of COX-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "during the nitrosative cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "two selective COX-2 inhibitors,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0085387:Cyclooxygenase Inhibitors [Pharmacologic Substance]
   861   C2756982:Cyclooxygenase Inhibitors [Molecular Function]
   844 E C3536910:Cyclooxygenase Inhibitor [Pharmacologic Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "SC-58635,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0538926:SC 58635 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "NS-398,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0215737:NS 398 [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "coincubated with 2 mM SIN-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.141: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.142: 2B, both of these COX-2 selective inhibitors aggravated SIN-1-induced cytotoxicity. 

Phrase: "2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]

Phrase: "both of these COX-2 selective inhibitors"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   783   C0085387:Cyclooxygenase Inhibitors [Pharmacologic Substance]
   783   C2756982:Cyclooxygenase Inhibitors [Molecular Function]
   767 E C3536910:Cyclooxygenase Inhibitor [Pharmacologic Substance]
   753   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0238767:Both [Spatial Concept]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   753   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1565860:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1706086:Both [Qualitative Concept]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "aggravated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0436331:Aggravated [Finding]
  1000   C1444749:Aggravated [Qualitative Concept]

Phrase: "SIN-1-induced cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   741 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   741 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.143: View larger version (29K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.144: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.145: COX-2 and PPAR expression induced by cytotoxic concentrations of SIN-1 in PC12 cells. 

Phrase: "COX-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1565860:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "PPAR expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597360:receptor expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   771   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "induced by cytotoxic concentrations of SIN-1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0086045:Concentrations [Mental Process]
   748   C0205263:Induced [Functional Concept]
   748   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   748   C0815304:sin [Idea or Concept]
   748   C1511636:cytotoxic [Functional Concept]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "in PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.146: A, SIN-1-induced COX-2 expression and PGE2 production in PC12 cells. 

Phrase: "A,"

Phrase: "SIN-1-induced COX-2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PGE2 production in PC12 cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]
Processing 00000000.tx.147: Cells were exposed to 3 mM SIN-1 for indicated time periods. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to 3 mM SIN-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]

Phrase: "for indicated time periods."
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   901   C0439582:Time periods [Temporal Concept]
   873 E C0585019:Temporal periods [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C0439531:/period [Temporal Concept]
   793   C1948053:Period [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C0332182:Periodic [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]
   743 E C1706381:PERIODIC [Intellectual Product]
   721 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.148: COX-2 expression was examined by Western blot analysis, and PGE2 production was measured 24 h later by using the PGE2 enzyme immunoassay kit. 

Phrase: "COX-2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "examined by Western blot analysis,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0332128:Examined [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "PGE2 production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "24 h"

Phrase: "later by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0205087:Late [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the PGE2 enzyme immunoassay kit."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.149: B, aggravation of SIN-1-induced cytotoxicity by COX-2 inhibitors. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "aggravation of SIN-1-induced cytotoxicity"

Phrase: "by COX-2 inhibitors."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085387:Cyclooxygenase Inhibitors [Pharmacologic Substance]
  1000   C2756982:Cyclooxygenase Inhibitors [Molecular Function]
   983 E C3536910:Cyclooxygenase Inhibitor [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.150: PC12 cells were treated with SC-58635 (15 and 30 M) or NS-398 (30 M) in the presence or absence of 2 mM SIN-1 for 24 h. 

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with SC-58635"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C0538926:SC 58635 [Organic Chemical,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(15"

Phrase: "and"

Phrase: "30"

Phrase: "M)"

Phrase: "or"

Phrase: "NS-398"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0215737:NS 398 [Organic Chemical,Pharmacologic Substance]

Phrase: "(30"

Phrase: "M) in the presence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C0441923:M+ [Intellectual Product]

Phrase: "or"

Phrase: "absence of 2 mM SIN-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.151: The cell viability was measured by the MTT reduction assay. 

Phrase: "The cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured by the MTT reduction assay."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C0201596:MTT reduction assay [Laboratory Procedure]
   783   C2986858:MTT Assay [Research Activity]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]
   753   C0444706:Measured [Qualitative Concept]
   753   C0647210:mtt [Lipid]
   753   C1510438:Assay [Laboratory Procedure]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.152: C, SIN-1-induced PPAR expression. 

Phrase: "C,"

Phrase: "SIN-1-induced PPAR expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597360:receptor expression [Genetic Function]
   793   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.153: PC12 cells were exposed to 3 mM SIN-1 for indicated time periods. 

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to 3 mM SIN-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]

Phrase: "for indicated time periods."
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   901   C0439582:Time periods [Temporal Concept]
   873 E C0585019:Temporal periods [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C0439531:/period [Temporal Concept]
   793   C1948053:Period [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C0332182:Periodic [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]
   743 E C1706381:PERIODIC [Intellectual Product]
   721 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.154: PPAR induction was examined by Western blot analysis. 

Phrase: "PPAR induction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205263:Induction [Functional Concept]
   804   C0857127:induction [Therapeutic or Preventive Procedure]
   771   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   771   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "was"

Phrase: "examined by Western blot analysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0332128:Examined [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
Processing 00000000.tx.155: D, enhancement of SIN-1-induced cytotoxicity by the PPAR antagonist GW9662. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "enhancement of SIN-1-induced cytotoxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: "by the PPAR antagonist GW9662."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1137010:GW9662 [Organic Chemical,Pharmacologic Substance]
   734   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
Processing 00000000.tx.156: PC12 cells were treated with GW9662 (1, 5, or 10 M) together with 2 mM SIN-1 for 24 h. 

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with GW9662"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1137010:GW9662 [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "or"

Phrase: "10"

Phrase: "M) together with 2 mM SIN-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1418486:MM-1 [Gene or Genome]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C0815304:sin [Idea or Concept]
   748   C1883357:Together [Qualitative Concept]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.157: The results are presented as means  S.D. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "presented as means  S.D."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0449450:Presented [Idea or Concept]
   760   C1704970:Means [Conceptual Entity]
   726 E C0150312:Present [Quantitative Concept]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.158: (n = 3). 

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.159: *, significantly different from the group treated with SIN-1 alone (p < 0.01).  

Phrase: "*,"

Phrase: "significantly different from the group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "treated with SIN-1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0815304:sin [Idea or Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.160: PPAR is implicated in anti-inflammatory and proapoptotic properties of several NSAIDs. 

Phrase: "PPAR"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "is"

Phrase: "implicated in anti-inflammatory"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0003209:Anti-inflammatory [Pharmacologic Substance]
   833   C1515999:Anti-inflammatory [Qualitative Concept]
   770   C0333348:Inflammatory [Functional Concept]

Phrase: "and"

Phrase: "proapoptotic properties of several NSAIDs."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   742   C0871161:properties [Qualitative Concept]
   742   C1292721:properties [Functional Concept]
   708 E C1882134:Property [Conceptual Entity]
   708 E C2347695:Property [Entity]
Processing 00000000.tx.161: PPAR expression was increased in cells treated with a proapoptotic concentration of SIN-1 (Fig. 2C). 

Phrase: "PPAR expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597360:receptor expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   771   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "was"

Phrase: "increased in cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "treated with a proapoptotic concentration of SIN-1"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   744   C0086045:Concentration [Mental Process]
   744   C0815304:sin [Idea or Concept]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1522326:Treated [Functional Concept]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.162: To determine the role of PPAR during the nitrosative PC12 cell death, a PPAR antagonist GW9662 was added to the media together with SIN-1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the role of PPAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "during the nitrosative PC12 cell death,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007587:Cell Death [Cell Function]
   861   C0085262:PC12 Cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "a PPAR antagonist GW9662"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1137010:GW9662 [Organic Chemical,Pharmacologic Substance]
   734   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "was"

Phrase: "added to the media"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1524062:Added [Functional Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C1883712:Add [Functional Concept]
   737 E C3244283:medium [Intellectual Product]

Phrase: "together with SIN-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]
Processing 00000000.tx.163: As illustrated in Fig. 

Phrase: "As"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.164: 2D, GW9662 aggravated SIN-1-induced cytotoxicity. 

Phrase: "2D, GW9662 aggravated SIN-1-induced cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   795   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   724 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   724 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.165: Since pharmacologic inhibition of both COX-2 and PPAR further enhanced the SIN-1-induced cell death, it is likely that the product of COX-2 capable of acting as a PPAR ligand exerts cytoprotective effects. 

Phrase: "Since"

Phrase: "pharmacologic inhibition of both COX-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "PPAR further"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   937   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   937   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   840   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0752063:Peroxysome [Cell Component]
   804   C1517331:Further [Spatial Concept]
   804   C1879547:Activated [Activity]
   804   C2984308:Peroxisome [Functional Concept]
   771 E C0205108:far [Spatial Concept]
   771 E C1515877:Activate [Functional Concept]
   733 E C3546463:peroxisomal [Cell Component]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the SIN-1-induced cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0007587:Cell Death [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0011065:Death [Organism Function]
   804   C1269647:Cell [Cell]
   804   C1306577:Death, NOS [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the product of COX-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514468:product [Entity]
   770   C1704444:Product [Quantitative Concept]

Phrase: "capable of acting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "as"

Phrase: "a PPAR ligand"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1621296:receptor ligand [Molecular Function]
   804   C0023688:Ligand [Chemical]
   771   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   771   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "cytoprotective effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.166: Based on the fact that 15d-PGJ2 produced in the arachidonic cascade mediated by COX-2 is an endogenous activator of PPAR, the possible involvement of this cyclopentenone PG in the cellular defense mechanism against SIN-1-induced cell death was explored. 

Phrase: "Based on the fact"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "produced in the arachidonic cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707310:Cascade [Manufactured Object]

Phrase: "mediated by COX-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1565860:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "an endogenous activator of PPAR,"

Phrase: "the possible involvement of this cyclopentenone PG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1314939:Involvement [Functional Concept]

Phrase: "in the cellular defense mechanism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0011142:defense mechanism [Mental Process]
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]
   827   C1880266:Defense [Conceptual Entity]

Phrase: "against SIN-1-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0007587:Cell Death [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0011065:Death [Organism Function]
   804   C1269647:Cell [Cell]
   804   C1306577:Death, NOS [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "explored."
Processing 00000000.tx.167: 15d-PGJ2 was hence proposed as a probable common denominator in the COX-2- and PPAR-mediated processes that confer cell survival or adaptation in response to the nitrosative insult. 

Phrase: "15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "was"

Phrase: "hence"

Phrase: "proposed as a probable common denominator"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0033204:Probable [Quantitative Concept]
   753   C0205214:Common [Quantitative Concept]
   753   C0332148:Probable [Qualitative Concept]
   753   C1441414:PROPOSED [Idea or Concept]
   753   C1522138:Common [Functional Concept]
   753   C1553874:Proposed [Qualitative Concept]
   753   C1578820:Proposed [Idea or Concept]
   753   C2825218:Denominator [Quantitative Concept]
   753   C3245511:common [Intellectual Product]

Phrase: "in the COX-2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1565860:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "PPAR-"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "mediated processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "confer"

Phrase: "cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "adaptation in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0000934:adaptation [Organism Function]
   790   C0392673:Adaptation [Biologic Function]

Phrase: "to the nitrosative insult."
Processing 00000000.tx.168: The levels of 15d-PGJ2 was elevated in both culture media and cell lysates after SIN-1 stimulation (Fig. 3, A and B). 

Phrase: "The levels of 15d-PGJ2"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "elevated in both culture media"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0162867:Media [Tissue]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1254021:Media [Tissue]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3163633:Elevated [Qualitative Concept]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "cell lysates after SIN-1 stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.169: To clarify the role of elevated 15d-PGJ2 during the SIN-1-induced nitrosative cell death, two selective COX-2 inhibitors (SC-58635 and NS-398) were coincubated with SIN-1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the role of elevated 15d-PGJ2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "during the SIN-1-induced nitrosative cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007587:Cell Death [Cell Function]
   799   C0007634:Cell [Cell]
   799   C0011065:Death [Organism Function]
   799   C1269647:Cell [Cell]
   799   C1306577:Death, NOS [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "two selective COX-2 inhibitors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0085387:Cyclooxygenase Inhibitors [Pharmacologic Substance]
   861   C2756982:Cyclooxygenase Inhibitors [Molecular Function]
   844 E C3536910:Cyclooxygenase Inhibitor [Pharmacologic Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(SC-58635"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0538926:SC 58635 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "NS-398"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0215737:NS 398 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "coincubated with SIN-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0815304:sin [Idea or Concept]
Processing 00000000.tx.170: As illustrated in Fig. 

Phrase: "As"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.171: 3, A and B, both of SC-58635 and NS-398 significantly reduced SIN-1-induced 15d-PGJ2 production, at the concentration that aggravated nitrosative cell death. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "both of SC-58635"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0538926:SC 58635 [Organic Chemical,Pharmacologic Substance]
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "NS-398 significantly reduced SIN-1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   895   C0165193:NS-1 [Organic Chemical,Pharmacologic Substance]
   895   C1424660:NS-1 [Gene or Genome]
   799   C0815304:sin [Idea or Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "15d-PGJ2 production,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1514503:Prostaglandin Production [Physiologic Function]
   812   C0033268:production [Occupational Activity]

Phrase: "at the concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "that aggravated nitrosative cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.172: View larger version (33K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.173: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.174: Protective effect of 15d-PGJ2 against SIN-1-induced apoptosis in PC12 cells. 

Phrase: "Protective effect of 15d-PGJ2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "against SIN-1-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "in PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.175: A and B, SIN-1-induced 15d-PGJ2 production and the effect of COX-2 inhibitors. 

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "SIN-1-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "15d-PGJ2 production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1514503:Prostaglandin Production [Physiologic Function]
   812   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "the effect of COX-2 inhibitors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.176: PC12 cells were treated with SC-58635 (30 M) or NS-398 (30 M) in the absence or presence of SIN-1 (2 mM) for 24 h. 

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with SC-58635"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C0538926:SC 58635 [Organic Chemical,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(30"

Phrase: "M)"

Phrase: "or"

Phrase: "NS-398"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0215737:NS 398 [Organic Chemical,Pharmacologic Substance]

Phrase: "(30"

Phrase: "M) in the absence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332197:absence [Quantitative Concept]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "presence of SIN-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(2 mM) for 24 h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C0456680:mm/h [Quantitative Concept]
Processing 00000000.tx.177: 15d-PGJ2 production in the culture media (A) and cell lysates (B) was measured by using the 15d-PGJ2 enzyme immunoassay kit. 

Phrase: "15d-PGJ2 production in the culture media"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1514503:Prostaglandin Production [Physiologic Function]
   744   C0033268:production [Occupational Activity]

Phrase: "(A)"

Phrase: "and"

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "was"

Phrase: "measured by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0444706:Measured [Qualitative Concept]
   833   C3541902:MEASURED [Diagnostic Procedure]
   799 E C0079809:Measure [Quantitative Concept]
   799 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 15d-PGJ2 enzyme immunoassay kit."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0812225:KIT [Medical Device]
   799   C1150635:KIT [Molecular Function]
   799   C1705212:Kit [Medical Device]
   799   C1705213:KIT [Medical Device]
   799   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.178: C, 15d-PGJ2-mediated protection of PC12 cells from SIN-1-induced cytotoxicity. 

Phrase: "C,"

Phrase: "15d-PGJ2-mediated protection of PC12 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0524828:Cell Protection [Physiologic Function]
   744   C1545588:Protection [Finding]

Phrase: "from SIN-1-induced cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   741 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   741 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.179: After 24 h of preincubation with 15d-PGJ2 (0.5 or 2 M), PC12 cells were exposed to 3 mM SIN-1 for additional 24 h, and the cell viability was determined by the MTT reduction assay. 

Phrase: "After 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of preincubation"

Phrase: "with 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "(0.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "or"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "M)"

Phrase: ","

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to 3 mM SIN-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]

Phrase: "for additional 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "the cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined by the MTT reduction assay."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0201596:MTT reduction assay [Laboratory Procedure]
   783   C2986858:MTT Assay [Research Activity]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]
   753   C0647210:mtt [Lipid]
   753   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.180: The results are presented as means  S.D. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "presented as means  S.D."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0449450:Presented [Idea or Concept]
   760   C1704970:Means [Conceptual Entity]
   726 E C0150312:Present [Quantitative Concept]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.181: (n = 3). 

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.182: *, significantly different from the SIN-1 alone group (p < 0.01). 

Phrase: "*,"

Phrase: "significantly different from the SIN-1 alone group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]

Phrase: "(p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.183: D, attenuation of SIN-1-induced internucleosomal DNA fragmentation by 15d-PGJ2 in PC12 cells. a, untreated control cells. b, cells treated with 3 mM SIN-1 for 10 h. c, cells treated with 3 mM SIN-1 after 24 h of preincubation with 2 M 15d-PGJ2. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "attenuation of SIN-1-induced internucleosomal DNA fragmentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0599946:Attenuation [Activity]

Phrase: "by 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "in PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "a,"

Phrase: "untreated control cells. b,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with 3 mM SIN-1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for 10 h. c,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with 3 mM SIN-1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "after 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of preincubation"

Phrase: "with 2 M 15d-PGJ2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   804   C0442778:J2 [Finding]
   804   C1416167:J2 [Gene or Genome]
   804   C1421123:J2 [Gene or Genome]
Processing 00000000.tx.184: E, amelioration of SIN-1-induced perturbation of mitochondrial transmembrane permeability (m) by 15d-PGJ2. 

Phrase: "E,"

Phrase: "amelioration of SIN-1-induced perturbation of mitochondrial transmembrane permeability"

Phrase: "("

Phrase: "m) by 15d-PGJ2."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   797   C0049896:prostaglandin M [Eicosanoid]
   760   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0442778:J2 [Finding]
   760   C1266240:Prostaglandin [Laboratory Procedure]
   760   C1416167:J2 [Gene or Genome]
   760   C1421123:J2 [Gene or Genome]
Processing 00000000.tx.185: m was assessed by changes in the TMRE fluorescence as described under "Experimental Procedures." 

Phrase: "m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "assessed by changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1516048:Assessed [Activity]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in the TMRE fluorescence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   756   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.186: Images of the cellular fluorescence were acquired by using a confocal laser-scanning microscope. a, untreated control cells. b, cells treated with 3 mM SIN-1 for 5 h. c, cells treated with 3 mM SIN-1 after 24 h preincubation with 2 M 15d-PGJ2. 

Phrase: "Images of the cellular fluorescence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired by"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   833   C0439661:Acquired [Temporal Concept]
   833   C3245488:acquired [Intellectual Product]
   799 E C1706701:Acquire [Activity]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0205217:Increased [Quantitative Concept]
   740 E C0442805:Increase [Functional Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C1301820:Obtain [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a confocal laser-scanning microscope."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   902   C1626420:Confocal microscope [Medical Device]
   812   C0023089:Laser [Manufactured Object]
   812   C0034606:Scanning [Diagnostic Procedure]
   812   C0181839:Microscope [Medical Device]
   812   C0441633:Scanning [Diagnostic Procedure]
   812   C0458142:Laser [Phenomenon or Process]
   812   C1023865:Laser [Plant]
   812   C1706315:Laser [Medical Device]
   812   C1706379:Microscope [Medical Device]
   779 E C2826292:SCAN [Finding]

Phrase: "a,"

Phrase: "untreated control cells. b,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with 3 mM SIN-1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for 5 h. c,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with 3 mM SIN-1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "after 24 h preincubation"

Phrase: "with 2 M 15d-PGJ2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   804   C0442778:J2 [Finding]
   804   C1416167:J2 [Gene or Genome]
   804   C1421123:J2 [Gene or Genome]
Processing 00000000.tx.187: m was quantified by measuring average values of the red fluorescence intensity of four fields, each containing about 400 cells.  

Phrase: "m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "quantified by measuring average values of the red fluorescence intensity of four fields,"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   735   C0016315:Fluorescence [Natural Phenomenon or Process]
   735   C0042295:Values [Qualitative Concept]
   735   C0205450:Four [Quantitative Concept]
   735   C0332575:Red [Finding]
   735   C0444706:measuring [Qualitative Concept]
   735   C0449770:measuring [Quantitative Concept]
   735   C0522510:Intensity [Qualitative Concept]
   735   C1260956:Red [Qualitative Concept]
   735   C1510992:Average [Quantitative Concept]
   735   C2825518:AVERAGE [Quantitative Concept]
   702 E C0079809:Measure [Quantitative Concept]
   702 E C0242485:Measure [Functional Concept]
   702   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   702   C1521738:Field [Conceptual Entity]
   702 E C1522609:Value [Quantitative Concept]
   702   C1709793:Quantify [Quantitative Concept]
   702   C2346620:Field [Conceptual Entity]
   702   C2349184:Field [Conceptual Entity]
   702   C3539073:FIELD [Spatial Concept]

Phrase: "each"

Phrase: "containing about 400 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0332256:Containing [Functional Concept]
   770   C2700400:Containing [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.188: Though relatively high concentrations (>10 M) of 15d-PGJ2 alone elicited a proapoptotic response in PC12 cells (data not shown), 24 h treatment with nontoxic concentrations (0.5 or 2 M) of this cyclopentenone PG prior to SIN-1 exposure markedly restored the viability (Fig. 3C). 

Phrase: "Though"

Phrase: "relatively high concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: ">10"

Phrase: "M) of 15d-PGJ2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   797   C0049896:prostaglandin M [Eicosanoid]
   760   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0442778:J2 [Finding]
   760   C1266240:Prostaglandin [Laboratory Procedure]
   760   C1416167:J2 [Gene or Genome]
   760   C1421123:J2 [Gene or Genome]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "elicited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicited [Qualitative Concept]

Phrase: "a proapoptotic response in PC12 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "24 h treatment with nontoxic concentrations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "(0.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "or"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "M) of this cyclopentenone PG"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1413763:PG-M [Gene or Genome]
   760   C0111605:cyclopentenone [Organic Chemical,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1266240:PG [Laboratory Procedure]

Phrase: "prior to SIN-1 exposure markedly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0274281:Exposure, NOS [Injury or Poisoning]
   812   C0332157:Exposure [Clinical Attribute]

Phrase: "restored"

Phrase: "the viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.189: Co-treatment of 15d-PGJ2 failed to protect PC12 cells against the SIN-1-induced cytotoxicity (data not shown), suggesting that 15d-PGJ2 itself is not a direct peroxynitrite scavenger. 

Phrase: "Co-treatment of 15d-PGJ2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0814472:co-treatment [Health Care Activity]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "protect"

Phrase: "PC12 cells against the SIN-1-induced cytotoxicity"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0085262:PC12 Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   714   C0022686:Cytotoxic cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "itself"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a direct peroxynitrite scavenger."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017108:scavenger [Medical Device]
   827   C1003377:scavenger [Fish]
Processing 00000000.tx.190: The protective effect of 15d-PGJ2 against SIN-1-induced apoptosis was further confirmed by analyzing several hallmarks of apoptosis. 

Phrase: "The protective effect of 15d-PGJ2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "against SIN-1-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirmed by analyzing several hallmarks of apoptosis."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   748   C0162638:Apoptosis [Cell Function]
   748   C0750484:Confirmed [Idea or Concept]
   714 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.191: As illustrated in Fig. 

Phrase: "As"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.192: 3D, a nontoxic concentration (i.e. 2 M) of 15d-PGJ2 ameliorated SIN-1-induced internucleosomal DNA fragmentation as revealed by TUNEL staining. 

Phrase: "3D,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450363:3D [Spatial Concept]
  1000   C2986797:3D [Functional Concept]

Phrase: "a nontoxic concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(i.e. 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "M)"

Phrase: "of 15d-PGJ2 ameliorated SIN-1-induced internucleosomal DNA fragmentation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0376669:DNA Fragmentation [Molecular Function]
   790   C0332472:Fragmentation [Anatomical Abnormality]
   790   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "as"

Phrase: "revealed by TUNEL staining."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0443289:Revealed [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0487602:Staining [Laboratory Procedure]
   742   C1167624:Labeling [Mental Process]
   742   C1704680:Staining [Finding]
   742   C1947902:Labeling [Manufactured Object]
   742   C2746065:End [Temporal Concept]
   742   C2827499:Labeling [Governmental or Regulatory Activity]
   734   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
Processing 00000000.tx.193: Mitochondrial depolarization occurs in the cells undergoing apoptosis. 

Phrase: "Mitochondrial depolarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1816452:mitochondrial depolarisation [Cell Function]

Phrase: "occurs in the cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "undergoing"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.194: TMRE is detected as red fluorescence in the intact mitochondrial membrane. 

Phrase: "TMRE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   827   C0014898:Ester [Organic Chemical]

Phrase: "is"

Phrase: "detected as red fluorescence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0332575:Red [Finding]
   770   C0442726:Detected [Finding]
   770   C1260956:Red [Qualitative Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in the intact mitochondrial membrane."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0426199:intact membrane [Finding]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.195: In contrast, in cells treated with a proapoptotic concentration (i.e. 3mM) of SIN-1 alone for 5 h, the red staining disappeared, indicating the perturbation of the mitochondrial transmembrane potential (Fig. 3E). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with a proapoptotic concentration"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "(i.e. 3mM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: ")"

Phrase: "of SIN-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]

Phrase: "alone for 5 h,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Alone [Quantitative Concept]
   770   C0439044:alone [Finding]
   770   C0679994:alone [Group Attribute]

Phrase: "the red staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "disappeared"

Phrase: ","

Phrase: "indicating"

Phrase: "the perturbation of the mitochondrial transmembrane potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332453:perturbation [Functional Concept]

Phrase: "(Fig. 3E"

Phrase: ")."
Processing 00000000.tx.196: 15d-PGJ2 pretreatment restored the mitochondrial membrane potential (m). 

Phrase: "15d-PGJ2 pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1550147:Pretreatment [Substance]
   812   C2709094:pre treatment [Temporal Concept]
   812   C3539075:Pretreatment [Temporal Concept]
   812   C3539076:Pretreatment [Activity]

Phrase: "restored"

Phrase: "the mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "("

Phrase: "m)."
Processing 00000000.tx.197: Changes in m values were quantified by measuring the average values of the red fluorescence intensity of four fields, each containing about 400 cells (Fig. 3E). 

Phrase: "Changes in m values"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C0565965:Change values [Intellectual Product]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "quantified by measuring"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "the average values of the red fluorescence intensity of four fields,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0042295:Values [Qualitative Concept]
   704 E C1522609:Value [Quantitative Concept]

Phrase: "each"

Phrase: "containing about 400 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0332256:Containing [Functional Concept]
   770   C2700400:Containing [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3E"

Phrase: ")."
Processing 00000000.tx.198: It has been known that peroxynitrite may directly induce mitochondrial dysfunction through nitration of mitochondrial proteins, such as complex I, II, V respiratory system (2628). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that peroxynitrite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]

Phrase: "may"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "mitochondrial dysfunction through nitration of mitochondrial proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031847:dysfunction [Functional Concept]
   748   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "such as complex I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2245017:Complex I [Cell Component]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "II,"

Phrase: "V respiratory system"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0035237:Respiratory System [Body System]
   901   C0425442:RESPIRATORY SYSTEM [Finding]
   901   C1269561:Respiratory system [Body System]
   827   C0449913:System [Functional Concept]
   827   C0521346:respiratory [Functional Concept]
   827   C1546767:Respiratory [Intellectual Product]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(2628"

Phrase: ")."
Processing 00000000.tx.199: Preservation of m by 15d-PGJ2 implies that this cyclopentenone PG may increase the intracellular antioxidant capacity, which can efficiently quench peroxynitrite. 

Phrase: "Preservation of m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033085:Preservation [Laboratory Procedure]
   790   C1514402:Preservation [Laboratory Procedure]

Phrase: "by 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "implies"

Phrase: "that"

Phrase: "this cyclopentenone PG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the intracellular antioxidant capacity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003402:Antioxidant [Pharmacologic Substance]
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "which"

Phrase: "can"

Phrase: "efficiently"

Phrase: "quench"

Phrase: "peroxynitrite."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]
Processing 00000000.tx.200: 15d-PGJ2 Rescued PC12 Cells from Nitrosative Stress through Augmentation of Cellular GSHTo elucidate the plausible mechanism by which 15d-PGJ2 protected against apoptosis induced by SIN-1, the levels of peroxynitrite were initially compared in the cells with and without 15d-PGJ2 pretreatment (Fig. 4A). 

Phrase: "15d-PGJ2 Rescued PC12 Cells from Nitrosative Stress"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   764   C0085262:PC12 Cells [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "through Augmentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1293122:Augmentation [Therapeutic or Preventive Procedure]

Phrase: "of Cellular GSHTo"

Phrase: "elucidate"

Phrase: "the plausible mechanism by which 15d-PGJ2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "protected against apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by SIN-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induced [Functional Concept]
   770   C0815304:sin [Idea or Concept]

Phrase: "the levels of peroxynitrite"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "compared in the cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "with"

Phrase: "and without 15d-PGJ2 pretreatment"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   753   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   753   C0442778:J2 [Finding]
   753   C1266240:Prostaglandin [Laboratory Procedure]
   753   C1416167:J2 [Gene or Genome]
   753   C1421123:J2 [Gene or Genome]
   753   C1515981:And [Idea or Concept]
   753   C1550147:Pretreatment [Substance]
   753   C2709094:pre treatment [Temporal Concept]
   753   C3539075:Pretreatment [Temporal Concept]
   753   C3539076:Pretreatment [Activity]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.201: As illustrated in Fig. 

Phrase: "As"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.202: 4A, the accumulation of peroxynitrite in SIN-1-treated cells was significantly reduced by 2 M 15d-PGJ2. 

Phrase: "4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]

Phrase: "the accumulation of peroxynitrite"

Phrase: "in SIN-1-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced by 2 M 15d-PGJ2."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   774   C0049896:prostaglandin M [Eicosanoid]
   748   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0392756:Reduced [Qualitative Concept]
   748   C0441923:M+ [Intellectual Product]
   748   C0442778:J2 [Finding]
   748   C1266240:Prostaglandin [Laboratory Procedure]
   748   C1416167:J2 [Gene or Genome]
   748   C1421123:J2 [Gene or Genome]
Processing 00000000.tx.203: The free thiol group of GSH, the most abundant cellular antioxidant, is a target for peroxynitrite-mediated oxidation. 

Phrase: "The free thiol group of GSH,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "the most abundant cellular antioxidant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "is"

Phrase: "a target for peroxynitrite-mediated oxidation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.204: In support of this notion, intracellular GSH was substantially depleted at 6 h after SIN-1 treatment (Fig. 4B). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this notion,"

Phrase: "intracellular GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1260386:GSH [Disease or Syndrome]

Phrase: "was"

Phrase: "substantially"

Phrase: "depleted at 6 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0444953:H 6 [Intellectual Product]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0333668:Depleted [Functional Concept]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "after SIN-1 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.205: Preincubation of PC12 cells with 2 M 15d-PGJ2 for 24 h restored the GSH to the control level (SIN-1 alone, 64.8  5.55% of the control GSH level versus SIN-1 plus 15d-PGJ2, 102.1  6.51% of control, p < 0.05). 

Phrase: "Preincubation of PC12 cells"

Phrase: "with 2 M 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   804   C0442778:J2 [Finding]
   804   C1416167:J2 [Gene or Genome]
   804   C1421123:J2 [Gene or Genome]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "restored"

Phrase: "the GSH to the control level"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1260386:GSH [Disease or Syndrome]

Phrase: "(SIN-1 alone, 64.8  5.55%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0205171:Alone [Quantitative Concept]
   795   C0439044:alone [Finding]
   795   C0450382:55 [Intellectual Product]
   795   C0679994:alone [Group Attribute]
   795   C0815304:sin [Idea or Concept]

Phrase: "of the control GSH level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1260386:GSH [Disease or Syndrome]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "versus"

Phrase: "SIN-1 plus 15d-PGJ2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   799   C0442778:J2 [Finding]
   799   C1416167:J2 [Gene or Genome]
   799   C1421123:J2 [Gene or Genome]

Phrase: "102.1  6.51% of control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.206: The GSH depletion coincided with the cytotoxicity. 

Phrase: "The GSH depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]

Phrase: "coincided with the cytotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
Processing 00000000.tx.207: Moreover, the constitutive intracellular GSH concentration increased 140% following 15d-PGJ2 pretreatment (Fig. 4B). 

Phrase: "Moreover,"

Phrase: "the constitutive intracellular GSH concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "140%"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "15d-PGJ2 pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1550147:Pretreatment [Substance]
   812   C2709094:pre treatment [Temporal Concept]
   812   C3539075:Pretreatment [Temporal Concept]
   812   C3539076:Pretreatment [Activity]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.208: In another experiment, co-treatment of a physiological concentration (1 mM) of GSH significantly protected against SIN-1-induced cytotoxicity (SIN-1 alone, 11.8  1.2% versus SIN-1 plus GSH, 55.5  11.4% of control viability, p < 0.01) (Fig. 4C). 

Phrase: "In another experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "co-treatment of a physiological concentration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0814472:co-treatment [Health Care Activity]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "(1 mM) of GSH significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1418486:MM-1 [Gene or Genome]

Phrase: "protected against SIN-1-induced cytotoxicity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205263:Induced [Functional Concept]
   753   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   753   C0815304:sin [Idea or Concept]

Phrase: "(SIN-1 alone, 11.8  1.2%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0205171:Alone [Quantitative Concept]
   795   C0439044:alone [Finding]
   795   C0679994:alone [Group Attribute]
   795   C0815304:sin [Idea or Concept]

Phrase: "versus"

Phrase: "SIN-1 plus GSH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1260386:GSH [Disease or Syndrome]

Phrase: "55.5  11.4% of control viability,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0243148:control [Qualitative Concept]
   748   C0443348:viability [Qualitative Concept]
   748   C0450382:55 [Intellectual Product]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.209: View larger version (25K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.210: 4. 

Phrase: "4."
Processing 00000000.tx.211: Protection of nitrosative cell death by 15d-PGJ2 through augmentation of cellular GSH synthesis. 

Phrase: "Protection of nitrosative cell death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0524828:Cell Protection [Physiologic Function]
   760   C1545588:Protection [Finding]

Phrase: "by 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "through augmentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1293122:Augmentation [Therapeutic or Preventive Procedure]

Phrase: "of cellular GSH synthesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1523936:cellular synthesis [Cell Function]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
Processing 00000000.tx.212: A, reduced peroxynitrite accumulation by 15d-PGJ2 in SIN-1-treated PC12 cells. 

Phrase: "A,"

Phrase: "reduced peroxynitrite accumulation by 15d-PGJ2"

Phrase: "in SIN-1-treated PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0085262:PC12 Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.213: After 24 h of preincubation with 0.5 or 2 M 15d-PGJ2, PC12 cells were treated with 3 mM SIN-1 for additional 1 h. 

Phrase: "After 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of preincubation"

Phrase: "with 0.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "or"

Phrase: "2 M 15d-PGJ2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   804   C0442778:J2 [Finding]
   804   C1416167:J2 [Gene or Genome]
   804   C1421123:J2 [Gene or Genome]

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 3 mM SIN-1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for additional 1 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.214: Culture media were collected for measurement of the fluorescence intensity of DHR 123. 

Phrase: "Culture media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0162867:Media [Tissue]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1254021:Media [Tissue]
   861   C2242979:Culture [Laboratory Procedure]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "collected for measurement of the fluorescence intensity of DHR 123."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0058109:dihydrorhodamine 123 [Organic Chemical]
   739   C0016315:Fluorescence [Natural Phenomenon or Process]
   739   C0242485:Measurement [Functional Concept]
   739   C0522510:Intensity [Qualitative Concept]
   739   C1516695:Collected [Idea or Concept]
   739   C1516698:Collected [Functional Concept]
Processing 00000000.tx.215: The results are presented as means  S.D. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "presented as means  S.D."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0449450:Presented [Idea or Concept]
   760   C1704970:Means [Conceptual Entity]
   726 E C0150312:Present [Quantitative Concept]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.216: (n = 3). 

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.217: B, restoration of GSH by 15d-PGJ2 in SIN-1-treated cells. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "restoration of GSH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0449982:Restoration [Intellectual Product]

Phrase: "by 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "in SIN-1-treated cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.218: After 24 h of preincubation with 2 M 15d-PGJ2, PC12 cells were treated with 3 mM SIN-1 for additional 6 h. 

Phrase: "After 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of preincubation"

Phrase: "with 2 M 15d-PGJ2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   804   C0442778:J2 [Finding]
   804   C1416167:J2 [Gene or Genome]
   804   C1421123:J2 [Gene or Genome]

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 3 mM SIN-1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for additional 6 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.219: Intracellular GSH content was measured as described under "Experimental Procedures." 

Phrase: "Intracellular GSH content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1260386:GSH [Disease or Syndrome]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.220: Values represent means  S.D. of three samples. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "means  S.D."

Phrase: "of three samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.221: C, protective effect of GSH against SIN-1-induced cytotoxicity in PC12 cells. 

Phrase: "C,"

Phrase: "protective effect of GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "against SIN-1-induced cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   741 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   741 E C1511636:cytotoxic [Functional Concept]

Phrase: "in PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.222: Cells were treated with 3 mM SIN-1 in the absence or presence of 1 mM GSH for 10 h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 3 mM SIN-1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of 1 mM GSH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "for 10 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.223: D, PC12 cells were pre-exposed to 2 M 15d-PGJ2 with or without 1 mM BSO for 24 h, and then treated with 3 mM SIN-1. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pre-exposed to 2 M 15d-PGJ2"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   770   C0332157:Exposed to [Clinical Attribute]
           Exposed
   767   C0049896:prostaglandin M [Eicosanoid]
   744   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   744   C0332152:Pre [Temporal Concept]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C0442778:J2 [Finding]
   744   C0740175:Pre [Qualitative Concept]
   744   C1266240:Prostaglandin [Laboratory Procedure]
   744   C1416167:J2 [Gene or Genome]
   744   C1421123:J2 [Gene or Genome]
   744   C2257086:PRE [Genetic Function]

Phrase: "with"

Phrase: "or without 1 mM BSO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1418486:MM-1 [Gene or Genome]
   760   C0054252:BSO [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance,Pharmacologic Substance]

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with 3 mM SIN-1."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1418486:MM-1 [Gene or Genome]
   753   C0815304:sin [Idea or Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.224: Cytotoxicity was assessed by the MTT reduction assay 10 h later. 

Phrase: "Cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "was"

Phrase: "assessed by the MTT reduction assay 10 h later."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0201596:MTT reduction assay [Laboratory Procedure]
   762   C2986858:MTT Assay [Research Activity]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0033727:H+ [Element, Ion, or Isotope]
   742   C0243073:assay [Qualitative Concept]
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]
   742   C0441932:H+ [Classification]
   742   C0564385:/h [Quantitative Concept]
   742   C0647210:mtt [Lipid]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1516048:Assessed [Activity]
Processing 00000000.tx.225: The values are the means  S.D. 

Phrase: "The values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "the means  S.D."
Processing 00000000.tx.226: (n = 3).  

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.227: In order to link the GSH increase by 15d-PGJ2 to its cytoprotective effect, we have treated PC12 cells with 15d-PGJ2 and BSO for 24 h. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "the GSH increase by 15d-PGJ2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "to its cytoprotective effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "we"

Phrase: "have"

Phrase: "treated PC12 cells with 15d-PGJ2"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   778   C0085262:PC12 Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "BSO for 24 h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0054252:BSO [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance,Pharmacologic Substance]
Processing 00000000.tx.228: BSO inhibits the activity of GCL, the rate-determining enzyme in the de novo synthesis of GSH, thereby limiting the intracellular GSH. 

Phrase: "BSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0054252:BSO [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the activity of GCL,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "the rate-determining enzyme in the de novo synthesis of GSH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   718   C0597548:synthetic enzyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "thereby"

Phrase: "limiting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0439801:limiting [Functional Concept]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "the intracellular GSH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1260386:GSH [Disease or Syndrome]
Processing 00000000.tx.229: Again, 15d-PGJ2 protected PC12 cells from the SIN-1-induced cytotoxicity (SIN-1 alone, 10.3  1.6% of versus SIN-1 + 15d-PGJ2, 84.7  2.7% of the control viability, p < 0.01), which was significantly blocked by 1 mM BSO (SIN-1 + 15d-PGJ2 + BSO, 11.0  1.4% of the control viability, p < 0.01) as illustrated in Fig. 

Phrase: "Again,"

Phrase: "15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "protected"

Phrase: "PC12 cells from the SIN-1-induced cytotoxicity"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0085262:PC12 Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   714   C0022686:Cytotoxic cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(SIN-1 alone, 10.3  1.6% of"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1883310:10^3 [Quantitative Concept]
   767   C0439187:/10^6 [Quantitative Concept]
   767   C0877943:SIN-10 [Organic Chemical,Pharmacologic Substance]
   767   C1881839:10^6 [Quantitative Concept]
   744   C0205171:Alone [Quantitative Concept]
   744   C0439044:alone [Finding]
   744   C0679994:alone [Group Attribute]
   744   C0815304:sin [Idea or Concept]

Phrase: "versus"

Phrase: "SIN-1 + 15d-PGJ2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   804   C0442778:J2 [Finding]
   804   C1416167:J2 [Gene or Genome]
   804   C1421123:J2 [Gene or Genome]

Phrase: "84.7  2.7% of the control viability,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0243148:control [Qualitative Concept]
   744   C0443348:viability [Qualitative Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "significantly"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "by 1 mM BSO (SIN-1 + 15d-PGJ2 + BSO,"

Phrase: "11.0  1.4% of the control viability,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0243148:control [Qualitative Concept]
   744   C0443348:viability [Qualitative Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "as"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.230: 4D. 

Phrase: "4D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450377:4d [Intellectual Product]
  1000   C2986754:4D [Temporal Concept]
Processing 00000000.tx.231: These findings suggest that 15d-PGJ2 could enhance the cellular GSH level, thereby eliminating reactive peroxynitrite and exerting the cytoprotective effect. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "could"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the cellular GSH level,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1260386:GSH [Disease or Syndrome]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "thereby"

Phrase: "eliminating"

Phrase: "reactive peroxynitrite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]

Phrase: "and"

Phrase: "exerting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exerting [Organism Function]

Phrase: "the cytoprotective effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.232: 15d-PGJ2 Enhanced GCL mRNA Transcription and the Promotor ActivityTo elucidate the cellular mechanism responsible for increased GSH biosynthesis by 15d-PGJ2, its effect on the transcription of GCL was determined. 

Phrase: "15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "Enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "GCL mRNA Transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1158816:mRNA transcription [Genetic Function]
   827   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "the Promotor ActivityTo"

Phrase: "elucidate"

Phrase: "the cellular mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for increased GSH biosynthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "by 15d-PGJ2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "its effect on the transcription of GCL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.233: The GCL holoenzyme consists of catalytic (GCLC, 73 kDa) and modulatory (GCLM, 30 kDa) subunits, which are encoded by distinct genes. 

Phrase: "The GCL holoenzyme"

Phrase: "consists of catalytic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007382:Catalytic [Natural Phenomenon or Process]
   790   C0332529:CONSIST [Qualitative Concept]

Phrase: "(GCLC, 73 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "modulatory"

Phrase: "(GCLM, 30 kDa) subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1711351:Subunit [Quantitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "encoded by distinct genes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017337:Genes [Gene or Genome]
   770   C0679058:encoded [Mental Process]
   770   C2700640:Encoded [Activity]
Processing 00000000.tx.234: Treatment with 2 M 15d-PGJ2 increased the transcription of both GCLC and GCLM mRNA (Fig. 5A). 

Phrase: "Treatment with 2 M 15d-PGJ2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the transcription of both GCLC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0007382:Catalytic [Natural Phenomenon or Process]
   748   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "GCLM mRNA (Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.235: The GCLC promoter activity was highly elevated by 15d-PGJ2 treatment as revealed by the luciferase reporter gene assay (Fig. 5B). 

Phrase: "The GCLC promoter activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C1150651:ligase activity [Molecular Function]
   853   C0243102:catalytic activity [Molecular Function]
   853   C1264638:Catalytic activity [Functional Concept]
   853   C1547012:*Catalytic Activity [Quantitative Concept]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "elevated by 15d-PGJ2 treatment"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   753   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0205250:Elevated [Qualitative Concept]
   753   C0442778:J2 [Finding]
   753   C1266240:Prostaglandin [Laboratory Procedure]
   753   C1416167:J2 [Gene or Genome]
   753   C1421123:J2 [Gene or Genome]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3163633:Elevated [Qualitative Concept]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "as"

Phrase: "revealed by the luciferase reporter gene assay"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0206414:Reporter Gene [Gene or Genome]
   774   C1334435:Luciferase Gene [Gene or Genome]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0017337:Gene [Gene or Genome]
   748   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0243073:assay [Qualitative Concept]
   748   C0335038:Reporter [Professional or Occupational Group]
   748   C0443289:Revealed [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   748   C1705915:Reporter [Conceptual Entity]
   748   C1709908:Reporter [Group]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.236: Furthermore, PC12 cells treated with the same concentration of 15d-PGJ2 exhibited the significantly increased catalytic activity at 13 h compared with vehicle-treated control groups (2 M 15d-PGJ2 alone, 1.77  0.03 international unit/mg protein versus Me2SO, 0.99  0.31 international unit/mg protein, p < 0.05). 

Phrase: "Furthermore,"

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "treated with the same concentration of 15d-PGJ2"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   764   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   764   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   742   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   742   C0086045:Concentration [Mental Process]
   742   C0442778:J2 [Finding]
   742   C0445247:Same [Qualitative Concept]
   742   C1266240:Prostaglandin [Laboratory Procedure]
   742   C1416167:J2 [Gene or Genome]
   742   C1421123:J2 [Gene or Genome]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1522326:Treated [Functional Concept]
   708 E C1292734:TREAT [Functional Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "the significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "catalytic activity at 13 h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0243102:catalytic activity [Molecular Function]
   806   C1264638:Catalytic activity [Functional Concept]
   806   C1547012:*Catalytic Activity [Quantitative Concept]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "compared with vehicle-treated control groups"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   790   C0009932:Control Groups [Group]
   783   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0042444:Vehicle [Biomedical or Dental Material]
   753   C0243148:control [Qualitative Concept]
   753   C0348005:Vehicle [Manufactured Object]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1522326:Treated [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(2 M 15d-PGJ2 alone, 1.77  0.03 international unit/mg protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0700271:M Protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   786   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "versus"

Phrase: "Me2SO,"

Phrase: "0.99  0.31 international unit/mg protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.237: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.238: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.239: Enhancement of GCL mRNA expression and its promotor activity by 15d-PGJ2. 

Phrase: "Enhancement of GCL mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "and"

Phrase: "its promotor activity by 15d-PGJ2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.240: A, PC12 cells exposed to 2 M 15d-PGJ2 were harvested at indicated time intervals, and the total RNA samples were analyzed by RT-PCR for GCLC and GCLM mRNA transcripts as described under "Experimental Procedures." 

Phrase: "A,"

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to 2 M 15d-PGJ2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   774   C0049896:prostaglandin M [Eicosanoid]
   748   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C0442778:J2 [Finding]
   748   C1266240:Prostaglandin [Laboratory Procedure]
   748   C1416167:J2 [Gene or Genome]
   748   C1421123:J2 [Gene or Genome]

Phrase: "were"

Phrase: "harvested at indicated time intervals,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   773   C0872291:Time Interval [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C1272706:intervals [Temporal Concept]
   760   C1444656:Indicated [Finding]
   760   C3541383:Time [Temporal Concept]
   726   C1512335:Harvest [Health Care Activity]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "the total RNA samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by RT-PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C0936012:Analyzed [Research Activity]

Phrase: "for GCLC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0007382:Catalytic [Natural Phenomenon or Process]
   812   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0521125:For [Qualitative Concept]

Phrase: "and"

Phrase: "GCLM mRNA transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.241: GAPDH was used as an equal loading control. 

Phrase: "GAPDH"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "used as an equal loading control."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   753   C0205163:Equal [Qualitative Concept]
   753   C0243148:control [Qualitative Concept]
   753   C1273517:used [Finding]
   753   C1549782:Equal [Idea or Concept]
   753   C1550141:Control [Substance]
   753   C1708715:Loading [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.242: B, GCLC promoter activity was increased by 15d-PGJ2. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "GCLC promoter activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C1150651:ligase activity [Molecular Function]
   853   C0243102:catalytic activity [Molecular Function]
   853   C1264638:Catalytic activity [Functional Concept]
   853   C1547012:*Catalytic Activity [Quantitative Concept]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "increased by 15d-PGJ2."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   760   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442778:J2 [Finding]
   760   C0442805:Increased [Functional Concept]
   760   C1266240:Prostaglandin [Laboratory Procedure]
   760   C1416167:J2 [Gene or Genome]
   760   C1421123:J2 [Gene or Genome]
Processing 00000000.tx.243: PC12 cells were transiently transfected with a rat GCLC promoter-luciferase construct. 

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with a rat GCLC promoter-luciferase construct."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0007382:Catalytic [Natural Phenomenon or Process]
   739   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   739   C0034693:Rat, NOS [Mammal]
   739   C0034721:Rat [Mammal]
   739   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C2827421:Construct [Classification]
Processing 00000000.tx.244: Progressive 5' deletion mutant of the GCLC promoter extending from -1758 to +2 bp was generated and fused to the promoterless luciferase pGL3 enhancer. 

Phrase: "Progressive 5' deletion mutant of the GCLC promoter extending"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "from -1758 to +2 bp"

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "fused to the promoterless luciferase pGL3 enhancer."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0699952:Fused [Functional Concept]
   748   C1854336:PGL3 [Disease or Syndrome]
   748   C3273620:PGL3 [Gene or Genome]
   714 E C1414861:FUSE [Gene or Genome]
   714 E C1708111:Fuse [Manufactured Object]
Processing 00000000.tx.245: Cells were treated with 2 M 15d-PGJ2 () or vehicle () and analyzed for the luciferase activity 24 h later. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 2 M 15d-PGJ2"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   774   C0049896:prostaglandin M [Eicosanoid]
   748   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C0442778:J2 [Finding]
   748   C1266240:Prostaglandin [Laboratory Procedure]
   748   C1416167:J2 [Gene or Genome]
   748   C1421123:J2 [Gene or Genome]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "analyzed for the luciferase activity 24 h later."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C1151115:luciferase activity [Molecular Function]
   744   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0205177:Activity [Functional Concept]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]
   744   C0936012:Analyzed [Research Activity]
   744   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.246: Results represent means  S.D. of three individual experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "means  S.D."

Phrase: "of three individual experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.247: *, significantly different from the vehicle treated control groups (p < 0.01).   

Phrase: "*,"

Phrase: "significantly different from the vehicle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "control groups"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0009932:Control Groups [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.248: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Recently, nitrosative stress induced by reactive nitrogen species (RNS) has been implicated in diverse inflammation-related neurological disorders (4, 5). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "nitrosative stress induced by reactive nitrogen species (RNS)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0038435:Stress [Finding]
   748   C0205263:Induced [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in diverse inflammation-related neurological disorders"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0027765:Neurological Disorders [Disease or Syndrome]
   748   C0012634:Disorders [Disease or Syndrome]
   748   C0021368:Inflammation [Pathologic Function]
   748   C0205494:Neurological [Qualitative Concept]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1880371:Diverse [Qualitative Concept]
   748   C2707261:Neurological [Clinical Attribute]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.249: Although RNS can regulate physiological functions via the cyclic guanosine monophosphate-dependent mechanism, excessive RNS can destruct the cells. 

Phrase: "Although"

Phrase: "RNS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0969698:Reactive Nitrogen Species [Biologically Active Substance,Chemical Viewed Structurally]
   827   C0028158:Nitrogen [Element, Ion, or Isotope]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1550581:nitrogen [Human-caused Phenomenon or Process]
   827   C1705920:Species [Conceptual Entity]

Phrase: "can"

Phrase: "regulate"

Phrase: "physiological functions via the cyclic guanosine monophosphate-dependent mechanism,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0542341:Functions [Functional Concept]
   708 E C0031843:function [Physiologic Function]
   708 E C0700205:FUNCTION [Classification]
   708 E C1705273:Function [Intellectual Product]

Phrase: "excessive RNS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0969698:Reactive Nitrogen Species [Biologically Active Substance,Chemical Viewed Structurally]
   812   C0028158:Nitrogen [Element, Ion, or Isotope]
   812   C0205332:Reactive [Qualitative Concept]
   812   C1550581:nitrogen [Human-caused Phenomenon or Process]
   812   C1705920:Species [Conceptual Entity]

Phrase: "can"

Phrase: "destruct"

Phrase: "the cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.250: Therefore, regulation of RNS-mediated pro-inflammatory responses is important for cellular defense against nitrosative stress. 

Phrase: "Therefore,"

Phrase: "regulation of RNS-mediated pro-inflammatory responses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   798   C1327440:regulation of inflammatory response [Pathologic Function]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "important for cellular defense"

Phrase: "against nitrosative stress."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.251: Neuroinflammatory disorders are also characterized by up-regulation of COX-2 as well as iNOS, but the role of the former enzyme is yet to be clarified. 

Phrase: "Neuroinflammatory disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "are"

Phrase: "also"

Phrase: "characterized by up-regulation of COX-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
   753   C1565860:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1880022:Characterized [Activity]

Phrase: "as well as"

Phrase: "iNOS,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "but"

Phrase: "the role of the former enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "is"

Phrase: "yet to"

Phrase: "be"

Phrase: "clarified."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarified [Activity]
Processing 00000000.tx.252: The present study implies that peroxynitrite not only induces apoptosis in PC12 cells, but simultaneously provokes cellular adaptive response through induction of COX-2 and PPAR. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "implies"

Phrase: "that peroxynitrite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in PC12 cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "but"

Phrase: "simultaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "provokes"

Phrase: "cellular adaptive response through induction of COX-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0231193:Adaptive [Functional Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "PPAR."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.253: Induction of COX-2 expression during the RNS-mediated inflammation was observed in several experimental systems (29, 30). 

Phrase: "Induction of COX-2 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "during the RNS-mediated inflammation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0021368:Inflammation [Pathologic Function]
   717   C0969698:Reactive Nitrogen Species [Biologically Active Substance,Chemical Viewed Structurally]

Phrase: "was"

Phrase: "observed in several experimental systems"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1441672:Observed [Functional Concept]
   760   C1517586:Experimental [Qualitative Concept]
   726   C0449913:System [Functional Concept]
   726   C1553451:System [Manufactured Object]
   726   C1704459:System [Medical Device]

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.254: However, regulation of COX-2 by RNS is conflicting in various cellular systems. 

Phrase: "However,"

Phrase: "regulation of COX-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]

Phrase: "by RNS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0969698:Reactive Nitrogen Species [Biologically Active Substance,Chemical Viewed Structurally]
   827   C0028158:Nitrogen [Element, Ion, or Isotope]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1550581:nitrogen [Human-caused Phenomenon or Process]
   827   C1705920:Species [Conceptual Entity]

Phrase: "is"

Phrase: "conflicting in various cellular systems."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0007634:Cellular [Cell]
   760   C0009671:conflicting [Individual Behavior]
   760   C0178539:Cellular [Functional Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   726   C0449913:System [Functional Concept]
   726   C1553451:System [Manufactured Object]
   726   C1704459:System [Medical Device]
   726 E C1705242:Conflict [Qualitative Concept]
Processing 00000000.tx.255: Peroxynitrite has been reported to activate constitutive and inducible COX, by serving as a substrate for COX better than NO (29). 

Phrase: "Peroxynitrite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "constitutive"

Phrase: "and"

Phrase: "inducible COX,"

Phrase: "by serving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519269:Serving [Quantitative Concept]

Phrase: "as a substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "for COX"

Phrase: "better than NO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332272:Better [Qualitative Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.256: Since COX-2 is a wellknown pro-inflammatory enzyme, its induction was initially expected to provoke an excessive inflammatory response, contributing to SIN-1-induced cell death. 

Phrase: "Since"

Phrase: "COX-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1565860:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a wellknown pro-inflammatory enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "its induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provoke"

Phrase: "an excessive inflammatory response,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1155266:Inflammatory Response [Pathologic Function]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "contributing to SIN-1-induced cell death."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0007587:Cell Death [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0011065:Death [Organism Function]
   748   C0205263:Induced [Functional Concept]
   748   C0815304:sin [Idea or Concept]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1880177:Contributing [Activity]
   748   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.257: Contrary to this initial expectation, we found that COX-2 could play a role in protecting against nitrosative PC12 cell death. 

Phrase: "Contrary to this initial expectation,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that COX-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1565860:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "could"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in protecting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "against nitrosative PC12 cell death."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007587:Cell Death [Cell Function]
   861   C0085262:PC12 Cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.258: COX-2 expression occurred transiently in cells treated with SIN-1, and COX-2 inhibition by SC-58635- or NS-398-sensitized PC12 cells to SIN-1-induced toxicity. 

Phrase: "COX-2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "transiently in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "treated with SIN-1,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0815304:sin [Idea or Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "COX-2 inhibition by SC-58635-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "or"

Phrase: "NS-398-sensitized PC12 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   840   C0085262:PC12 Cells [Cell]
   836   C0312864:Sensitized cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "to SIN-1-induced toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   812   C0040539:toxicity [Qualitative Concept]
   812   C0600688:Toxicity [Injury or Poisoning]
   741 E C1407029:Toxic [Qualitative Concept]
   719 E C0032346:Poison [Hazardous or Poisonous Substance]
   719 E C1548769:Poison [Intellectual Product]
   719 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.259: Oxidative/nitrosative stress can activate the cellular antioxidant system, thereby making cells better adapt themselves to subsequent insults (31). 

Phrase: "Oxidative/nitrosative stress"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the cellular antioxidant system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "thereby making cells better"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C2347578:Cells/well [Quantitative Concept]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "adapt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2937289:adapt [Organic Chemical]

Phrase: "themselves to subsequent insults"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332282:Subsequent [Temporal Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.260: In this context, COX-2 induction in response to nitrosative stress may contribute to the adaptive response of PC12 cells. 

Phrase: "In this context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "COX-2 induction in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "to nitrosative stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "may"

Phrase: "contribute to the adaptive response of PC12 cells."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   770   C0085262:PC12 Cells [Cell]
           PC-12
   744   C0007634:Cells [Cell]
   744   C0231193:Adaptive [Functional Concept]
   744   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C1880177:Contribute [Activity]
   744   C2911692:Response [Mental Process]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.261: We hypothesize that peroxynitrite treatment initially triggers the COX-2-mediated arachidonic acid cascade to produce a series of distinct PGs of which 15d-PGJ2 is considered to prevent excessive inflammatory responses by inducing antioxidant protein expression (Fig. 6). 

Phrase: "We"

Phrase: "hypothesize"

Phrase: "that peroxynitrite treatment initially"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "the COX-2-mediated arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0003695:Arachidonic Acid [Eicosanoid]
   861   C2316832:Arachidonic Acid [Laboratory Procedure]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707310:Cascade [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "a series of distinct PGs of which 15d-PGJ2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   766   C0033555:A series prostaglandin [Eicosanoid,Pharmacologic Substance]
   739   C0205549:Series [Quantitative Concept]
   739   C2348044:Series [Intellectual Product]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "excessive inflammatory responses by inducing antioxidant protein expression"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1155266:inflammatory responses [Pathologic Function]
   744   C0871261:responses [Organism Attribute]
   711 E C1704632:Response [Finding]
   711 E C1706817:Response [Intellectual Product]
   711 E C2911692:Response [Mental Process]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.262: Indeed, SIN-1 treatment led to enhanced production of 15d-PGJ2 in PC12 cells. 

Phrase: "Indeed,"

Phrase: "SIN-1 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "led to enhanced production of 15d-PGJ2"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   770   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   767   C1514503:Prostaglandin Production [Physiologic Function]
   744   C0033268:production [Occupational Activity]
   744   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   744   C0442778:J2 [Finding]
   744   C1266240:Prostaglandin [Laboratory Procedure]
   744   C1416167:J2 [Gene or Genome]
   744   C1421123:J2 [Gene or Genome]
   744   C1708698:LED [Manufactured Object]
   744   C2349975:Enhanced [Activity]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1522538:Lead [Functional Concept]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.263: Moreover, pretreatment with nontoxic concentrations of 15d-PGJ2 not only reduced the peroxynitrite accumulation but also enhanced the viability in PC12 cells exposed to SIN-1, lending further support to the above hypothesis. 

Phrase: "Moreover,"

Phrase: "pretreatment with nontoxic concentrations of 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1550147:Pretreatment [Substance]
   744   C2709094:pre treatment [Temporal Concept]
   744   C3539075:Pretreatment [Temporal Concept]
   744   C3539076:Pretreatment [Activity]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the peroxynitrite accumulation"

Phrase: "but"

Phrase: "also"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the viability in PC12 cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C0007620:Cell Viability [Cell Function]
   762 E C1441322:Viable cells [Cell]
   760   C0443348:viability [Qualitative Concept]

Phrase: "exposed to SIN-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0815304:sin [Idea or Concept]

Phrase: "lending"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "support to the above hypothesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0183683:Support [Medical Device]
   760   C1512571:Hypothesis [Idea or Concept]
   760   C1521721:Support [Conceptual Entity]
Processing 00000000.tx.264: View larger version (27K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.265: 6. 

Phrase: "6."
Processing 00000000.tx.266: Proposed pathways of the 15d-PGJ2-mediated cellular adaptive response to peroxynitrite-induced nitrosative stress. 

Phrase: "Proposed pathways of the 15d-PGJ2-mediated cellular adaptive response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1704259:Pathways [Molecular Function]
   738   C1705987:Pathways [Conceptual Entity]

Phrase: "to peroxynitrite-induced nitrosative stress."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0038435:Stress [Finding]
   741 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.267: SIN-1 induces apoptotic death, which is accompanied by depletion of intracellular GSH, JNK activation, disruption of mitochondrial transmembrane potential, the cleavage of PARP and DNA fragmentation. 

Phrase: "SIN-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptotic death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "which"

Phrase: "is"

Phrase: "accompanied by depletion of intracellular GSH,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0175996:intracellular [Cell Component]
   753   C0178719:Intracellular [Spatial Concept]
   753   C0333668:Depletion [Functional Concept]
   753   C1260386:GSH [Disease or Syndrome]

Phrase: "JNK activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "disruption of mitochondrial transmembrane potential,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "the cleavage of PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "DNA fragmentation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376669:DNA Fragmentation [Molecular Function]
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]
Processing 00000000.tx.268: SIN-1 simultaneously provokes cellular adaptive response through induction of COX-2 and PPAR. 

Phrase: "SIN-1 simultaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0815304:sin [Idea or Concept]

Phrase: "provokes"

Phrase: "cellular adaptive response through induction of COX-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0231193:Adaptive [Functional Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "PPAR."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.269: 15d-PGJ2, as a product of COX-2 and a PPAR ligand, may act as a survival mediator by modulating the cellular signaling to up-regulate the GCL, thereby augmenting the intracellular GSH pool.  

Phrase: "15d-PGJ2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "as"

Phrase: "a product of COX-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514468:product [Entity]
   770   C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "a PPAR ligand,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1621296:receptor ligand [Molecular Function]
   804   C0023688:Ligand [Chemical]
   771   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   771   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "may"

Phrase: "act as a survival mediator"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0038952:Survival [Activity]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0220921:survival [Functional Concept]
   760   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "the cellular signaling to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037083:Signaling [Cell Function]
   770   C3537152:signaling [Biologic Function]

Phrase: "up-regulate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "the GCL,"

Phrase: "thereby"

Phrase: "augmenting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205217:augment [Quantitative Concept]

Phrase: "the intracellular GSH pool."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0337051:Pool [Geographic Area]
   827   C1509144:pool [Clinical Attribute]
   827   C2349200:Pool [Functional Concept]
Processing 00000000.tx.270: Although there have been numerous studies investigating the role of COX-2 in inflammatory cell death or tissue damage, the results are conflicting and discordant, depending on the experimental conditions employed. 

Phrase: "Although"

Phrase: "there"

Phrase: "have"

Phrase: "been"

Phrase: "numerous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "investigating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigating [Functional Concept]

Phrase: "the role of COX-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in inflammatory cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007587:Cell Death [Cell Function]
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]
   734   C0440752:Inflammatory cell [Cell]

Phrase: "or"

Phrase: "tissue damage,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010957:Tissue damage [Injury or Poisoning]
           Damage
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   861   C1883709:Damage [Functional Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "conflicting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009671:conflicting [Individual Behavior]
   966 E C1705242:Conflict [Qualitative Concept]

Phrase: "and"

Phrase: "discordant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3639994:Discordant [Conceptual Entity]

Phrase: "depending on the experimental conditions"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C1517586:Experimental [Qualitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C0725813:depend [Medical Device]
   726   C1705253:Condition [Conceptual Entity]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]

Phrase: "employed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]
Processing 00000000.tx.271: Thus, Colville-Nash and Gilroy (32) have suggested that the function of COX-2 may vary during the inflammatory process. 

Phrase: "Thus,"

Phrase: "Colville-Nash"

Phrase: "and"

Phrase: "Gilroy"

Phrase: "(32"

Phrase: ")"

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the function of COX-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "may"

Phrase: "vary during the inflammatory process."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0333348:Inflammatory [Functional Concept]
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.272: While early peak of COX-2 expression is primarily responsible for the onset of inflammation and PGE2 production, on which COX inhibitors exert an inhibitory effect, the much greater second peak in COX-2 reflects the resolution of the inflammation. 

Phrase: "While"

Phrase: "early peak of COX-2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0444505:Peak [Quantitative Concept]

Phrase: "is"

Phrase: "primarily responsible for the onset of inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "PGE2 production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "on which COX inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0085387:COX inhibitor [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "an inhibitory effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "the much greater second peak in COX-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0444505:Peak [Quantitative Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the resolution of the inflammation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514893:Resolution [Idea or Concept]
   760   C1706463:Resolution [Quantitative Concept]
   760   C2699488:Resolution [Conceptual Entity]
Processing 00000000.tx.273: Treatment with the COX-2 selective inhibitors during the resolving phase resulted in a prolongation of the inflammatory response and significant retardation of wound healing (33, 34). 

Phrase: "Treatment with the COX-2 selective inhibitors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "during the resolving phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "resulted in a prolongation of the inflammatory response"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1155266:Inflammatory Response [Pathologic Function]
   744   C0333348:Inflammatory [Functional Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "and"

Phrase: "significant retardation of wound healing"

Phrase: "(33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.274: Cyclopentenone PGs, such as 15d-PGJ2, is considered to contribute to the resolution of inflammation, as their levels have been elevated in the late phases of inflammation. 

Phrase: "Cyclopentenone PGs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0033554:Prostaglandins [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   827 E C1266240:Prostaglandin [Laboratory Procedure]

Phrase: "such as 15d-PGJ2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to the resolution of inflammation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021368:Inflammation [Pathologic Function]
   753   C1514893:Resolution [Idea or Concept]
   753   C1706463:Resolution [Quantitative Concept]
   753   C1880177:Contribute [Activity]
   753   C2699488:Resolution [Conceptual Entity]

Phrase: "as"

Phrase: "their levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "elevated in the late phases of inflammation."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0021368:Inflammation [Pathologic Function]
   748   C0205087:Late [Temporal Concept]
   748   C0205250:Elevated [Qualitative Concept]
   748   C0585064:Phases [Temporal Concept]
   748   C1067936:Phasis [Eukaryote]
   748   C3163633:Elevated [Qualitative Concept]
   714 E C0205390:Phase [Temporal Concept]
Processing 00000000.tx.275: COX-2 function should be defined in concert with expression profiles of other proteins, since the intracellular micro-environment can determine the distinct profile of COX-2 products and their physiologic functions. 

Phrase: "COX-2 function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "should"

Phrase: "be"

Phrase: "defined in concert"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1704788:Defined [Conceptual Entity]
   790   C3539106:Defined [Intellectual Product]

Phrase: "with expression profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "of other proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "since"

Phrase: "the intracellular micro-environment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014406:Environment [Spatial Concept]
   827   C0085672:MICRO [Laboratory Procedure]
   827   C1553035:Micro [Quantitative Concept]

Phrase: "can"

Phrase: "determine"

Phrase: "the distinct profile of COX-2 products"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1979963:Profile [Laboratory Procedure]
   753   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "their physiologic functions."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.276: Combined expression of cytosolic phospholipase A2 and PGD synthase together with COX-2 can produce sufficient endogenous cyclopentenone PGs to counteract the proinflammatory damage (16). 

Phrase: "Combined expression of cytosolic phospholipase A2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PGD synthase together with COX-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0072296:PGD synthase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "produce"

Phrase: "sufficient endogenous cyclopentenone PGs to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0033554:Prostaglandins [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   771 E C1266240:Prostaglandin [Laboratory Procedure]

Phrase: "counteract"

Phrase: "the proinflammatory damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.277: Transfection of PGD synthase cDNA or up-regulation of the enzyme by lamina shear stress could protect against apoptotic cell death (35). 

Phrase: "Transfection of PGD synthase cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "or"

Phrase: "up-regulation of the enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041904:Up-Regulation [Cell Function,Molecular Function]
   806   C0162493:Up-Regulation [Genetic Function]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by lamina shear stress"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C1171318:shear stress [Natural Phenomenon or Process]
   827   C0038435:Stress [Finding]
   827   C0175735:shear [Medical Device]
   827   C0205013:shear [Therapeutic or Preventive Procedure]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "could"

Phrase: "protect against apoptotic cell death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0162638:apoptotic cell death [Cell Function]
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1516044:Apoptotic [Qualitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.278: In addition, the increased activation of PPAR signaling renders cells more responsive to 15d-PGJ2. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the increased activation of PPAR signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1514758:Receptor Activation [Cell Function]
   742   C1879547:Activation [Activity]

Phrase: "renders"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "more responsive to 15d-PGJ2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205342:Responsive [Functional Concept]
Processing 00000000.tx.279: Knethen and Brune (36) have suggested that activation of the PPAR signaling induced by NO could switch monocyte/macrophage functions from a pro- to an anti-inflammatory phenotype (36). 

Phrase: "Knethen"

Phrase: "and"

Phrase: "Brune"

Phrase: "(36"

Phrase: ")"

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that activation of the PPAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1514758:Receptor Activation [Cell Function]
   744   C1879547:Activation [Activity]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "induced by NO"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C0030015:oxide [Inorganic Chemical]
   770   C0205263:Induced [Functional Concept]
   770   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "could"

Phrase: "switch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707719:Switch [Manufactured Object]

Phrase: "monocyte/macrophage functions from a pro-"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0024432:macrophage [Cell]
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "to an anti-inflammatory phenotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]
   734   C0003209:Anti-inflammatory [Pharmacologic Substance]
   734   C1515999:Anti-inflammatory [Qualitative Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.280: PPAR plays a key role in preventing a self-perpetuating autodestructive loop by down-regulating p47 phagocyte oxidase, a component of the NAD(P)H oxidase system, causing inhibition of superoxide radical formation, while activation of COX-2 is a standard response to lipopolysaccharide/interferon- (36). 

Phrase: "PPAR"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a key role in preventing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "a self-perpetuating autodestructive loop by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0419518:Loop [Medical Device]
   753   C0445022:Loop [Spatial Concept]

Phrase: "down-regulating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "p47 phagocyte oxidase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031307:Phagocyte [Cell]
   827   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a component of the NAD(P)H oxidase system,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "inhibition of superoxide radical formation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "while"

Phrase: "activation of COX-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "a standard response to lipopolysaccharide/interferon-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1819415:response to lipopolysaccharide [Organism Function]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.281: The role of COX-2 may vary depending on inflammatory conditions, which brings about expression of various proteins in the experimental system. 

Phrase: "The role of COX-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "may"

Phrase: "vary"

Phrase: "depending on inflammatory conditions,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0333348:Inflammatory [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C0725813:depend [Medical Device]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "which"

Phrase: "brings about expression of various proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1171362:expression protein [Genetic Function]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]

Phrase: "in the experimental system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.282: Here, we found that the cytoprotective effect of 15d-PGJ2 was attributable to up-regulation of intracellular antioxidant GSH synthesis. 

Phrase: "Here,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the cytoprotective effect of 15d-PGJ2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "attributable to up-regulation of intracellular antioxidant GSH synthesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   784   C1157723:regulation of synthesis [Molecular Function]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.283: GSH up-regulation seems to be caused by the characteristic reaction of cyclopentenone PGs with the signaling proteins. 

Phrase: "GSH up-regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "caused by the characteristic reaction of cyclopentenone PGs"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0033554:Prostaglandins [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   744   C0111605:cyclopentenone [Organic Chemical,Pharmacologic Substance]
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1521970:Characteristic [Qualitative Concept]
   711   C0015127:cause [Functional Concept]
   711 E C1266240:Prostaglandin [Laboratory Procedure]
   711   C1524003:Cause [Conceptual Entity]

Phrase: "with the signaling proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.284: The chemically reactive ,-unsaturated carbonyl group of the cyclopentenone PGs including 15d-PGJ2, as the Michael Reaction acceptor, might covalently modify cysteine residues on key cellular target proteins, resulting in loss or gain of their biological functions. 

Phrase: "The chemically reactive ,-unsaturated carbonyl group of the cyclopentenone PGs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0596259:carbonyl group [Inorganic Chemical]
   739   C0441833:Group [Idea or Concept]
   739   C0687744:group [Population Group]
   739   C1257890:Group [Population Group]
   739   C1552516:Group [Health Care Related Organization]
   739   C1705428:Group [Conceptual Entity]
   739   C1705429:Group [Population Group]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "15d-PGJ2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "as"

Phrase: "the Michael Reaction acceptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0000901:acceptor [Population Group]

Phrase: "might"

Phrase: "covalently"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "cysteine residues on key cellular target proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "resulting in loss"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332294:Resulting in [Functional Concept]
   790   C0678226:resulting [Functional Concept]
   790   C1517945:Loss [Quantitative Concept]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C2825142:Result [Finding]

Phrase: "or"

Phrase: "gain of their biological functions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.285: For example, 15d-PGJ2 directly inhibits NF-B-dependent gene expression through covalent modifications of critical thiol groups located in IB kinase and the DNA-binding domains of NF-B subunits (13, 16, 37). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "15d-PGJ2 directly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   812   C0442778:J2 [Finding]
   812   C1416167:J2 [Gene or Genome]
   812   C1421123:J2 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "NF-B-dependent gene expression through covalent modifications of critical thiol groups"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017262:Gene Expression [Genetic Function]
   736   C0017337:Gene [Gene or Genome]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "located in IB kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the DNA-binding domains of NF-B subunits"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1148673:DNA Binding [Genetic Function]
   767   C1511662:DNA Binding Domain [Amino Acid Sequence]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   711   C1880389:Domain [Functional Concept]
   711   C1883221:Domain [Conceptual Entity]
   711   C3541951:Domain [Intellectual Product]

Phrase: "(13,"

Phrase: "16,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.286: Direct inhibition of NF-B signaling by 15d-PGJ2 may contribute to negative regulation of inflammation. 

Phrase: "Direct inhibition of NF-B signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "by 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "may"

Phrase: "contribute to negative regulation of inflammation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0021368:Inflammation [Pathologic Function]
   753   C0205160:Negative [Qualitative Concept]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
   753   C1513916:Negative [Finding]
   753   C1880177:Contribute [Activity]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.287: Recently, the mechanism by which cyclopentenone PGs induce phase II detoxification enzymes, such as glutathione S-transferase (GST), UDP-glucuronosyl transferases, NAD(P)H:quinone oxidoreductase (18, 38), and stress proteins including heat shock proteins as well as GCL, have been actively investigated (3943). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the mechanism by which cyclopentenone PGs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "phase II detoxification enzymes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0014442:Enzymes [Enzyme,Organic Chemical]
   812   C0014445:enzymes [Functional Concept]
   756   C1563755:Phase II Detoxification [Organism Function]

Phrase: "such as glutathione S-transferase (GST),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "UDP-glucuronosyl transferases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1373183:Glucuronosyl transferases [Molecular Function]
   827   C0040676:Transferases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041986:UDP [Biologically Active Substance,Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "NAD(P)H:quinone oxidoreductase"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1136197:NAD(P)H:Quinone Oxidoreductase [Amino Acid, Peptide, or Protein,Enzyme]
           Quinone Oxidoreductase
   933   C0027298:NAD(P)H oxidoreductase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0027280:Quinone oxidoreductase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1413742:QUINONE OXIDOREDUCTASE [Gene or Genome]
   804   C0030016:Oxidoreductase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0034435:quinone [Organic Chemical]
   804   C0053241:Quinone [Organic Chemical]
   804   C1096793:Quinone [Organic Chemical,Pharmacologic Substance]
   804   C1537381:oxidoreductase [Gene or Genome]

Phrase: "(18,"

Phrase: "38"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "stress proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018850:Stress Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "heat shock proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018850:Heat shock proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0282498:Heat Shock [Physiologic Function]
   827   C0018837:Heat [Natural Phenomenon or Process]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0036974:Shock [Pathologic Function]

Phrase: "as well as"

Phrase: "GCL,"

Phrase: "have"

Phrase: "been"

Phrase: "actively"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "(3943"

Phrase: ")."
Processing 00000000.tx.288: The 5'-flanking regions of the genes encoding above enzymes harbor the so-called antioxidant responsive element (ARE). 

Phrase: "The 5'-flanking regions of the genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0230171:flanking [Body Location or Region]
   714   C0017446:Region [Geographic Area]
   714   C0205147:Region [Spatial Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "above enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "harbor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475311:Harbor [Manufactured Object]

Phrase: "the so-called antioxidant responsive element (ARE)."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0205342:Responsive [Functional Concept]
   804   C1705248:Element [Conceptual Entity]
   733 E C2371924:Responsivity [Mental Process]
Processing 00000000.tx.289: Many basic leucine zipper transcription factors including Nrf, Jun, Fos, Fra, and Maf bind to the ARE sequences, thereby inducing the expression of aforementioned antioxidant or detoxification enzymes. 

Phrase: "Many basic leucine zipper transcription factors"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0167220:Basic-Leucine Zipper Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1515557:Basic Leucine Zipper [Amino Acid Sequence]
   840   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0079686:Leucine Zipper [Amino Acid, Peptide, or Protein]
   804   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0040649:Transcription [Genetic Function]
   804   C0453984:Zipper [Manufactured Object]
   804   C1527178:Basic [Functional Concept]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]
   733 E C0920750:basicity [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Nrf,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538066:NRF [Gene or Genome]

Phrase: "Jun,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Fos,"

Phrase: "Fra,"

Phrase: "and"

Phrase: "Maf"

Phrase: "bind to the ARE sequences,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0003402:Antioxidant [Pharmacologic Substance]
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C0162326:Sequences [Nucleotide Sequence]
   748   C0205342:Responsive [Functional Concept]
   748   C1145667:Bind [Activity]
   748   C1167622:bind [Molecular Function]
   748   C1705248:Element [Conceptual Entity]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "thereby"

Phrase: "inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Inducing [Functional Concept]

Phrase: "the expression of aforementioned antioxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "detoxification enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.290: NF-E2-related factor-2 (Nrf2) is a representative transcription factor responsible for regulating expression of the stress proteins or phase II detoxification enzymes. 

Phrase: "NF-E2-related factor-2 (Nrf2)"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C0289507:NF-E2-Related Factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417701:NF-E2-related factor 2 [Gene or Genome]
   875   C1420639:E2-2 [Gene or Genome]
   840   C1417699:NF-E2 [Gene or Genome]
   840   C2985444:NF-E2 [Gene or Genome]
   804   C0439849:Related [Qualitative Concept]
   804   C0445223:Related [Finding]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3539520:E2 [Gene or Genome]
   771 E C0163712:Relate [Organic Chemical]
   733 E C0080103:Relation [Family Group]
   733 E C0869014:Relations [Social Behavior]

Phrase: "is"

Phrase: "a representative transcription factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "responsible for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1273518:Responsible [Finding]

Phrase: "regulating"

Phrase: "expression of the stress proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "phase II detoxification enzymes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0014442:Enzymes [Enzyme,Organic Chemical]
   812   C0014445:enzymes [Functional Concept]
   756   C1563755:Phase II Detoxification [Organism Function]
Processing 00000000.tx.291: By forming a complex with its inhibitory counterpart Keap1, Nrf2 functions as an intracellular sensor that recognizes redox signaling by detecting electrophiles or reactive oxygen species and is known to be activated through thiol modification in the cysteine residues of Keap1 (44, 45). 

Phrase: "By forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "a complex with its inhibitory counterpart Keap1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "Nrf2 functions as an intracellular sensor"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0542341:Functions [Functional Concept]
   706 E C0031843:function [Physiologic Function]
   706 E C0700205:FUNCTION [Classification]
   706 E C1705273:Function [Intellectual Product]

Phrase: "that"

Phrase: "recognizes"

Phrase: "redox signaling by detecting electrophiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037083:Signaling [Cell Function]
   760   C3537152:signaling [Biologic Function]

Phrase: "or"

Phrase: "reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "activated through thiol modification"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0038734:thiol [Organic Chemical]
   770   C0392747:Modification [Functional Concept]
   770   C1554963:modification [Qualitative Concept]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "in the cysteine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "of Keap1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1427969:KEAP1 [Gene or Genome]

Phrase: "(44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.292: Nrf2 activation mediated by 15d-PGJ2 has been reported to contribute to an anti-inflammatory process, which was negated in Nrf2-deficient mice (46). 

Phrase: "Nrf2 activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1879547:Activation [Activity]
   780   C0289507:NF-E2-Related Factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   780   C1417701:NF-E2-related factor 2 [Gene or Genome]

Phrase: "mediated by 15d-PGJ2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   760   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0442778:J2 [Finding]
   760   C1266240:Prostaglandin [Laboratory Procedure]
   760   C1416167:J2 [Gene or Genome]
   760   C1421123:J2 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to an anti-inflammatory process,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0003209:Anti-inflammatory [Pharmacologic Substance]
   790   C1515999:Anti-inflammatory [Qualitative Concept]
   753   C0333348:Inflammatory [Functional Concept]
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1522240:Process [Phenomenon or Process]
   753   C1880177:Contribute [Activity]

Phrase: "which"

Phrase: "was"

Phrase: "negated in Nrf2-deficient mice"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   849   C0289507:NF-E2-Related Factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C1417701:NF-E2-related factor 2 [Gene or Genome]
   764   C1417699:NF-E2 [Gene or Genome]
   764   C2985444:NF-E2 [Gene or Genome]
   762   C1420639:E2-2 [Gene or Genome]
   742   C0011155:Deficient [Functional Concept]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1518422:Negated [Functional Concept]
   742   C1521761:Factor [Functional Concept]
   742   C1636779:% deficient [Quantitative Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C3539520:E2 [Gene or Genome]
   708 E C0163712:Relate [Organic Chemical]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.293: It has been reported that electrophilic 15d-PGJ2 can oxidize the thiol groups retained in the Keap1 protein, thereby activating the Nrf2 signaling pathway and subsequently inducing GCL genes (47). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that electrophilic 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   812   C0442778:J2 [Finding]
   812   C1416167:J2 [Gene or Genome]
   812   C1421123:J2 [Gene or Genome]

Phrase: "can"

Phrase: "oxidize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:oxidize [Molecular Function]

Phrase: "the thiol groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "retained in the Keap1 protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0333118:Retained [Functional Concept]
   760   C1427969:KEAP1 [Gene or Genome]

Phrase: "thereby"

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the Nrf2 signaling pathway"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   818   C0037083:signaling pathway [Cell Function]
   818   C0086982:Signaling Pathway [Molecular Function]
   801 E C0037080:Signal Pathway [Molecular Function]
   795   C1704259:Pathway [Molecular Function]
   795   C1705987:Pathway [Conceptual Entity]
   747   C0289507:NF-E2-Related Factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C1417701:NF-E2-related factor 2 [Gene or Genome]

Phrase: "and"

Phrase: "subsequently"

Phrase: "inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Inducing [Functional Concept]

Phrase: "GCL genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.294: These results imply that redox modification of signaling protein by 15d-PGJ2 plays an important role in regulation of inflammation or induction of antioxidant proteins. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "imply"

Phrase: "that redox modification of signaling protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0033666:Protein Modification [Molecular Function]
   783   C2263112:protein modification [Molecular Function]
   753   C0392747:Modification [Functional Concept]
   753   C1554963:modification [Qualitative Concept]

Phrase: "by 15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in regulation of inflammation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "or"

Phrase: "induction of antioxidant proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.295: 15d-PGJ2 conjugates with GSH in the presence of GSTs, especially human GST 4A-4 (48). 

Phrase: "15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "conjugates with GSH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0301869:Conjugate [Immunologic Factor]
   790   C1260386:GSH [Disease or Syndrome]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of GSTs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0069227:GSTS [Carbohydrate]
  1000   C1865138:GSTS [Gene or Genome]

Phrase: "especially human GST 4A-4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   879   C1415335:GLUTATHIONE S-TRANSFERASE 4 [Gene or Genome]
   845   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   795   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0086418:Human [Human]
   795   C0450373:4a [Intellectual Product]
   795   C1553636:4a [Medical Device]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.296: This can be a mechanism for the inactivation and subsequent elimination of this highly reactive PG. 

Phrase: "This"

Phrase: "can"

Phrase: "be"

Phrase: "a mechanism for the inactivation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "subsequent elimination of this highly reactive PG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0221102:Elimination [Physiologic Function]
Processing 00000000.tx.297: Although efficiently eliminated by GSH under normal physiological conditions, in such circumstances in which GSH is depleted, 15d-PGJ2 can escape the GSH conjugation, and preferentially interact with the thiol groups of Keap1 and thereby stimulate Nrf2 activation, leading to induction of antioxidant defense enzymes and proteins. 

Phrase: "Although"

Phrase: "efficiently"

Phrase: "eliminated by GSH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0849355:Eliminated [Qualitative Concept]
   790   C1260386:GSH [Disease or Syndrome]

Phrase: "under normal physiological conditions,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   896   C0231162:Normal condition [Finding]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "in such circumstances"

Phrase: "in which GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: "is"

Phrase: "depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ","

Phrase: "15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "can"

Phrase: "escape"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870509:escape [Mental Process]
  1000   C1880554:ESCAPE [Event]

Phrase: "the GSH conjugation,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1160466:conjugation [Cell Function]
   789 E C0522529:Conjugated [Spatial Concept]

Phrase: "and"

Phrase: "preferentially"

Phrase: "interact with the thiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0038734:thiol [Organic Chemical]

Phrase: "groups of Keap1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0441833:Group [Idea or Concept]
   790   C0687744:group [Population Group]
   790   C1257890:Group [Population Group]
   790   C1427969:KEAP1 [Gene or Genome]
   790   C1552516:Group [Health Care Related Organization]
   790   C1552839:groups [Idea or Concept]
   790   C1705428:Group [Conceptual Entity]
   790   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "thereby"

Phrase: "stimulate"

Phrase: "Nrf2 activation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1879547:Activation [Activity]
   780   C0289507:NF-E2-Related Factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   780   C1417701:NF-E2-related factor 2 [Gene or Genome]

Phrase: "leading to induction of antioxidant defense enzymes"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   757   C0014431:Enzyme Induction [Genetic Function]
   748   C0003402:Antioxidant [Pharmacologic Substance]
   748   C0014442:Enzymes [Enzyme,Organic Chemical]
   748   C0014445:enzymes [Functional Concept]
   748   C0205263:Induction [Functional Concept]
   748   C0332152:Leading [Temporal Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
   748   C1522538:Leading [Functional Concept]
   748   C1880266:Defense [Conceptual Entity]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.298: This will culminate with extinction of detrimental cellular emergency caused by oxidative/nitrosative stress. 

Phrase: "This"

Phrase: "will"

Phrase: "culminate with extinction of detrimental cellular emergency"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0007634:Cellular [Cell]
   748   C0013956:Emergency [Phenomenon or Process]
   748   C0015347:extinction [Mental Process]
   748   C0175673:Emergency [Temporal Concept]
   748   C0178539:Cellular [Functional Concept]
   748   C2745965:Emergency [Pathologic Function]

Phrase: "caused by oxidative/nitrosative stress."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.299: 15d-PGJ2 is an endogenous ligand for PPAR. 

Phrase: "15d-PGJ2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "is"

Phrase: "an endogenous ligand for PPAR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1621296:receptor ligand [Molecular Function]
   744   C0023688:Ligand [Chemical]
Processing 00000000.tx.300: Although SIN-1 induced expression of PPAR and pharmacologic blockade of this receptor aggravated SIN-1-mediated cytotoxicity, we are unaware whether cytoprotective effects exerted by 15d-PGJ2 via up-regulation of GSH synthesis is PPAR-dependent or not because there is no PPAR responsive element in the GCL promoter. 

Phrase: "Although"

Phrase: "SIN-1 induced expression of PPAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0597360:receptor expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "pharmacologic blockade of this receptor aggravated SIN-1-mediated cytotoxicity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332206:Blockade [Functional Concept]
   739   C3540676:Blockade [Pharmacologic Substance]

Phrase: "we"

Phrase: "are"

Phrase: "unaware"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0150114:UNAWARE [Research Activity]
   928 E C0041657:unawareness [Finding]
   928 E C0589402:Unawareness [Finding]

Phrase: "whether"

Phrase: "cytoprotective effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "exerted by 15d-PGJ2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   760   C0015264:Exerted [Organism Function]
   760   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   760   C0442778:J2 [Finding]
   760   C1266240:Prostaglandin [Laboratory Procedure]
   760   C1416167:J2 [Gene or Genome]
   760   C1421123:J2 [Gene or Genome]

Phrase: "via up-regulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0041904:Up-Regulation [Cell Function,Molecular Function]
  1000   C0162493:Up-Regulation [Genetic Function]
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]
   861   C1327622:Regulation [Biologic Function]

Phrase: "of GSH synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "is"

Phrase: "PPAR-"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "because"

Phrase: "there"

Phrase: "is"

Phrase: "no PPAR responsive element in the GCL promoter."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0013879:Element [Element, Ion, or Isotope]
   738   C0205342:Responsive [Functional Concept]
   738   C1705248:Element [Conceptual Entity]
Processing 00000000.tx.301: In summary, peroxynitrite-induced COX-2 expression may contribute to the resolution of or adaptation to nitrosative cell death by producing 15d-PGJ2. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "peroxynitrite-induced COX-2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "contribute to the resolution of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1514893:Resolution [Idea or Concept]
   760   C1706463:Resolution [Quantitative Concept]
   760   C1880177:Contribute [Activity]
   760   C2699488:Resolution [Conceptual Entity]

Phrase: "or"

Phrase: "adaptation to nitrosative cell death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0000934:adaptation [Organism Function]
   760   C0392673:Adaptation [Biologic Function]

Phrase: "by producing 15d-PGJ2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   812   C0442778:J2 [Finding]
   812   C1416167:J2 [Gene or Genome]
   812   C1421123:J2 [Gene or Genome]
Processing 00000000.tx.302: Further work is in progress to elucidate the upstream events in the redox-regulated signaling network responsible for the 15d-PGJ2-induced cytoprotection against nitrosative cell death.  

Phrase: "Further work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "in progress to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1272688:In progress [Functional Concept]
           progress
   901   C1548387:in progress [Idea or Concept]
   827   C0150312:In [Quantitative Concept]
   827   C0332285:In [Spatial Concept]
   827   C1280477:Progress [Functional Concept]

Phrase: "elucidate"

Phrase: "the upstream events in the redox-regulated signaling network"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441471:Events [Event]
   742   C3541888:Events [Classification]

Phrase: "responsible for the 15d-PGJ2-induced cytoprotection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "against nitrosative cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.303: FOOTNOTES  * This work was supported by Grant R02-2004-000-10197-0 from the Basic Research Program of the Korea Science and Engineering Foundation (to Y.-J. S.), the National Institutes of Health Grant DK-45334 (to S. C. L.), and the Environmental Health Sciences Center support ES01247 (to I. R.). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Grant R02-2004-000-10197-0"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0018173:Grant [Quantitative Concept]
   744   C1521721:Supported [Conceptual Entity]
   744   C1548284:Grant [Idea or Concept]
   744   C1549875:R02 [Intellectual Product]
   711 E C0183683:Support [Medical Device]

Phrase: "from the Basic Research Program"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0683935:research program [Research Activity]
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]
   734   C0681833:Basic Research [Research Activity]

Phrase: "of the Korea Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Engineering Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "("

Phrase: "to Y.-J."

Phrase: "S."

Phrase: ")"

Phrase: ","

Phrase: "the National Institutes of Health Grant DK-45334"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   877   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   795   C0011318:DK [Geographic Area]
   795   C0018173:Grant [Quantitative Concept]
   795   C0018684:Health [Idea or Concept]
   795   C0021622:Institutes [Organization]
   795   C1548284:Grant [Idea or Concept]
   795   C3245503:national [Intellectual Product]
   762 E C1272753:Institute [Idea or Concept]

Phrase: "("

Phrase: "to S. C. L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0439394:s l [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Environmental Health Sciences"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0014413:Environmental Health Sciences [Biomedical Occupation or Discipline]
           Environmental Health
   913   C0013546:Environmental Sciences [Occupation or Discipline]
   901   C1512352:Health Sciences [Biomedical Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]

Phrase: "Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: "support ES01247"

Phrase: "("

Phrase: "to I. R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.304: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.305: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.306: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.307: Both authors contributed equally to this work. 

Phrase: "Both authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.308: ** To whom correspondence should be addressed: College of Pharmacy, Seoul National University, Shinlim-dong, Kwanak-ku, Seoul 151-742, South Korea. 

Phrase: "*"

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "College of Pharmacy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0036381:college pharmacy [Health Care Related Organization,Manufactured Object]
   790   C0557806:College [Manufactured Object]

Phrase: "Seoul National University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C3245503:national [Intellectual Product]

Phrase: "Shinlim-dong,"

Phrase: "Kwanak-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Seoul 151-742,"

Phrase: "South Korea."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0022773:South Korea [Geographic Area]
   861   C0022771:Korea [Geographic Area]
   789 E C1556095:Korean [Population Group]
Processing 00000000.tx.309: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.310: 82-2-880-7845; 

Phrase: "82-2-880-7845"

Phrase: ";"
Processing 00000000.tx.311: Fax: 82-2-874-9775; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "82-2-874-9775"

Phrase: ";"
Processing 00000000.tx.312: E-mail: surh{at}plaza.snu.ac.kr . 1 The abbreviations used are: COX-2, cyclooxygenase 2; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "surh{at}plaza.snu.ac.kr . 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0022773:KR [Geographic Area]
   795   C1412573:AC [Gene or Genome]
   795   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   795   C3539770:AC [Gene or Genome]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "COX-2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1565860:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cyclooxygenase 2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0387583:Cyclo-Oxygenase II [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367485:CYCLOOXYGENASE 2 [Gene or Genome]
  1000   C1565860:Cyclo-Oxygenase-2 [Amino Acid, Peptide, or Protein,Enzyme]
           Cyclooxygenase
   861   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.313: NSAID, non-steroidal anti-inflammatory drug; 

Phrase: "NSAID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003211:NSAID [Pharmacologic Substance]

Phrase: "non-steroidal anti-inflammatory drug"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
  1000   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
  1000   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   910   C0003212:steroidal anti-inflammatory drugs [Pharmacologic Substance,Steroid]
   884   C0003209:anti inflammatory drug [Pharmacologic Substance]
           Anti-inflammatory
   840   C1515999:Anti-inflammatory [Qualitative Concept]
   839   C0260264:steroid drug [Steroid]
   804   C0013227:Drug [Pharmacologic Substance]
   804   C0333348:Inflammatory [Functional Concept]
   804   C1254351:Drug [Pharmacologic Substance]
   804   C1518422:Non [Functional Concept]
   748 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   748 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   733   C0038317:Steroid [Steroid]
   711 E C0456386:Medicament [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.314: PG, prostaglandin; 

Phrase: "PG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1266240:PG [Laboratory Procedure]

Phrase: "prostaglandin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
  1000   C1266240:Prostaglandin [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.315: DMEM, Dulbecco's modified Eagle's medium; 

Phrase: "DMEM,"

Phrase: "Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.316: MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; 

Phrase: "MTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0647210:mtt [Lipid]

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(4,"

Phrase: "5-dimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyltetrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006222:Bromide [Inorganic Chemical]

Phrase: ";"
Processing 00000000.tx.317: DHR 123, dihydrorhodamine 123; 

Phrase: "DHR 123,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058109:dihydrorhodamine 123 [Organic Chemical]

Phrase: "dihydrorhodamine 123"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058109:dihydrorhodamine 123 [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.318: TMRE, tetramethylrhodamine ethyl ester; 

Phrase: "TMRE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   827   C0014898:Ester [Organic Chemical]

Phrase: "tetramethylrhodamine ethyl ester"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   827   C0014898:Ester [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.319: TUNEL, terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling; 

Phrase: "TUNEL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1167624:Labeling [Mental Process]
   799   C1947902:Labeling [Manufactured Object]
   799   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   918   C0872284:terminal deoxynucleotidyl transferase nick end labeling [Molecular Biology Research Technique]
   911   C0600528:terminal nick end labeling [Molecular Biology Research Technique]
   795   C1167624:Labeling [Mental Process]
   795   C1947902:Labeling [Manufactured Object]
   795   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: ";"
Processing 00000000.tx.320: JNK, Jun N-terminal kinase; 

Phrase: "JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "Jun N-terminal kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1367731:JUN N-terminal kinase [Gene or Genome]
   902   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C1334482:Jun kinase [Gene or Genome]
   902   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.321: BSO, buthionine-[S,R]-sulfoximine; 

Phrase: "BSO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0054252:BSO [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance,Pharmacologic Substance]

Phrase: "buthionine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0054251:buthionine [Amino Acid, Peptide, or Protein]

Phrase: "[S,R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]

Phrase: "]-sulfoximine"

Phrase: ";"
Processing 00000000.tx.322: PPAR, peroxisome proliferator-activated receptor-; 

Phrase: "PPAR,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "peroxisome proliferator-activated receptor-"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: ";"
Processing 00000000.tx.323: 15d-PGJ2, 15-deoxy-12,14-PGJ2; 

Phrase: "15d-PGJ2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0050218:prostaglandin J2 [Eicosanoid,Pharmacologic Substance]
   827   C0442778:J2 [Finding]
   827   C1416167:J2 [Gene or Genome]
   827   C1421123:J2 [Gene or Genome]

Phrase: "15-deoxy-12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "14-PGJ2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050218:PGJ2 [Eicosanoid,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.324: SIN-1, 3-morpholinosydnonimine hydrochloride; 

Phrase: "SIN-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]

Phrase: "3-morpholinosydnonimine hydrochloride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0951117:3-morpholinosydnonimine hydrochloride [Organic Chemical,Pharmacologic Substance]
   901   C0525082:3-morpholino-sydnonimine [Organic Chemical,Pharmacologic Substance]
   827   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.325: RNS, reactive nitrogen species; 

Phrase: "RNS,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0969698:Reactive Nitrogen Species [Biologically Active Substance,Chemical Viewed Structurally]
   827   C0028158:Nitrogen [Element, Ion, or Isotope]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1550581:nitrogen [Human-caused Phenomenon or Process]
   827   C1705920:Species [Conceptual Entity]

Phrase: "reactive nitrogen species"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0969698:Reactive Nitrogen Species [Biologically Active Substance,Chemical Viewed Structurally]
   827   C0028158:Nitrogen [Element, Ion, or Isotope]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1550581:nitrogen [Human-caused Phenomenon or Process]
   827   C1705920:Species [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.326: PARP, poly-(ADP-ribose)polymerase; 

Phrase: "PARP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1538577:PARP [Gene or Genome]
  1000   C1709384:PARP [Gene or Genome]

Phrase: "poly-(ADP-ribose)polymerase"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0032405:Poly ADP Ribose Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           poly ADP polymerase
  1000   C1538577:POLY(ADP-RIBOSE) POLYMERASE [Gene or Genome]
   923   C0032403:Poly ADP Ribose [Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001461:ADP Ribose [Biologically Active Substance,Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035549:Ribose [Carbohydrate]
   812   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0523452:ADP [Laboratory Procedure]
   812   C0747726:POLY [Conceptual Entity]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.327: GCLC, glutamylcysteine ligase catalytic; 

Phrase: "GCLC, glutamylcysteine ligase catalytic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0007382:Catalytic [Natural Phenomenon or Process]
   799   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.328: GCLM, glutamylcysteine ligase modulatory.  

Phrase: "GCLM, glutamylcysteine ligase modulatory."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.329: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Breitner, J. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Breitner,"

Phrase: "J."
Processing 00000000.tx.330: C. 

Phrase: "C."
Processing 00000000.tx.331: (1996) Neurobiol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.332: Aging 17, 789-794[CrossRef][Medline] [OrderarticleviaInfotrieve] McGeer, E. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "17,"

Phrase: "789-794"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] McGeer,"

Phrase: "E."
Processing 00000000.tx.333: G., and McGeer, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "McGeer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.334: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.335: (1998) Exp. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.336: Gerontol. 

Phrase: "Gerontol."
Processing 00000000.tx.337: 33, 371-378[CrossRef][Medline] [OrderarticleviaInfotrieve] Colangelo, V., Schurr, J., Ball, M. 

Phrase: "33,"

Phrase: "371-378"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Colangelo,"

Phrase: "V.,"

Phrase: "Schurr,"

Phrase: "J.,"

Phrase: "Ball,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706910:Ball [Manufactured Object]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.338: J., Pelaez, R. 

Phrase: "J.,"

Phrase: "Pelaez,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.339: P., Bazan, N. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bazan,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.340: G., and Lukiw, W. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Lukiw,"

Phrase: "W."
Processing 00000000.tx.341: J. 

Phrase: "J."
Processing 00000000.tx.342: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.343: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.344: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.345: 70, 462-473[CrossRef][Medline] [OrderarticleviaInfotrieve] Luth, H. 

Phrase: "70,"

Phrase: "462-473"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Luth,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.346: J., Munch, G., and Arendt, T. 

Phrase: "J.,"

Phrase: "Munch"

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Arendt,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.347: (2002) Brain Res. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.348: 953, 135-143[CrossRef][Medline] [OrderarticleviaInfotrieve] Heales, S. 

Phrase: "953,"

Phrase: "135-143"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Heales,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.349: J., Bolanos, J. 

Phrase: "J.,"

Phrase: "Bolanos,"

Phrase: "J."
Processing 00000000.tx.350: P., Stewart, V. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Stewart,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551641:Stewart [Population Group]

Phrase: "V."
Processing 00000000.tx.351: C., Brookes, P. 

Phrase: "C., Brookes,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.352: S., Land, J. 

Phrase: "S."

Phrase: ","

Phrase: "Land,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0557668:land [Manufactured Object]

Phrase: "J."
Processing 00000000.tx.353: M., and Clark, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Clark,"

Phrase: "J."
Processing 00000000.tx.354: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.355: (1999) Biochim. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.356: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.357: Acta 1410, 215-228[Medline] [OrderarticleviaInfotrieve] Brune, B., Gotz, C., Messmer, U. 

Phrase: "Acta 1410,"

Phrase: "215-228"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Brune,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gotz,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Messmer,"

Phrase: "U."
Processing 00000000.tx.358: K., Sandau, K., Hirvonen, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sandau,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hirvonen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.359: R., and Lapetina, E. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Lapetina,"

Phrase: "E."
Processing 00000000.tx.360: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.361: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.362: Biol. 

Phrase: "Biol."
Processing 00000000.tx.363: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.364: 272, 7253-7258[Abstract/Free FullText] Szabo, C., Day, B. 

Phrase: "272,"

Phrase: "7253-7258"

Phrase: "[Abstract/Free FullText"

Phrase: "] Szabo,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332173:/day [Temporal Concept]
  1000   C0439228:day [Temporal Concept]
  1000   C0439505:/day [Temporal Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.365: J., and Salzman, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Salzman,"

Phrase: "A."
Processing 00000000.tx.366: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.367: (1996) FEBS Lett. 

Phrase: "(1996"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.368: 381, 82-86[CrossRef][Medline] [OrderarticleviaInfotrieve] Beal, M. 

Phrase: "381,"

Phrase: "82-86"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Beal,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.369: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.370: (2002) Free Radic. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.371: Biol. 

Phrase: "Biol."
Processing 00000000.tx.372: Med. 

Phrase: "Med."
Processing 00000000.tx.373: 32, 797-803[CrossRef][Medline] [OrderarticleviaInfotrieve] Kitamura, Y., Shimohama, S., Koike, H., Kakimura, J., Matsuoka, Y., Nomura, Y., Gebicke-Haerter, P. 

Phrase: "32,"

Phrase: "797-803"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kitamura,"

Phrase: "Y.,"

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "Koike,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kakimura,"

Phrase: "J.,"

Phrase: "Matsuoka,"

Phrase: "Y.,"

Phrase: "Nomura,"

Phrase: "Y.,"

Phrase: "Gebicke-Haerter,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.374: J., and Taniguchi, T. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Taniguchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.375: (1999) Biochem. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.376: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.377: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.378: Commun. 

Phrase: "Commun."
Processing 00000000.tx.379: 254, 582-586[CrossRef][Medline] [OrderarticleviaInfotrieve] Nogawa, S., Zhang, F., Ross, M. 

Phrase: "254,"

Phrase: "582-586"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nogawa,"

Phrase: "S."

Phrase: ","

Phrase: "Zhang,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.380: E., and Iadecola, C. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Iadecola,"

Phrase: "C."
Processing 00000000.tx.381: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.382: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.383: 17, 2746-2755[Abstract/Free FullText] Stewart, W. 

Phrase: "17,"

Phrase: "2746-2755"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stewart,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551641:Stewart [Population Group]

Phrase: "W."
Processing 00000000.tx.384: F., Kawas, C., Corrada, M., and Metter, E. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kawas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521083:Kawas [Plant]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Corrada,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Metter,"

Phrase: "E."
Processing 00000000.tx.385: J. 

Phrase: "J."
Processing 00000000.tx.386: (1997) Neurology 48, 626-632[Abstract] Asanuma, M., Miyazaki, I., Tsuji, T., and Ogawa, N. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurology 48,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "626-632"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Asanuma,"

Phrase: "M."

Phrase: ","

Phrase: "Miyazaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0315755:Miyazaki [Bacterium]

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tsuji,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Ogawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.387: (2003) Nihon Shinkei Seishin Yakurigaku Zasshi 23, 111-119[Medline] [OrderarticleviaInfotrieve] Straus, D. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nihon Shinkei Seishin Yakurigaku Zasshi 23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0450348:23 [Quantitative Concept]

Phrase: "111-119"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Straus,"

Phrase: "D."
Processing 00000000.tx.388: S., and Glass, C. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Glass,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017596:Glass [Manufactured Object]
  1000   C1947936:Glass [Medical Device]
   928 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   928 E C0522500:Glassy [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.389: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.390: (2001) Med. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Med."
Processing 00000000.tx.391: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.392: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.393: 21, 185-210[CrossRef][Medline] [OrderarticleviaInfotrieve] Levonen, A. 

Phrase: "21,"

Phrase: "185-210"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Levonen,"

Phrase: "A."
Processing 00000000.tx.394: L., Dickinson, D. 

Phrase: "L., Dickinson,"

Phrase: "D."
Processing 00000000.tx.395: A., Moellering, D. 

Phrase: "A.,"

Phrase: "Moellering,"

Phrase: "D."
Processing 00000000.tx.396: R., Mulcahy, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mulcahy,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.397: T., Forman, H. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Forman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.398: J., and Darley-Usmar, V. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Darley-Usmar,"

Phrase: "V."
Processing 00000000.tx.399: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.400: (2001) Arterioscler. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Arterioscler."
Processing 00000000.tx.401: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.402: Vasc. 

Phrase: "Vasc."
Processing 00000000.tx.403: Biol. 

Phrase: "Biol."
Processing 00000000.tx.404: 21, 1846-1851[Abstract/Free FullText] Fukushima, M. 

Phrase: "21,"

Phrase: "1846-1851"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fukushima,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.405: (1990) Eicosanoids 3, 189-199[Medline] [OrderarticleviaInfotrieve] Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., and Santoro, M. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Eicosanoids 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013725:Eicosanoids [Eicosanoid]

Phrase: "189-199"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rossi,"

Phrase: "A.,"

Phrase: "Kapahi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Natoli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Y.,"

Phrase: "Karin,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Santoro,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.406: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.407: (2000) Nature 403, 103-108[CrossRef][Medline] [OrderarticleviaInfotrieve] Emi M., and Maeyama K. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 403,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "103-108"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Emi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880489:EMI [Phenomenon or Process]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Maeyama K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.408: (2004) Biochem. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.409: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.410: 67, 1259-1267[CrossRef][Medline] [OrderarticleviaInfotrieve] Na, H. 

Phrase: "67,"

Phrase: "1259-1267"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Na,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1272460:{NA} [Qualitative Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.411: K., and Surh, Y. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Surh,"

Phrase: "Y."
Processing 00000000.tx.412: J. 

Phrase: "J."
Processing 00000000.tx.413: (2003) Biochem. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.414: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.415: 66, 1381-1391[CrossRef][Medline] [OrderarticleviaInfotrieve] Jang, J. 

Phrase: "66,"

Phrase: "1381-1391"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jang,"

Phrase: "J."
Processing 00000000.tx.416: H., and Surh, Y. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Surh,"

Phrase: "Y."
Processing 00000000.tx.417: J. 

Phrase: "J."
Processing 00000000.tx.418: (2003) Free Radic Biol. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Free Radic Biol."
Processing 00000000.tx.419: Med. 

Phrase: "Med."
Processing 00000000.tx.420: 34, 1100-1110[CrossRef][Medline] [OrderarticleviaInfotrieve] Crow, J. 

Phrase: "34,"

Phrase: "1100-1110"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Crow,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0326391:Crow [Bird]
  1000   C1551958:Crow [Language]
  1000   C1555179:Crow [Population Group]

Phrase: "J."
Processing 00000000.tx.421: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.422: (1997) Nitric Oxide 1, 145-157[CrossRef][Medline] [OrderarticleviaInfotrieve] Takakura, K., Beckman, J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nitric Oxide 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "145-157"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Takakura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Beckman,"

Phrase: "J."
Processing 00000000.tx.423: S., MacMillan-Crow, L. 

Phrase: "S."

Phrase: ","

Phrase: "MacMillan-Crow,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0326391:Crow [Bird]
   861   C1551958:Crow [Language]
   861   C1555179:Crow [Population Group]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.424: A., and Crow, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Crow,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0326391:Crow [Bird]
  1000   C1551958:Crow [Language]
  1000   C1555179:Crow [Population Group]

Phrase: "J."
Processing 00000000.tx.425: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.426: (1999) Arch. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.427: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.428: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.429: 369, 197-207[CrossRef][Medline] [OrderarticleviaInfotrieve] Tian, L., Shi, M. 

Phrase: "369,"

Phrase: "197-207"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tian,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Shi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.430: M., and Forman, H. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Forman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.431: J. 

Phrase: "J."
Processing 00000000.tx.432: (1997) Arch. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.433: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.434: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.435: 342, 126-133[CrossRef][Medline] [OrderarticleviaInfotrieve] Yang, H., Wang, J., Huang, Z. 

Phrase: "342,"

Phrase: "126-133"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "J.,"

Phrase: "Huang,"

Phrase: "Z."
Processing 00000000.tx.436: Z., Ou, X., and Lu, S. 

Phrase: "Z.,"

Phrase: "Ou,"

Phrase: "X.,"

Phrase: "and"

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.437: C. 

Phrase: "C."
Processing 00000000.tx.438: (2001) Biochem. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.439: J. 

Phrase: "J."
Processing 00000000.tx.440: 357, 447-455[CrossRef][Medline] [OrderarticleviaInfotrieve] Seelig, G. 

Phrase: "357,"

Phrase: "447-455"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Seelig,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.441: F., and Meister, A. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Meister,"

Phrase: "A."
Processing 00000000.tx.442: (1984) J. 

Phrase: "(1984"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.443: Biol. 

Phrase: "Biol."
Processing 00000000.tx.444: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.445: 259, 3534-3538[Abstract/Free FullText] Kang, C. 

Phrase: "259,"

Phrase: "3534-3538"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kang,"

Phrase: "C."
Processing 00000000.tx.446: D., Jang, J. 

Phrase: "D."

Phrase: ","

Phrase: "Jang,"

Phrase: "J."
Processing 00000000.tx.447: H., Kim, K. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.448: W., Lee, H. 

Phrase: "W., Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.449: J., Jeong, C. 

Phrase: "J.,"

Phrase: "Jeong,"

Phrase: "C."
Processing 00000000.tx.450: S., Kim, C. 

Phrase: "S."

Phrase: ","

Phrase: "Kim,"

Phrase: "C."
Processing 00000000.tx.451: M., Kim, S. 

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.452: H., and Chung, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Chung,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.453: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.454: (1998) Neurosci. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.455: Lett. 

Phrase: "Lett."
Processing 00000000.tx.456: 256, 37-40[CrossRef][Medline] [OrderarticleviaInfotrieve] Boyd, C. 

Phrase: "256,"

Phrase: "37-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Boyd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347048:Boyd [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.457: S., and Cadenas, E. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Cadenas,"

Phrase: "E."
Processing 00000000.tx.458: (2002) Biol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Biol."
Processing 00000000.tx.459: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.460: 383, 411-423[Medline] [OrderarticleviaInfotrieve] Brown, G. 

Phrase: "383,"

Phrase: "411-423"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.461: C., and Borutaite, V. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Borutaite,"

Phrase: "V."
Processing 00000000.tx.462: (1999) Biochem. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.463: Soc. 

Phrase: "Soc."
Processing 00000000.tx.464: Symp. 

Phrase: "Symp."
Processing 00000000.tx.465: 66, 17-25[Medline] [OrderarticleviaInfotrieve] Leist, M., Single, B., Naumann, H., Fava, E., Simon, B., Kuhnle, S., and Nicotera, P. 

Phrase: "66,"

Phrase: "17-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450333:17/25 [Quantitative Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Leist,"

Phrase: "M."

Phrase: ","

Phrase: "Single,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037179:Single [Population Group]
  1000   C0087136:single [Finding]
  1000   C0205171:Single [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Naumann,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fava,"

Phrase: "E.,"

Phrase: "Simon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:Simon [Intellectual Product]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kuhnle,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Nicotera,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.466: (1999) Exp. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.467: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.468: 249, 396-403[CrossRef][Medline] [OrderarticleviaInfotrieve] Landino, L. 

Phrase: "249,"

Phrase: "396-403"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Landino,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.469: M., Crews, B. 

Phrase: "M."

Phrase: ","

Phrase: "Crews,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.470: C., Timmons, M. 

Phrase: "C., Timmons,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.471: D., Morrow, J. 

Phrase: "D."

Phrase: ","

Phrase: "Morrow,"

Phrase: "J."
Processing 00000000.tx.472: D., and Marnett, L. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Marnett,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.473: J. 

Phrase: "J."
Processing 00000000.tx.474: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.475: Natl. 

Phrase: "Natl."
Processing 00000000.tx.476: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.477: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.478: U. 

Phrase: "U."
Processing 00000000.tx.479: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.480: A. 

Phrase: "A."
Processing 00000000.tx.481: 93, 15069-15074[Abstract/Free FullText] Baker, C. 

Phrase: "93,"

Phrase: "15069-15074"

Phrase: "[Abstract/Free FullText"

Phrase: "] Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.482: S., Hall, R. 

Phrase: "S."

Phrase: ","

Phrase: "Hall,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.483: J., Evans, T. 

Phrase: "J.,"

Phrase: "Evans,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.484: J., Pomerance, A., Maclouf, J., Creminon, C., Yacoub, M. 

Phrase: "J.,"

Phrase: "Pomerance,"

Phrase: "A.,"

Phrase: "Maclouf,"

Phrase: "J.,"

Phrase: "Creminon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Yacoub,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.485: H., and Polak, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Polak,"

Phrase: "J."
Processing 00000000.tx.486: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.487: (1999) Arterioscler. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Arterioscler."
Processing 00000000.tx.488: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.489: Vasc. 

Phrase: "Vasc."
Processing 00000000.tx.490: Biol. 

Phrase: "Biol."
Processing 00000000.tx.491: 19, 646-655[Abstract/Free FullText] Rahman, I., and MacNee, W. 

Phrase: "19,"

Phrase: "646-655"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rahman,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "MacNee,"

Phrase: "W."
Processing 00000000.tx.492: (1999) Am. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.493: J. 

Phrase: "J."
Processing 00000000.tx.494: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.495: 277, L1067-1088[Medline] [OrderarticleviaInfotrieve] Colville-Nash, P. 

Phrase: "277,"

Phrase: "L1067-1088"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Colville-Nash,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.496: R., and Gilroy, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Gilroy,"

Phrase: "D."
Processing 00000000.tx.497: W. 

Phrase: "W."
Processing 00000000.tx.498: (2000) Prostaglandins Other Lipid Mediat. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Prostaglandins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0033554:Prostaglandins [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   966 E C1266240:Prostaglandin [Laboratory Procedure]

Phrase: "Other Lipid Mediat."
Processing 00000000.tx.499: 62, 33-43[CrossRef][Medline] [OrderarticleviaInfotrieve] Reuter, B. 

Phrase: "62,"

Phrase: "33-43"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Reuter,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.500: K., Asfaha, S., Buret, A., Sharkey, K. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Asfaha,"

Phrase: "S."

Phrase: ","

Phrase: "Buret,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0179462:buret [Medical Device]

Phrase: "A.,"

Phrase: "Sharkey,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.501: A., and Wallace, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.502: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.503: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.504: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.505: Investig. 

Phrase: "Investig."
Processing 00000000.tx.506: 98, 2076-2085[Abstract/Free FullText] Mizuno, H., Sakamoto, C., Matsuda, K., Wada, K., Uchida, T., Noguchi, H., Akamatsu, T., and Kasuga, M. 

Phrase: "98,"

Phrase: "2076-2085"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mizuno,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sakamoto,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Matsuda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wada,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Uchida,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Noguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Akamatsu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kasuga,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.507: (1997) Gastroenterology 112, 387-397[Medline] [OrderarticleviaInfotrieve] Taba, Y., Miyagi, M., Miwa, Y., Inoue, H., Takahashi-Yanaga, F., Morimoto, S., and Sasaguri, T. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Gastroenterology 112,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017163:Gastroenterology [Biomedical Occupation or Discipline]

Phrase: "387-397"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Taba,"

Phrase: "Y.,"

Phrase: "Miyagi,"

Phrase: "M."

Phrase: ","

Phrase: "Miwa,"

Phrase: "Y.,"

Phrase: "Inoue,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takahashi-Yanaga,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Morimoto,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Sasaguri,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.508: (2003) Am. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.509: J. 

Phrase: "J."
Processing 00000000.tx.510: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.511: Heart Circ. 

Phrase: "Heart Circ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332520:Circ [Quantitative Concept]
   861   C2347774:circ [Quantitative Concept]
Processing 00000000.tx.512: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.513: 285, H38-46[Abstract/Free FullText] Von Knethen, A. 

Phrase: "285,"

Phrase: "H38-46"

Phrase: "[Abstract/Free FullText"

Phrase: "] Von Knethen,"

Phrase: "A."
Processing 00000000.tx.514: A., and Brune, B. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Brune,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.515: (2001) FASEB J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.516: 15, 535-544[Abstract/Free FullText] Perez-Sala, D., Cernuda-Morollon, E., Pineda-Molina, E., and Canada, F. 

Phrase: "15,"

Phrase: "535-544"

Phrase: "[Abstract/Free FullText"

Phrase: "] Perez-Sala,"

Phrase: "D."

Phrase: ","

Phrase: "Cernuda-Morollon,"

Phrase: "E.,"

Phrase: "Pineda-Molina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1915092:Molina [Eukaryote]

Phrase: "E.,"

Phrase: "and"

Phrase: "Canada,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.517: J. 

Phrase: "J."
Processing 00000000.tx.518: (2002) Ann. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.519: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.520: Y. 

Phrase: "Y."
Processing 00000000.tx.521: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.522: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.523: 973, 533-536[Abstract/Free FullText] Uchida, K. 

Phrase: "973,"

Phrase: "533-536"

Phrase: "[Abstract/Free FullText"

Phrase: "] Uchida,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.524: (2000) Mech. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Mech."
Processing 00000000.tx.525: Ageing Dev. 

Phrase: "Ageing Dev."
Processing 00000000.tx.526: 116, 135-140[CrossRef][Medline] [OrderarticleviaInfotrieve] Kondo, M., Shibata, T., Kumagai, T., Osawa, T., Shibata, N., Kobayashi, M., Sasaki, S., Iwata, M., Noguchi, N., and Uchida, K. 

Phrase: "116,"

Phrase: "135-140"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kondo,"

Phrase: "M."

Phrase: ","

Phrase: "Shibata,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kumagai,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Osawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shibata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kobayashi,"

Phrase: "M."

Phrase: ","

Phrase: "Sasaki,"

Phrase: "S."

Phrase: ","

Phrase: "Iwata,"

Phrase: "M."

Phrase: ","

Phrase: "Noguchi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Uchida,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.527: (2002) Proc. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.528: Natl. 

Phrase: "Natl."
Processing 00000000.tx.529: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.530: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.531: U. 

Phrase: "U."
Processing 00000000.tx.532: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.533: A. 

Phrase: "A."
Processing 00000000.tx.534: 99, 7367-7372[Abstract/Free FullText] Kitamura, Y., Kakimura, J., Matsuoka, Y., Nomura, Y., Gebicke-Haerter, P. 

Phrase: "99,"

Phrase: "7367-7372"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kitamura,"

Phrase: "Y.,"

Phrase: "Kakimura,"

Phrase: "J.,"

Phrase: "Matsuoka,"

Phrase: "Y.,"

Phrase: "Nomura,"

Phrase: "Y.,"

Phrase: "Gebicke-Haerter,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.535: J., and Taniguchi, T. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Taniguchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.536: (1999) Neurosci. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.537: Lett. 

Phrase: "Lett."
Processing 00000000.tx.538: 262, 129-132[CrossRef][Medline] [OrderarticleviaInfotrieve] Colville-Nash, P. 

Phrase: "262,"

Phrase: "129-132"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Colville-Nash,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.539: R., Qureshi, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Qureshi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.540: S., Willis, D., and Willoughby, D. 

Phrase: "S."

Phrase: ","

Phrase: "Willis,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Willoughby,"

Phrase: "D."
Processing 00000000.tx.541: A. 

Phrase: "A."
Processing 00000000.tx.542: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.543: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.544: 161, 978-984[Abstract/Free FullText] Santoro, M. 

Phrase: "161,"

Phrase: "978-984"

Phrase: "[Abstract/Free FullText"

Phrase: "] Santoro,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.545: G., Garaci, E., and Amici, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Garaci,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Amici,"

Phrase: "C."
Processing 00000000.tx.546: (1989) Proc. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.547: Natl. 

Phrase: "Natl."
Processing 00000000.tx.548: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.549: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.550: U. 

Phrase: "U."
Processing 00000000.tx.551: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.552: A. 

Phrase: "A."
Processing 00000000.tx.553: 86, 8407-8411[Abstract] Amici, C., Sistonen, L., Santoro, M. 

Phrase: "86,"

Phrase: "8407-8411"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Amici,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Sistonen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Santoro,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.554: G., and Morimoto, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Morimoto,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.555: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.556: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.557: Natl. 

Phrase: "Natl."
Processing 00000000.tx.558: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.559: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.560: U. 

Phrase: "U."
Processing 00000000.tx.561: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.562: A. 

Phrase: "A."
Processing 00000000.tx.563: 89, 6227-6231[Abstract] Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. 

Phrase: "89,"

Phrase: "6227-6231"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Itoh,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wakabayashi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Katoh,"

Phrase: "Y.,"

Phrase: "Ishii,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Igarashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Engel,"

Phrase: "J."
Processing 00000000.tx.564: D., and Yamamoto, M. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.565: (1999) Genes Dev. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.566: 13, 76-86[Abstract/Free FullText] Surh, Y. 

Phrase: "13,"

Phrase: "76-86"

Phrase: "[Abstract/Free FullText"

Phrase: "] Surh,"

Phrase: "Y."
Processing 00000000.tx.567: J. 

Phrase: "J."
Processing 00000000.tx.568: (2003) Nat. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.569: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.570: Cancer 3, 768-780[CrossRef][Medline] [OrderarticleviaInfotrieve] Itoh, K., Mochizuki, M., Ishii, Y., Ishii, T., Shibata, T., Kawamoto, Y., Kelly, V., Sekizawa, K., Uchida, K., and Yamamoto, M. 

Phrase: "Cancer 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "768-780"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Itoh,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mochizuki,"

Phrase: "M."

Phrase: ","

Phrase: "Ishii,"

Phrase: "Y.,"

Phrase: "Ishii,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shibata,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kawamoto,"

Phrase: "Y.,"

Phrase: "Kelly,"

Phrase: "V.,"

Phrase: "Sekizawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Uchida,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.571: (2004) Mol. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.572: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.573: Biol. 

Phrase: "Biol."
Processing 00000000.tx.574: 24, 36-45[Abstract/Free FullText] Levonen, A. 

Phrase: "24,"

Phrase: "36-45"

Phrase: "[Abstract/Free FullText"

Phrase: "] Levonen,"

Phrase: "A."
Processing 00000000.tx.575: L., Landar, A., Ramachandran, A., Ceaser, E. 

Phrase: "L., Landar,"

Phrase: "A.,"

Phrase: "Ramachandran,"

Phrase: "A.,"

Phrase: "Ceaser,"

Phrase: "E."
Processing 00000000.tx.576: K., Dickinson, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dickinson,"

Phrase: "D."
Processing 00000000.tx.577: A., Zanoni, G., Morrow, J. 

Phrase: "A.,"

Phrase: "Zanoni,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443070:Zanoni [Intellectual Product]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Morrow,"

Phrase: "J."
Processing 00000000.tx.578: D., and Darley-Usmar, V. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Darley-Usmar,"

Phrase: "V."
Processing 00000000.tx.579: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.580: (2004) Biochem. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.581: J. 

Phrase: "J."
Processing 00000000.tx.582: 378, 373-382[CrossRef][Medline] [OrderarticleviaInfotrieve] Hubatsch, I., Mannervik, B., Gao, L., Roberts, L. 

Phrase: "378,"

Phrase: "373-382"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hubatsch,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Mannervik,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gao,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.583: J., Chen, Y., and Morrow, J. 

Phrase: "J.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Y.,"

Phrase: "and"

Phrase: "Morrow,"

Phrase: "J."
Processing 00000000.tx.584: D. 

Phrase: "D."
Processing 00000000.tx.585: (2002) Chem. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.586: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.587: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.588: 15, 1114-1118[CrossRef][Medline] [OrderarticleviaInfotrieve]

Phrase: "15,"

Phrase: "1114-1118"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

